| Year |
Citation |
Score |
| 2024 |
Konuma T, Miyao K, Nakasone H, Ouchi F, Fukuda T, Tanaka M, Ozawa Y, Ota S, Kawakita T, Uchida N, Sawa M, Katayama Y, Hiramoto N, Eto T, Ichinohe T, et al. Allogeneic transplantation of bone marrow versus peripheral blood stem cells from HLA-identical sibling donors for hematological malignancies in 6064 adults from 2003 to 2020: different impacts on survival according to time period. Cytotherapy. PMID 38639671 DOI: 10.1016/j.jcyt.2024.03.489 |
0.409 |
|
| 2024 |
Yamaguchi K, Yamamoto H, Izutsu K, Yuasa M, Kaji D, Nishida A, Ishiwata K, Takagi S, Yamamoto G, Asano-Mori Y, Uchida N, Taniguchi S. Fatal outcome of BK virus encephalitis in an allogeneic stem cell transplantation recipient. Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy. PMID 38514025 DOI: 10.1016/j.jiac.2024.03.012 |
0.351 |
|
| 2024 |
Konuma T, Uchida N, Takeda W, Doki N, Yoshihara S, Nishida T, Kuriyama T, Tanaka M, Ohigashi H, Nakamae H, Katayama Y, Ota S, Hashii Y, Ishimaru F, Fukuda T, et al. RhD mismatch does not affect haematopoietic recovery, graft-versus-host disease and survival in allogeneic haematopoietic cell transplantation: A Japanese registry-based study. Vox Sanguinis. PMID 38425018 DOI: 10.1111/vox.13610 |
0.407 |
|
| 2024 |
Jo T, Ueda T, Akahoshi Y, Kondo T, Uchida N, Tanaka M, Nakamae H, Doki N, Ota S, Sawa M, Ohigashi H, Maruyama Y, Takayama N, Nishida T, Hiramoto N, et al. First complete remission favours haploidentical haematopoietic stem cell transplantation with post-transplant cyclophosphamide over cord blood transplantation in acute lymphoblastic leukaemia. British Journal of Haematology. PMID 38420726 DOI: 10.1111/bjh.19372 |
0.463 |
|
| 2024 |
Tsumita K, Takagi S, Asano-Mori Y, Watanabe O, Shindo M, Yamaguchi K, Yuasa M, Kageyama K, Kaji D, Taya Y, Nishida A, Ishiwata K, Yamamoto H, Araoka H, Yamamoto G, ... ... Uchida N, et al. Long-term lymphocyte subset number reconstitution is unique but comparable between umbilical cord blood and unrelated bone marrow transplantation. International Journal of Hematology. PMID 38407785 DOI: 10.1007/s12185-024-03727-x |
0.358 |
|
| 2024 |
Sakatoku K, Murata M, Shimazu Y, Uchida N, Yoshihara S, Uehara Y, Takahashi S, Kobayashi H, Tanaka H, Nakano N, Ishimaru F, Ichinohe T, Atsuta Y, Nagamura-Inoue T, Nakamae H. Comparison of haploidentical transplantation and single cord blood transplantation for myelofibrosis. Bone Marrow Transplantation. PMID 38378917 DOI: 10.1038/s41409-024-02244-z |
0.37 |
|
| 2024 |
Nakaya Y, Nakamae H, Nishikubo M, Kondo E, Fukuda T, Hiramoto N, Mori Y, Nagafuji K, Eto T, Onishi Y, Uchida N, Ishikawa J, Matsuoka KI, Yui S, Takase K, et al. Peripheral blood stem cell transplantation using HLA-haploidentical donor with post-transplant cyclophosphamide versus HLA-matched sibling donor for lymphoma. Bone Marrow Transplantation. PMID 38355911 DOI: 10.1038/s41409-024-02229-y |
0.436 |
|
| 2024 |
Yamamoto R, Hiramoto N, Fujimoto A, Yamazaki H, Mori T, Uchida N, Doki N, Kato J, Nishikubo M, Kako S, Nishida T, Ota S, Onizuka M, Eto T, Onodera K, et al. Impact of antithymocyte globulin usage and risk stratification for posttransplant lymphoproliferative disorders in aplastic anemia patients after allogeneic hematopoietic cell transplantation. Bone Marrow Transplantation. PMID 38341498 DOI: 10.1038/s41409-024-02234-1 |
0.354 |
|
| 2024 |
Kuwatsuka Y, Kasajima R, Yamaguchi R, Uchida N, Konuma T, Tanaka M, Shingai N, Miyakoshi S, Kozai Y, Uehara Y, Eto T, Toyosaki M, Nishida T, Ishimaru F, Kato K, et al. Machine Learning Prediction Model for Neutrophil Recovery after Unrelated Cord Blood Transplantation. Transplantation and Cellular Therapy. PMID 38336299 DOI: 10.1016/j.jtct.2024.02.001 |
0.306 |
|
| 2024 |
Kurosawa S, Shimomura Y, Ishiyama K, Fuse K, Shimazu Y, Doki N, Uchida N, Tanaka M, Takahashi S, Sakurai M, Kobayashi H, Katayama Y, Takada S, Ozeki K, Nakamae H, et al. Updated comparable efficacy of cord blood transplantation for chronic myelomonocytic leukaemia: a nationwide study. Bone Marrow Transplantation. PMID 38331981 DOI: 10.1038/s41409-024-02223-4 |
0.437 |
|
| 2024 |
Kurosawa S, Shimomura Y, Itonaga H, Katayama Y, Onizuka M, Tanaka M, Kobayashi H, Ozawa Y, Sawa M, Kanda J, Doki N, Fujisawa S, Uchida N, Fukuda T, Atsuta Y, et al. Comparison of Melphalan Dose in Patients with Myelodysplastic Syndrome Undergoing Allogeneic Transplantation with Reduced-Intensity Conditioning. Transplantation and Cellular Therapy. PMID 38331193 DOI: 10.1016/j.jtct.2024.01.083 |
0.35 |
|
| 2024 |
Kurita N, Imahashi N, Chiba S, Tanaka M, Kobayashi H, Uchida N, Kuriyama T, Anzai N, Nawa Y, Nakano N, Ara T, Onizuka M, Katsuoka Y, Koi S, Kimura T, et al. Comparison of fludarabine-based conditioning regimens in adult cord blood transplantation for myeloid malignancy: A retrospective, registry-based study. American Journal of Hematology. PMID 38165068 DOI: 10.1002/ajh.27172 |
0.353 |
|
| 2024 |
Okada Y, Usui Y, Hayashi H, Nishikubo M, Toubai T, Uchida N, Tanaka M, Onizuka M, Takahashi S, Doki N, Uehara Y, Maruyama Y, Ishiwata K, Kawakita T, Sawa M, et al. Development of an umbilical cord blood transplantation-specific non-relapse mortality risk assessment score. Blood Advances. PMID 38163321 DOI: 10.1182/bloodadvances.2023011837 |
0.367 |
|
| 2023 |
Yanada M, Yamasaki S, Kondo T, Kawata T, Harada K, Uchida N, Doki N, Yoshihara S, Katayama Y, Eto T, Tanaka M, Takada S, Kawakita T, Nishida T, Ota S, et al. Allogeneic hematopoietic cell transplantation for patients with acute myeloid leukemia not in remission. Leukemia. PMID 38129514 DOI: 10.1038/s41375-023-02119-0 |
0.418 |
|
| 2023 |
Hayashi H, Iwasaki M, Nakasone H, Tanoshima R, Shimabukuro M, Takeda W, Nishida T, Kako S, Fujiwara SI, Katayama Y, Sawa M, Serizawa K, Matsuoka KI, Uchida N, Ikeda T, et al. Impact of stem cell selection between bone marrow and peripheral blood stem cells for unrelated hematopoietic stem cell transplantation for hematologic malignancies: on behalf of the Donor/Source Working Group of the Japanese Society for Transplantation and Cellular Therapy. Cytotherapy. PMID 38108686 DOI: 10.1016/j.jcyt.2023.11.012 |
0.367 |
|
| 2023 |
Watanabe M, Kanda J, Volt F, Ruggeri A, Suzuki R, Rafii-Elayoubi H, Kimura F, Cappelli B, Kondo E, Scigliuolo GM, Takahashi S, Kenzey C, Rivera Franco MM, Okamoto S, Rocha V, ... ... Uchida N, et al. Cord blood transplantation for adult lymphoid neoplasms in Europe and Japan. Blood Advances. PMID 38100431 DOI: 10.1182/bloodadvances.2023010598 |
0.402 |
|
| 2023 |
Konuma T, Yamasaki S, Ishiyama K, Mizuno S, Hayashi H, Uchida N, Shimabukuro M, Tanaka M, Kuriyama T, Onizuka M, Ishiwata K, Sawa M, Tanaka T, Ohigashi H, Fujiwara SI, et al. Comparison of Allogeneic Transplant Outcomes Between Matched Sibling Donors and Alternative Donors in Patients Over 50 Years of Age with Acute Myeloid Leukemia: 8/8 Allele-Matched Unrelated Donors and Unrelated Cord Blood Provide Better Leukemia-Free Survival Compared with Matched Sibling Donors During Nonremission Status. Transplantation and Cellular Therapy. PMID 38081415 DOI: 10.1016/j.jtct.2023.12.002 |
0.419 |
|
| 2023 |
Takenaka K, Fuji S, Matsukawa T, Uchida N, Kobayashi T, Tanaka M, Ara T, Ikegame K, Ozawa Y, Kanda Y, Sawa M, Maruyama Y, Fukuda T, Nakamae H, Kimura T, et al. Outcomes of allogeneic hematopoietic cell transplantation under letermovir prophylaxis for cytomegalovirus infection. Annals of Hematology. PMID 37947825 DOI: 10.1007/s00277-023-05474-1 |
0.305 |
|
| 2023 |
Koresawa-Shimizu R, Suzuki R, Uehara Y, Hiramoto N, Sawa M, Fukuda T, Kataoka K, Kanda Y, Oyake T, Kubota Y, Uchida N, Yano S, Kobayashi H, Tanaka J, Atsuta Y, et al. Comparison of MEAM, MCEC and LEED high-dose chemotherapy followed by autologous stem cell transplantation in relapsed/refractory diffuse large B-cell lymphoma: data from the Japan Society for Hematopoietic and Cellular Therapy Registry. Bone Marrow Transplantation. PMID 37805626 DOI: 10.1038/s41409-023-02118-w |
0.308 |
|
| 2023 |
Ohbiki M, Ito Y, Inamoto Y, Miyamura K, Uchida N, Fukuda T, Fujiwara H, Nishida T, Hayashi M, Tanaka M, Kawakita T, Ikegame K, Katayama Y, Ara T, Ichinohe T, et al. Improved long-term net survival after allogeneic hematopoietic cell transplantation in patients with hematologic malignancies over two decades. Transplantation and Cellular Therapy. PMID 37739224 DOI: 10.1016/j.jtct.2023.09.010 |
0.39 |
|
| 2023 |
Onishi Y, Mori T, Yamazaki H, Hiramoto N, Zaimoku Y, Kanaya M, Matsue K, Onizuka M, Aotsuka N, Uchida N, Onodera K, Kanda J, Nakamae H, Yamamoto R, Kuriyama T, et al. Comparison of Haploidentical Stem Cell Transplantation with Post-Transplantation Cyclophosphamide versus Umbilical Cord Blood Transplantation in Adult Patients with Aplastic Anemia. Transplantation and Cellular Therapy. PMID 37730121 DOI: 10.1016/j.jtct.2023.09.009 |
0.425 |
|
| 2023 |
Watanabe M, Kanda J, Fukuda T, Uchida N, Ikegame K, Kataoka K, Kobayashi H, Ara T, Ishikawa J, Matsuoka KI, Sugio Y, Nakazawa H, Ikeda T, Atsuta Y, Kondo E, et al. Impact of GVHD on lymphoma progression: Nationwide study from Japanese Society for Transplantation and Cellular Therapy. British Journal of Haematology. PMID 37614023 DOI: 10.1111/bjh.19041 |
0.365 |
|
| 2023 |
Konuma T, Itonaga H, Shimomura Y, Fujioka M, Aoki K, Uchida N, Onizuka M, Jinguji A, Tanaka M, Ueda Y, Katayama Y, Sawa M, Tanaka H, Nakamae H, Kawakita T, et al. Single-unit unrelated cord blood transplantation versus HLA-matched sibling transplantation in adults with advanced myelodysplastic syndrome: A registry-based study from the adult MDS working group of the Japanese society for transplantation and cellular therapy. Hematological Oncology. PMID 37592904 DOI: 10.1002/hon.3217 |
0.398 |
|
| 2023 |
Fuji S, Hakoda A, Kanda J, Fukuda T, Doki N, Katayama Y, Uchida N, Ozawa Y, Kanda Y, Tanaka M, Kataoka K, Ara T, Sawa M, Onizuka M, Onishi Y, et al. Impact of HLA disparity on overall mortality risk in patients with extensive chronic GVHD: The HLA Working Group of Japanese Society for Transplantation and Cellular Therapy. Bone Marrow Transplantation. PMID 37550450 DOI: 10.1038/s41409-023-02076-3 |
0.317 |
|
| 2023 |
Morishima Y, Watanabe-Okochi N, Kai S, Azuma F, Kimura T, Matsumoto K, Hatasa S, Araki N, Miyamoto A, Sekimoto T, Minemoto M, Ishii H, Uchida N, Takahashi S, Tanaka M, et al. Selection of Cord Blood Unit by CD34 Cell and GM-CFU Numbers and Allele-Level HLA Matching in Single Cord Blood Transplantation. Transplantation and Cellular Therapy. PMID 37536453 DOI: 10.1016/j.jtct.2023.07.022 |
0.339 |
|
| 2023 |
Murao M, Kato R, Kusano S, Hisamatsu R, Endo H, Kawabata Y, Kimura S, Sato A, Mori H, Itami K, Torii KU, Hagihara S, Uchida N. A Small Compound, HYGIC, Promotes Hypocotyl Growth Through Ectopic Ethylene Response. Plant & Cell Physiology. PMID 37498972 DOI: 10.1093/pcp/pcad083 |
0.537 |
|
| 2023 |
Hirabayashi S, Kondo T, Nishiwaki S, Mizuta S, Doki N, Fukuda T, Uchida N, Ozawa Y, Kanda Y, Imanaka R, Takahashi S, Ishikawa J, Yano S, Nakamae H, Eto T, et al. Impact of MRD on clinical outcomes of unrelated hematopoietic stem cell transplantation in patients with Ph ALL: A retrospective nationwide study. American Journal of Hematology. PMID 37493218 DOI: 10.1002/ajh.27041 |
0.375 |
|
| 2023 |
Araie H, Arai Y, Kida M, Aoki J, Uchida N, Doki N, Fukuda T, Tanaka M, Ozawa Y, Sawa M, Katayama Y, Matsuo Y, Onizuka M, Kanda Y, Kawakita T, et al. Poor outcome of allogeneic transplantation for therapy-related acute myeloid leukemia induced by prior chemoradiotherapy. Annals of Hematology. PMID 37477669 DOI: 10.1007/s00277-023-05356-6 |
0.309 |
|
| 2023 |
Takamatsu H, Matsuda T, Mizuno S, Takahashi T, Fuchida SI, Hanamura I, Kataoka K, Tsukada N, Matsumoto M, Hangaishi A, Doki N, Uchida N, Sawa M, Maruyama Y, Kurahashi S, et al. Changing trends in the risk factors for second primary malignancies after autologous stem cell transplantation for multiple myeloma before and after the introduction of proteasome inhibitors and immunomodulatory drugs. Haematologica. PMID 37470160 DOI: 10.3324/haematol.2023.283202 |
0.319 |
|
| 2023 |
Yanada M, Shimomura Y, Mizuno S, Matsuda K, Kondo T, Doki N, Tanaka M, Fukuda T, Ara T, Uchida N, Onizuka M, Sawa M, Ozawa Y, Hiramoto N, Ota S, et al. External validation and extended application of the transplant conditioning intensity score in acute myeloid leukemia. Bone Marrow Transplantation. PMID 37443251 DOI: 10.1038/s41409-023-02037-w |
0.428 |
|
| 2023 |
Jo T, Arai Y, Kanda J, Kondo T, Ikegame K, Uchida N, Doki N, Fukuda T, Ozawa Y, Tanaka M, Ara T, Kuriyama T, Katayama Y, Kawakita T, Kanda Y, et al. Author Correction: A convolutional neural network-based model that predicts acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Communications Medicine. 3: 89. PMID 37349499 DOI: 10.1038/s43856-023-00323-8 |
0.323 |
|
| 2023 |
Tamaki M, Akahoshi Y, Okada Y, Uchida N, Tanaka M, Doki N, Sawa M, Maruyama Y, Ueda Y, Miyakoshi S, Katayama Y, Kawakita T, Kimura T, Onizuka M, Fukuda T, et al. Unrelated female-to-male bone marrow transplantation would be preferred over cord blood transplantation in male patients. Cytotherapy. PMID 37341665 DOI: 10.1016/j.jcyt.2023.06.002 |
0.358 |
|
| 2023 |
Saburi M, Oshima K, Takano K, Inoue Y, Harada K, Uchida N, Fukuda T, Doki N, Ikegame K, Matsuo Y, Katayama Y, Ozawa Y, Matsuoka KI, Kawakita T, Mori Y, et al. Risk factors and outcome of Stenotrophomonas maltophilia infection after allogeneic hematopoietic stem cell transplantation: JSTCT, Transplant Complications Working Group. Annals of Hematology. PMID 37338625 DOI: 10.1007/s00277-023-05320-4 |
0.426 |
|
| 2023 |
Jo T, Arai Y, Oshima S, Kondo T, Harada K, Uchida N, Doki N, Fukuda T, Tanaka M, Ozawa Y, Kuriyama T, Ikegame K, Katayama Y, Ota S, Ara T, et al. Prognostic impact of complex and/or monosomal karyotypes in post-transplant poor cytogenetic acute myeloid leukaemia: A quantitative approach. British Journal of Haematology. PMID 37211753 DOI: 10.1111/bjh.18855 |
0.381 |
|
| 2023 |
Jo T, Arai Y, Kanda J, Kondo T, Ikegame K, Uchida N, Doki N, Fukuda T, Ozawa Y, Tanaka M, Ara T, Kuriyama T, Katayama Y, Kawakita T, Kanda Y, et al. A convolutional neural network-based model that predicts acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Communications Medicine. 3: 67. PMID 37193882 DOI: 10.1038/s43856-023-00299-5 |
0.323 |
|
| 2023 |
Konuma T, Itonaga H, Ishiyama K, Doki N, Uchida N, Sawa M, Katayama Y, Tanaka M, Ueda Y, Onizuka M, Miyakoshi S, Ozawa Y, Fukuda T, Matsuoka KI, Tanaka J, et al. Should a matched sibling donor still be considered the primary option for allogeneic hematopoietic cell transplantation in patients over 50 years of age with myelodysplastic syndrome? Bone Marrow Transplantation. PMID 37156881 DOI: 10.1038/s41409-023-01997-3 |
0.442 |
|
| 2023 |
Yamasaki S, Mizuno S, Iwasaki M, Seo S, Uchida N, Shigesaburo M, Nakano N, Ishiwata K, Uehara Y, Eto T, Takase K, Kawakita T, Tanaka M, Sawa M, Katayama Y, et al. Efficacy and safety of allogeneic hematopoietic cell transplantation in acute myeloid leukemia patients aged > 65 years with unfavorable cytogenetics. Annals of Hematology. PMID 37126115 DOI: 10.1007/s00277-023-05243-0 |
0.458 |
|
| 2023 |
Kimura SI, Akahoshi Y, Shiratori S, Okinaka K, Harada K, Uchida N, Doki N, Ikegame K, Nakamae H, Tanaka M, Takada S, Kawakita T, Matsuoka KI, Ara T, Ota S, et al. Association Between Candidemia and Noninfectious Interstitial Pneumonia After Allogeneic Hematopoietic Cell Transplantation: JSTCT Transplant Complications Working Group. Open Forum Infectious Diseases. 10: ofad163. PMID 37089776 DOI: 10.1093/ofid/ofad163 |
0.373 |
|
| 2023 |
Okinaka K, Inoue Y, Uchida N, Toya T, Ogawa H, Ozawa Y, Eto T, Mori T, Sugita J, Kondo T, Kato K, Suzuki R, Fukuda T. Clinical characteristics and risk factors of pneumococcal diseases in recipients of allogeneic hematopoietic stem cell transplants in the late phase: A retrospective registry study. Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy. PMID 37088144 DOI: 10.1016/j.jiac.2023.04.015 |
0.389 |
|
| 2023 |
Nakashima Y, Kobayashi Y, Murao M, Kato R, Endo H, Higo A, Iwasaki R, Kojima M, Takebayashi Y, Sato A, Nomoto M, Sakakibara H, Tada Y, Itami K, Kimura S, ... ... Uchida N, et al. Identification of a pluripotency-inducing small compound, PLU, that induces callus formation Heat Shock Protein 90-mediated activation of auxin signaling. Frontiers in Plant Science. 14: 1099587. PMID 36968385 DOI: 10.3389/fpls.2023.1099587 |
0.551 |
|
| 2023 |
Fuji S, Inoue Y, Makiyama J, Nakano N, Ito A, Kawakita T, Eto T, Suehiro Y, Itonaga H, Sawayama Y, Mori Y, Uchida N, Morishima S, Onizuka M, Ishitsuka K, et al. The clinical benefit of acute GVHD depends on the age at transplantation in patients with adult T-cell leukemia-lymphoma on behalf of the ATL Working Group of the Japan Society for Transplantation and Cellular Therapy. Bone Marrow Transplantation. PMID 36966214 DOI: 10.1038/s41409-023-01969-7 |
0.372 |
|
| 2023 |
Konuma T, Matsuda K, Shimomura Y, Tanoue S, Sugita J, Inamoto Y, Hirayama M, Ara T, Nakamae H, Ota S, Maruyama Y, Eto T, Uchida N, Tanaka M, Ishiwata K, et al. Effect of graft-versus-host disease on posttransplant outcomes following single cord blood transplantation in comparison to haploidentical transplantation with posttransplant cyclophosphamide for adult acute myeloid leukemia. Transplantation and Cellular Therapy. PMID 36889507 DOI: 10.1016/j.jtct.2023.03.001 |
0.423 |
|
| 2023 |
Wakamatsu M, Murata M, Kanda J, Fukushima K, Fukuda T, Najima Y, Katayama Y, Ozawa Y, Tanaka M, Kanda Y, Eto T, Takada S, Kako S, Uchida N, Kawakita T, et al. Different effects of thymoglobulin on acute leukemia with pre-transplant residual blasts in HLA mismatch transplantation. International Journal of Hematology. PMID 36814041 DOI: 10.1007/s12185-023-03563-5 |
0.441 |
|
| 2023 |
Shibata S, Arai Y, Kondo T, Mizuno S, Harada K, Miyakoshi S, Uchida N, Maruyama Y, Eto T, Katsuoka Y, Matsue K, Nishiwaki K, Takada S, Doki N, Itoh M, et al. Advantages of Higher Busulfan Dose Intensity in Fludarabine-Combined Conditioning for Patients with Acute Myeloid Leukemia Undergoing Cord Blood Transplantation. Transplantation and Cellular Therapy. PMID 36796517 DOI: 10.1016/j.jtct.2023.02.004 |
0.412 |
|
| 2023 |
Tokunaga M, Nakano N, Fuji S, Wake A, Utsunomiya A, Ito A, Eto T, Kawakita T, Mori Y, Moriuchi Y, Suehiro Y, Miyazaki Y, Uchida N, Sawayama Y, Ishitsuka K, et al. Cord blood is a suitable donor source of allogeneic hematopoietic cell transplantation for adult T-cell leukemia-lymphoma: a nationwide retrospective study. Bone Marrow Transplantation. PMID 36681773 DOI: 10.1038/s41409-023-01919-3 |
0.358 |
|
| 2023 |
Akahoshi Y, Nakasone H, Takenaka K, Yamasaki S, Nakamura M, Doki N, Tanaka M, Ozawa Y, Uchida N, Ara T, Nakamae H, Ota S, Onizuka M, Yano S, Tanaka J, et al. CMV reactivation after allogeneic HCT is associated with a reduced risk of relapse in acute lymphoblastic leukemia. Blood Advances. PMID 36661335 DOI: 10.1182/bloodadvances.2022009376 |
0.361 |
|
| 2023 |
Kaida K, Ikegame K, Inoue T, Maruyama S, Ishii S, Uchida N, Doki N, Eto T, Fukuda T, Katayama Y, Takada S, Kawakita T, Ichinohe T, Atsuta Y, Daimon T, et al. Peritransplant glucocorticoid haploidentical stem cell transplantation is a promising strategy for AML patients with high leukemic burden: Comparison with transplants using other donor types. Transplantation and Cellular Therapy. PMID 36641032 DOI: 10.1016/j.jtct.2023.01.005 |
0.449 |
|
| 2023 |
Konuma T, Itonaga H, Ishiyama K, Hamamura A, Uchida N, Ozawa Y, Katayama Y, Sakurai M, Ueda Y, Matsuoka KI, Kawakita T, Eto T, Ara T, Kanda J, Makoto O, et al. Progress in survival following three decades of allogeneic hematopoietic cell transplantation for myelodysplastic syndrome: a real-world registry study in Japan. American Journal of Hematology. PMID 36633538 DOI: 10.1002/ajh.26839 |
0.366 |
|
| 2022 |
Shimomura Y, Kitamura T, Nishikubo M, Sobue T, Uchida N, Doki N, Tanaka M, Ito A, Ishikawa J, Ara T, Ota S, Onizuka M, Sawa M, Ozawa Y, Maruyama Y, et al. Effect of the COVID-19 pandemic on allogeneic stem cell transplantation in Japan. International Journal of Hematology. 1-8. PMID 36515796 DOI: 10.1007/s12185-022-03508-4 |
0.432 |
|
| 2022 |
Yanagisawa R, Tamaki M, Tanoshima R, Misaki Y, Uchida N, Koi S, Tanaka T, Ozawa Y, Matsuo Y, Tanaka M, Ikegame K, Katayama Y, Matsuoka KI, Ara T, Kanda Y, et al. Risk factors for fatal cardiac complications after allogeneic hematopoietic cell transplantation: JSTCT Transplant Complications Working Group. Hematological Oncology. PMID 36385399 DOI: 10.1002/hon.3101 |
0.33 |
|
| 2022 |
Nakamura Y, Mori T, Kako S, Yamazaki H, Kanda Y, Uchida N, Tanaka M, Nawa Y, Fukuda T, Ichinohe T, Atsuta Y, Onishi Y. Outcome of peripheral blood stem cell transplantation from HLA-identical sibling donors for adult patients with aplastic anemia. International Journal of Hematology. PMID 36378405 DOI: 10.1007/s12185-022-03487-6 |
0.464 |
|
| 2022 |
Yanada M, Yamasaki S, Konuma T, Mizuno S, Uchida N, Onai D, Fukuda T, Tanaka M, Ozawa Y, Eto T, Ikegame K, Sawa M, Katayama Y, Kawakita T, Onizuka M, et al. Age and allogeneic hematopoietic cell transplantation outcomes in acute myeloid leukemia. International Journal of Hematology. PMID 36335534 DOI: 10.1007/s12185-022-03486-7 |
0.311 |
|
| 2022 |
Matsuda K, Konuma T, Fuse K, Masuko M, Kawamura K, Hirayama M, Uchida N, Ikegame K, Wake A, Eto T, Doki N, Miyakoshi S, Tanaka M, Takahashi S, Onizuka M, et al. Comparison of transplant outcomes between haploidentical transplantation and single cord blood transplantation in non-remission acute myeloid leukaemia: A nationwide retrospective study. British Journal of Haematology. PMID 36281887 DOI: 10.1111/bjh.18530 |
0.461 |
|
| 2022 |
Konuma T, Kanda J, Uchida N, Nishijima A, Tanaka M, Ozawa Y, Sawa M, Onizuka M, Ota S, Maruyama Y, Kanda Y, Kawakita T, Ara T, Eto T, Nakamae H, et al. Intensified conditioning regimens improved disease-free survival and engraftment after unrelated single-unit cord blood transplantation but not after matched sibling or matched unrelated donor allogeneic hematopoietic cell transplantation. Hematological Oncology. PMID 36268564 DOI: 10.1002/hon.3094 |
0.421 |
|
| 2022 |
Konuma T, Harada K, Kondo T, Masuko M, Uchida N, Yano S, Kawakita T, Onizuka M, Ota S, Sakaida E, Miyakoshi S, Ozawa Y, Imamura Y, Kimura T, Kanda Y, et al. Salvage single-unit unrelated cord blood transplantation for graft failure following initial allogeneic transplantation in adult acute myeloid leukemia: trends in outcomes over the past 20 years. Bone Marrow Transplantation. PMID 36195770 DOI: 10.1038/s41409-022-01840-1 |
0.388 |
|
| 2022 |
Sakatoku K, Kim SW, Okamura H, Kanaya M, Kato K, Yamasaki S, Uchida N, Kobayashi H, Fukuda T, Takayama N, Ishikawa J, Nakazawa H, Sakurai M, Ikeda T, Kondo T, et al. Improved survival after single-unit cord blood transplantation using fludarabine and melphalan-based reduced-intensity conditioning for malignant lymphoma: impact of melphalan dose and graft-versus-host disease prophylaxis with mycophenolate mofetil. Annals of Hematology. PMID 36195679 DOI: 10.1007/s00277-022-04990-w |
0.336 |
|
| 2022 |
Yanada M, Matsuda K, Ishii H, Fukuda T, Ozeki K, Ota S, Tashiro H, Uchida N, Kako S, Doki N, Kawakita T, Onishi Y, Takada S, Kondo Y, Tanaka J, et al. Allogeneic hematopoietic cell transplantation for patients with relapsed acute promyelocytic leukemia. Transplantation and Cellular Therapy. PMID 36179987 DOI: 10.1016/j.jtct.2022.09.021 |
0.415 |
|
| 2022 |
Taniguchi S, Utsumi S, Kochi Y, Taya Y, Mori Y, Semba YI, Sugio T, Miyawaki K, Kikushige Y, Kunisaki Y, Yoshimoto G, Numata A, Kato K, Uchida N, Maeda T, et al. Successful pseudo-autologous stem cell transplantation for donor-derived Burkitt lymphoma occurring 9 years after allogeneic transplantation. International Journal of Hematology. PMID 36136227 DOI: 10.1007/s12185-022-03458-x |
0.437 |
|
| 2022 |
Konuma T, Shimomura Y, Ishiyama K, Ara T, Nakamae H, Hiramoto N, Eto T, Maruyama Y, Nagafuji K, Ishikawa J, Uchida N, Tanaka M, Onizuka M, Ueda Y, Anzai N, et al. Haploidentical transplantation with post-transplant cyclophosphamide versus single cord blood transplantation for myelodysplastic syndrome: A retrospective study from the Adult Myelodysplastic Syndrome Working Group of the Japanese Society for Transplantation and Cellular Therapy (JSTCT). American Journal of Hematology. PMID 36088638 DOI: 10.1002/ajh.26722 |
0.375 |
|
| 2022 |
Inamoto Y, Takeda W, Hirakawa T, Sakaguchi H, Nakano N, Uchida N, Doki N, Ikegame K, Katayama Y, Sawa M, Kuriyama T, Hiramoto N, Ota S, Ozawa Y, Kataoka K, et al. Adenovirus disease after hematopoietic cell transplantation: A Japanese transplant registry analysis. American Journal of Hematology. PMID 36087061 DOI: 10.1002/ajh.26723 |
0.389 |
|
| 2022 |
Sugita J, Atsuta Y, Nakamae H, Maruyama Y, Ishiyama K, Shiratori S, Fukuda T, Kurata M, Shingai N, Ozawa Y, Masuko M, Nagafuji K, Uchida N, Tanaka M, Onizuka M, et al. Comparable survival outcomes with haploidentical stem cell transplantation and cord blood transplantation. Bone Marrow Transplantation. PMID 35987912 DOI: 10.1038/s41409-022-01770-y |
0.439 |
|
| 2022 |
Konuma T, Mizuno S, Harada K, Uchida N, Takahashi S, Eto T, Ota S, Kobayashi H, Katayama Y, Mori Y, Maruyama Y, Onizuka M, Yonezawa A, Kawakita T, Kimura T, et al. Reducing mortality of single-unit unrelated cord blood transplantation for relapsed acute myeloid leukemia after a previous allogeneic transplantation: a real-world retrospective study over the past 19 years in Japan. Transplantation and Cellular Therapy. PMID 35964936 DOI: 10.1016/j.jtct.2022.08.006 |
0.439 |
|
| 2022 |
Okada Y, Takenaka K, Murata M, Shimazu Y, Tachibana T, Ozawa Y, Uchida N, Wakayama T, Doki N, Sugio Y, Tanaka M, Masuko M, Kobayashi H, Ino K, Ishikawa J, et al. Prognostic impact of complex karyotype on post-transplant outcomes of myelofibrosis. Hematological Oncology. PMID 35964301 DOI: 10.1002/hon.3058 |
0.32 |
|
| 2022 |
Oyama T, Kageyama K, Araoka H, Mitsuki T, Yamaguchi K, Kaji D, Taya Y, Nishida A, Ishiwata K, Takagi S, Yamamoto H, Yamamoto G, Asano-Mori Y, Uchida N, Wake A, et al. Clinical and microbiological characteristics of bacterial meningitis in umbilical cord blood transplantation recipients. International Journal of Hematology. PMID 35932398 DOI: 10.1007/s12185-022-03425-6 |
0.317 |
|
| 2022 |
Kanda Y, Doki N, Kojima M, Kako S, Inoue M, Uchida N, Onishi Y, Kamata R, Kotaki M, Kobayashi R, Tanaka J, Fukuda T, Fujii N, Miyamura K, Mori SI, et al. Effect of Cryopreservation in Unrelated Bone Marrow and Peripheral Blood Stem Cell Transplantation in the Era of the COVID-19 Pandemic: An Update from the Japan Marrow Donor Program. Transplantation and Cellular Therapy. PMID 35803526 DOI: 10.1016/j.jtct.2022.06.022 |
0.419 |
|
| 2022 |
Morita-Fujita M, Arai Y, Kondo T, Harada K, Uchida N, Toya T, Ozawa Y, Fukuda T, Ota S, Onizuka M, Kanda Y, Maruyama Y, Takada S, Kawakita T, Ara T, et al. Adult patients with Ph+ ALL benefit from conditioning regimen of medium-dose VP16 plus CY/TBI. Hematological Oncology. PMID 35790020 DOI: 10.1002/hon.3046 |
0.305 |
|
| 2022 |
Konuma T, Mizuno S, Kondo T, Arai Y, Uchida N, Takahashi S, Tanaka M, Kuriyama T, Miyakoshi S, Onizuka M, Ota S, Sugio Y, Kouzai Y, Kawakita T, Kobayashi H, et al. Improved trends in survival and engraftment after single cord blood transplantation for adult acute myeloid leukemia. Blood Cancer Journal. 12: 81. PMID 35614057 DOI: 10.1038/s41408-022-00678-6 |
0.417 |
|
| 2022 |
Kanda J, Hirabayashi S, Yokoyama H, Kawase T, Tanaka H, Uchida N, Taniguchi S, Takahashi S, Onizuka M, Tanaka M, Sugio Y, Eto T, Kanda Y, Kimura T, Ichinohe T, et al. Effect of multiple HLA-locus mismatches on outcomes after single cord blood transplantation. Transplantation and Cellular Therapy. PMID 35577322 DOI: 10.1016/j.jtct.2022.05.005 |
0.317 |
|
| 2022 |
Yokoyama H, Kanaya M, Iemura T, Hirayama M, Yamasaki S, Kondo T, Uchida N, Takahashi S, Tanaka M, Onizuka M, Ozawa Y, Kozai Y, Eto T, Sugio Y, Hamamura A, et al. Improved outcomes of single-unit cord blood transplantation for acute myeloid leukemia by killer immunoglobulin-like receptor 2DL1-ligand mismatch. Bone Marrow Transplantation. PMID 35538140 DOI: 10.1038/s41409-022-01700-y |
0.365 |
|
| 2022 |
Shimazu Y, Murata M, Kondo T, Minami Y, Tachibana T, Doki N, Uchida N, Ozawa Y, Yano S, Fukuda T, Kato J, Ara T, Eto T, Ishikawa J, Nakamae H, et al. The new generation tyrosine kinase inhibitor improves the survival of chronic myeloid leukemia patients after allogeneic stem cell transplantation. Hematological Oncology. PMID 35394658 DOI: 10.1002/hon.3000 |
0.368 |
|
| 2022 |
Kameda K, Kako S, Kim SW, Usui Y, Kato K, Fukuda T, Uchida N, Kobayashi H, Wakayama T, Sakaida E, Yano S, Imada K, Nara M, Ikeda T, Fuchida SI, et al. Autologous or allogeneic hematopoietic cell transplantation for relapsed or refractory PTCL-NOS or AITL. Leukemia. PMID 35347237 DOI: 10.1038/s41375-022-01545-w |
0.324 |
|
| 2022 |
Iwasaki M, Kanda J, Tanaka H, Shindo T, Sato T, Doki N, Fukuda T, Ozawa Y, Eto T, Uchida N, Katayama Y, Kataoka K, Ara T, Ota S, Onizuka M, et al. Impact of HLA Epitope Matching on Outcomes After Unrelated Bone Marrow Transplantation. Frontiers in Immunology. 13: 811733. PMID 35309307 DOI: 10.3389/fimmu.2022.811733 |
0.366 |
|
| 2022 |
Kaito S, Kurosawa S, Najima Y, Sakaida E, Shingai N, Fukuda T, Tachibana T, Uchida N, Ozawa Y, Sawa M, Nakazawa H, Ota S, Kato J, Nakamae H, Katayama Y, et al. Allogeneic Hematopoietic Stem Cell Transplantation for Adult Philadelphia Chromosome-Negative B-Cell Acute Lymphoblastic Leukemia in Second Complete Remission. Transplantation and Cellular Therapy. PMID 35306218 DOI: 10.1016/j.jtct.2022.03.017 |
0.353 |
|
| 2022 |
Itonaga H, Kida M, Hamamura A, Uchida N, Ozawa Y, Fukuda T, Ueda Y, Kataoka K, Katayama Y, Ota S, Matsuoka KI, Kondo T, Eto T, Kanda J, Ichinohe T, et al. Outcome of therapy-related myelodysplastic syndrome and oligoblastic acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation: A propensity score matched analysis. Hematological Oncology. PMID 35299289 DOI: 10.1002/hon.2991 |
0.337 |
|
| 2022 |
Tamaki M, Kameda K, Kimura SI, Harada N, Uchida N, Doki N, Tanaka M, Ikegame K, Sawa M, Katayama Y, Miyakoshi S, Ara T, Kanda J, Onizuka M, Fukuda T, et al. Deletion of Y-chromosome before allogeneic hematopoietic stem cell transplantation in male recipients with female donors. Blood Advances. PMID 35108728 DOI: 10.1182/bloodadvances.2021006456 |
0.311 |
|
| 2022 |
Onizuka M, Fujii N, Nakasone H, Ogata M, Atsuta Y, Suzuki R, Uchida N, Ohashi K, Ozawa Y, Eto T, Ikegame K, Nakamae H, Inoue M, Fukuda T. Risk factors and prognosis of non-infectious pulmonary complications after allogeneic hematopoietic stem cell transplantation. International Journal of Hematology. PMID 35088350 DOI: 10.1007/s12185-021-03282-9 |
0.391 |
|
| 2022 |
Kawajiri A, Kawase T, Tanaka H, Fukuda T, Mukae J, Ozawa Y, Eto T, Uchida N, Mori T, Ashida T, Kondo T, Onizuka M, Ichinohe T, Atsuta Y, Morishima S, et al. Human leukocyte antigen (HLA) haplotype matching in unrelated single HLA allele mismatch bone marrow transplantation. Bone Marrow Transplantation. PMID 35058581 DOI: 10.1038/s41409-021-01552-y |
0.391 |
|
| 2022 |
Fuji S, Hirakawa T, Takano K, Doki N, Sawa M, Kanda Y, Uchida N, Ara T, Miyamoto T, Eto T, Matsuoka KI, Kawakita T, Ozawa Y, Katayama Y, Onizuka M, et al. Disease-specific impact of anti-thymocyte globulin in allogeneic hematopoietic cell transplantation: a nationwide retrospective study on behalf of the JSTCT, transplant complications working group. Bone Marrow Transplantation. PMID 35039621 DOI: 10.1038/s41409-022-01569-x |
0.43 |
|
| 2022 |
Kimura SI, Kameda K, Harada K, Saburi M, Okinaka K, Shinohara A, Uchida N, Nishijima A, Ozawa Y, Tanaka M, Kuriyama T, Katayama Y, Sawa M, Ikegame K, Kawakita T, et al. Risk and predictive factors for candidemia after allogeneic hematopoietic cell transplantation: JSTCT Transplant Complications Working Group. Transplantation and Cellular Therapy. PMID 34995815 DOI: 10.1016/j.jtct.2021.12.020 |
0.358 |
|
| 2022 |
Wada F, Watanabe M, Konuma T, Okabe M, Kobayashi S, Uchida N, Ikegame K, Tanaka M, Sugio Y, Mukae J, Onizuka M, Kawakita T, Kuriyama T, Takahashi S, Fukuda T, et al. HLA 1-3 antigen-mismatched related peripheral blood stem cells transplantation using low-dose antithymocyte globulin versus unrelated cord blood transplantation. American Journal of Hematology. PMID 34978726 DOI: 10.1002/ajh.26446 |
0.424 |
|
| 2021 |
Miyao K, Kuwatsuka Y, Murata M, Nagafuji K, Teshima T, Takeuchi Y, Shiratori S, Najima Y, Uchida N, Tanaka M, Sawa M, Ota S, Fukuda T, Ozawa Y, Kako S, et al. Anti-thymocyte globulin could potentially overcome an adverse effect of acute GVHD in matched-related PBSCT. Transplantation and Cellular Therapy. PMID 34954151 DOI: 10.1016/j.jtct.2021.12.009 |
0.41 |
|
| 2021 |
Kako S, Hayakawa F, Miyamura K, Tanaka J, Imai K, Kanda J, Morishima S, Uchida N, Doki N, Ikegame K, Ozawa Y, Takada S, Usui N, Ohtake S, Kiyoi H, et al. Decision Analysis for Unrelated Bone Marrow Transplantation or Immediate Cord Blood Transplantation for Patients with Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia in First Complete Remission. Transplantation and Cellular Therapy. PMID 34875401 DOI: 10.1016/j.jtct.2021.11.021 |
0.396 |
|
| 2021 |
Imahashi N, Terakura S, Kondo E, Kato K, Kim SW, Shinohara A, Watanabe M, Fukuda T, Uchida N, Kobayashi H, Ishikawa J, Kataoka K, Shiratori S, Ikeda T, Matsuoka KI, et al. Impact of donor types on reduced-intensity conditioning allogeneic stem cell transplant for mature lymphoid malignancies. Bone Marrow Transplantation. PMID 34815519 DOI: 10.1038/s41409-021-01525-1 |
0.409 |
|
| 2021 |
Shimomura Y, Sobue T, Hirabayashi S, Kondo T, Mizuno S, Kanda J, Fujino T, Kataoka K, Uchida N, Eto T, Miyakoshi S, Tanaka M, Kawakita T, Yokoyama H, Doki N, et al. Comparing cord blood transplantation and matched related donor transplantation in non-remission acute myeloid leukemia. Leukemia. PMID 34815516 DOI: 10.1038/s41375-021-01474-0 |
0.415 |
|
| 2021 |
Kuno M, Yamasaki S, Fujii N, Ishida Y, Fukuda T, Kataoka K, Uchida N, Katayama Y, Sato M, Onai D, Miyamoto T, Ota S, Yoshioka S, Ara T, Hangaishi A, et al. Characterization of myeloid neoplasms following allogeneic hematopoietic cell transplantation. American Journal of Hematology. PMID 34738245 DOI: 10.1002/ajh.26401 |
0.419 |
|
| 2021 |
Yanada M, Ota S, Mukae J, Nara M, Kako S, Nishikawa A, Uchida N, Sawa M, Nakano N, Onizuka M, Kanda Y, Ichinohe T, Atsuta Y, Yano S. Autologous hematopoietic cell transplantation during second or subsequent complete remission of acute promyelocytic leukemia: a prognostic factor analysis. Bone Marrow Transplantation. PMID 34645925 DOI: 10.1038/s41409-021-01501-9 |
0.365 |
|
| 2021 |
Kanda J, Hayashi H, Ruggeri A, Kimura F, Volt F, Takahashi S, Kako S, Tozatto-Maio K, Yanada M, Sanz G, Uchida N, Angelucci E, Kato S, Mohty M, Forcade E, et al. The impact of GVHD on outcomes after adult single cord blood transplantation in European and Japanese populations. Bone Marrow Transplantation. PMID 34635798 DOI: 10.1038/s41409-021-01479-4 |
0.361 |
|
| 2021 |
Kobayashi S, Kanda Y, Konuma T, Inamoto Y, Matsumoto K, Uchida N, Ikegame K, Miyamoto T, Doki N, Nakamae H, Katayama Y, Takahashi S, Shiratori S, Saito S, Kawakita T, et al. Outcomes of third allogeneic hematopoietic stem cell transplantation in relapsed/refractory acute leukemia after a second transplantation. Bone Marrow Transplantation. PMID 34625663 DOI: 10.1038/s41409-021-01485-6 |
0.431 |
|
| 2021 |
Yokoyama H, Hirayama M, Takahashi Y, Uchida N, Tanaka M, Onizuka M, Ozawa Y, Onai D, Katsuoka Y, Wake A, Sawa M, Kobayashi H, Maruyama Y, Ozeki K, Kimura T, et al. Altered effect of killer immunoglobulin-like receptor-ligand mismatch by graft versus host disease prophylaxis in cord blood transplantation. Bone Marrow Transplantation. PMID 34561558 DOI: 10.1038/s41409-021-01469-6 |
0.305 |
|
| 2021 |
Kurosawa S, Mizuno S, Arai Y, Masuko M, Kanda J, Kohno K, Onai D, Fukuda T, Ozawa Y, Katayama Y, Tanaka M, Ikegame K, Uchida N, Eto T, Ota S, et al. Syngeneic hematopoietic stem cell transplantation for acute myeloid leukemia: a propensity score-matched analysis. Blood Cancer Journal. 11: 159. PMID 34561419 DOI: 10.1038/s41408-021-00553-w |
0.415 |
|
| 2021 |
Hiramoto N, Yamazaki H, Nakamura Y, Uchida N, Murata M, Kondo T, Yoshioka S, Eto T, Nishikawa A, Kimura T, Ichinohe T, Atsuta Y, Onishi Y, Suzuki R, Mori T, et al. Total body irradiation-containing conditioning regimens without antithymocyte globulin in adults with aplastic anemia undergoing umbilical cord blood transplantation. Annals of Hematology. PMID 34546409 DOI: 10.1007/s00277-021-04664-z |
0.392 |
|
| 2021 |
Yanada M, Konuma T, Yamasaki S, Harada K, Iwasaki M, Kobayashi A, Nishijima A, Tanaka M, Uchida N, Nakamae H, Fukuda T, Onizuka M, Ozawa Y, Sawa M, Katayama Y, et al. Allogeneic Hematopoietic Cell Transplantation from Alternative Donors in Acute Myeloid Leukemia: A Comparative Analysis. Transplantation and Cellular Therapy. PMID 34500125 DOI: 10.1016/j.jtct.2021.08.027 |
0.409 |
|
| 2021 |
Kimura SI, Tamaki M, Okinaka K, Seo S, Uchida N, Igarashi A, Ozawa Y, Ikegame K, Eto T, Tanaka M, Shiratori S, Nakamae H, Sawa M, Kawakita T, Onizuka M, et al. Cytomegalovirus reactivation is associated with an increased risk of late-onset invasive aspergillosis independently of grade II-IV acute graft-versus-host disease in allogeneic hematopoietic stem cell transplantation: JSTCT Transplant Complications Working Group. Annals of Hematology. PMID 34490500 DOI: 10.1007/s00277-021-04660-3 |
0.426 |
|
| 2021 |
Fuji S, Hakoda A, Kanda J, Murata M, Terakura S, Inamoto Y, Uchida N, Toya T, Eto T, Nakamae H, Ikegame K, Tanaka M, Kawakita T, Kondo T, Miyamoto T, et al. Impact of HLA disparity on the risk of overall mortality in patients with grade II-IV acute GVHD on behalf of the HLA Working Group of Japan Society for Hematopoietic Cell Transplantation. Bone Marrow Transplantation. PMID 34480119 DOI: 10.1038/s41409-021-01443-2 |
0.382 |
|
| 2021 |
Yanada M, Konuma T, Yamasaki S, Mizuno S, Hirabayashi S, Nishiwaki S, Uchida N, Doki N, Tanaka M, Ozawa Y, Sawa M, Eto T, Kawakita T, Ota S, Fukuda T, et al. The differential effect of disease status at allogeneic hematopoietic cell transplantation on outcomes in acute myeloid and lymphoblastic leukemia. Annals of Hematology. PMID 34477952 DOI: 10.1007/s00277-021-04661-2 |
0.368 |
|
| 2021 |
Inoue Y, Nakano N, Fuji S, Eto T, Kawakita T, Suehiro Y, Miyamoto T, Sawayama Y, Uchida N, Kondo T, Kanda J, Atsuta Y, Fukuda T, Yoshimitsu M, Kato K, et al. Impact of conditioning intensity and regimen on transplant outcomes in patients with adult T-cell leukemia-lymphoma. Bone Marrow Transplantation. PMID 34462567 DOI: 10.1038/s41409-021-01445-0 |
0.302 |
|
| 2021 |
Yanada M, Mizuno S, Yamasaki S, Harada K, Konuma T, Tamaki H, Shingai N, Uchida N, Ozawa Y, Tanaka M, Onizuka M, Sawa M, Nakamae H, Shiratori S, Matsuoka KI, et al. Difference in outcomes following allogeneic hematopoietic cell transplantation for patients with acute myeloid leukemia and myelodysplastic syndromes. Leukemia & Lymphoma. 1-9. PMID 34348554 DOI: 10.1080/10428194.2021.1961242 |
0.403 |
|
| 2021 |
Akahoshi Y, Arai Y, Nishiwaki S, Tachibana T, Shinohara A, Doki N, Uchida N, Tanaka M, Kanda Y, Shiratori S, Ozawa Y, Shono K, Katayama Y, Tanaka J, Fukuda T, et al. Newly proposed threshold and validation of white blood cell count at diagnosis for Philadelphia chromosome-positive acute lymphoblastic leukemia: risk assessment of relapse in patients with negative minimal residual disease at transplantation-a report from the Adult Acute Lymphoblastic Leukemia Working Group of the JSTCT. Bone Marrow Transplantation. PMID 34331021 DOI: 10.1038/s41409-021-01422-7 |
0.363 |
|
| 2021 |
Konuma T, Kondo T, Masuko M, Shimizu H, Shiratori S, Fukuda T, Kato J, Sawa M, Ozawa Y, Ota S, Uchida N, Kanda Y, Kako S, Fujisawa S, Fukushima K, et al. Prognostic value of measurable residual disease at allogeneic transplantation for adults with core binding factor acute myeloid leukemia in complete remission. Bone Marrow Transplantation. PMID 34272486 DOI: 10.1038/s41409-021-01409-4 |
0.394 |
|
| 2021 |
Nakamura M, Arai Y, Hirabayashi S, Kondo T, Doki N, Uchida N, Fukuda T, Ozawa Y, Tanaka M, Sawa M, Katayama Y, Kanda Y, Shiratori S, Nakamae H, Yoshioka S, et al. Residual disease is a strong prognostic marker in patients with acute lymphoblastic leukaemia with chemotherapy-refractory or relapsed disease prior to allogeneic stem cell transplantation. British Journal of Haematology. PMID 34159580 DOI: 10.1111/bjh.17646 |
0.457 |
|
| 2021 |
Konuma T, Kanda J, Kuwatsuka Y, Yanada M, Kondo T, Hirabayashi S, Kako S, Akahoshi Y, Uchida N, Doki N, Ozawa Y, Tanaka M, Eto T, Sawa M, Yoshioka S, et al. Differential effect of graft-versus-host disease on survival in acute leukemia according to donor type. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 34158357 DOI: 10.1158/1078-0432.CCR-20-4856 |
0.358 |
|
| 2021 |
Hirabayashi S, Uozumi R, Kondo T, Arai Y, Kawata T, Uchida N, Marumo A, Ikegame K, Fukuda T, Eto T, Tanaka M, Wake A, Kanda J, Kimura T, Tabuchi K, et al. Personalized prediction of overall survival in patients with AML in non-complete remission undergoing allo-HCT. Cancer Medicine. 10: 4250-4268. PMID 34132501 DOI: 10.1002/cam4.3920 |
0.422 |
|
| 2021 |
Shimomura Y, Hara M, Konuma T, Itonaga H, Doki N, Ozawa Y, Eto T, Uchida N, Aoki J, Kato J, Onishi Y, Takahashi S, Fukushima K, Nakamae H, Kawakita T, et al. Allogeneic hematopoietic stem cell transplantation for myelodysplastic syndrome in adolescent and young adult patients. Bone Marrow Transplantation. PMID 33993196 DOI: 10.1038/s41409-021-01324-8 |
0.421 |
|
| 2021 |
Konuma T, Aoki J, Ozawa Y, Uchida N, Kobayashi T, Onizuka M, Katayama Y, Ohta T, Nakano N, Ota S, Onishi Y, Kobayashi H, Fukuda T, Kanda Y, Atsuta Y, et al. Pre-transplant red blood cell and platelet transfusion burden in de novo myelodysplastic syndrome undergoing allogeneic transplantation: Pre-transplant red blood cell and platelet transfusion burden in de novo MDS after allogeneic transplantation. Transplantation and Cellular Therapy. PMID 33991723 DOI: 10.1016/j.jtct.2021.05.003 |
0.37 |
|
| 2021 |
Seo S, Usui Y, Matsuo K, Atsuta Y, Igarashi A, Fukuda T, Ozawa Y, Katayama Y, Yoshida S, Uchida N, Kondo T, Kako S, Tsukada N, Kato S, Onizuka M, et al. Impact of the combination of donor age and HLA disparity on the outcomes of unrelated bone marrow transplantation. Bone Marrow Transplantation. PMID 33990702 DOI: 10.1038/s41409-021-01289-8 |
0.351 |
|
| 2021 |
Kurosawa S, Kaito S, Uchida N, Fukuda T, Doki N, Mori T, Hasegawa Y, Takada S, Sakaida E, Tanaka M, Ikegame K, Kanda J, Atsuta Y, Kako S. Allogeneic hematopoietic stem cell transplantation for adult patients with B-cell acute lymphoblastic leukemia with high hyperdiploidy: a retrospective nationwide study. Leukemia & Lymphoma. 1-7. PMID 33977832 DOI: 10.1080/10428194.2021.1924374 |
0.414 |
|
| 2021 |
Murata M, Terakura S, Wake A, Miyao K, Ikegame K, Uchida N, Kataoka K, Miyamoto T, Onizuka M, Eto T, Doki N, Ota S, Sato M, Hashii Y, Ichinohe T, et al. Off-the-shelf bone marrow-derived mesenchymal stem cell treatment for acute graft-versus-host disease: real-world evidence. Bone Marrow Transplantation. PMID 33976381 DOI: 10.1038/s41409-021-01304-y |
0.301 |
|
| 2021 |
Kanda Y, Inoue M, Uchida N, Onishi Y, Kamata R, Kotaki M, Kobayashi R, Tanaka J, Fukuda T, Fujii N, Miyamura K, Mori SI, Mori Y, Morishima Y, Yabe H, et al. Cryopreservation of unrelated hematopoietic stem cells from a blood and marrow donor bank during the COVID-19 pandemic. A nationwide survey by the Japan Marrow Donor Program. Transplantation and Cellular Therapy. PMID 33964514 DOI: 10.1016/j.jtct.2021.04.022 |
0.365 |
|
| 2021 |
Harada K, Kimura SI, Fuji S, Najima Y, Yakushijin K, Uchida N, Onizuka M, Ikegame K, Yano S, Shingai N, Matsuoka KI, Onishi Y, Sawa M, Takada S, Kawakita T, et al. Prognostic factors in salvage transplantation for graft failure following allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplantation. PMID 33927346 DOI: 10.1038/s41409-021-01310-0 |
0.38 |
|
| 2021 |
Inoue Y, Okinaka K, Fuji S, Inamoto Y, Uchida N, Toya T, Ikegame K, Eto T, Ozawa Y, Iwato K, Kanda Y, Atsuta Y, Ogata M, Fukuda T. Severe acute graft-versus-host disease increases the incidence of blood stream infection and mortality after allogeneic hematopoietic cell transplantation: Japanese transplant registry study. Bone Marrow Transplantation. PMID 33875815 DOI: 10.1038/s41409-021-01291-0 |
0.354 |
|
| 2021 |
Konuma T, Kanda J, Yamasaki S, Harada K, Shimomura Y, Terakura S, Mizuno S, Uchida N, Tanaka M, Doki N, Ozawa Y, Nakamae H, Sawa M, Matsuoka KI, Morishige S, et al. Single Cord Blood Transplantation Versus Unmanipulated Haploidentical Transplantation for Adults with Acute Myeloid Leukemia in Complete Remission. Transplantation and Cellular Therapy. 27: 334.e1-334.e11. PMID 33836881 DOI: 10.1016/j.jtct.2021.01.023 |
0.427 |
|
| 2021 |
Mizuno S, Takami A, Kawamura K, Arai Y, Kondo T, Kawata T, Uchida N, Marumo A, Fukuda T, Tanaka M, Ozawa Y, Yoshida S, Ota S, Takada S, Sawa M, et al. Allogeneic Hematopoietic Cell Transplantation for Adolescent and Young Adult Patients with Acute Myeloid Leukemia. Transplantation and Cellular Therapy. 27: 314.e1-314.e10. PMID 33836873 DOI: 10.1016/j.jtct.2020.12.013 |
0.367 |
|
| 2021 |
Kimura M, Yamamoto H, Uchida N, Ogura S, Yamamuro R, Mitsuki T, Yuasa M, Kaji D, Kageyama K, Nishida A, Taya Y, Ishiwata K, Takagi S, Yamamoto G, Asano-Mori Y, et al. Stenotrophomonas maltophilia bloodstream infections in adult recipients of umbilical cord blood transplantation. Transplantation and Cellular Therapy. 27: 269.e1-269.e7. PMID 33781536 DOI: 10.1016/j.jtct.2020.11.020 |
0.341 |
|
| 2021 |
Yuasa M, Asano-Mori Y, Mitsuki T, Yamaguchi K, Kageyama K, Kaji D, Taya Y, Nishida A, Ishiwata K, Takagi S, Yamamoto H, Yamamoto G, Araoka H, Wake A, Makino S, ... ... Uchida N, et al. Prognostic significance of lymphocyte reconstitution in the early phase after cord blood transplantation. British Journal of Haematology. PMID 33751547 DOI: 10.1111/bjh.17376 |
0.311 |
|
| 2021 |
Sasaki Y, Kishi A, Takagi S, Uchida N, Hayashi N. Eosinophilic pustular folliculitis after hematopoietic stem cell transplantation: A study of 11 cases. The Journal of Dermatology. 48: e231-e233. PMID 33715192 DOI: 10.1111/1346-8138.15846 |
0.343 |
|
| 2021 |
Fujimoto A, Anzai T, Fukuda T, Uchida N, Ohta T, Mori T, Sawa M, Yoshioka S, Miyamoto T, Uchiyama H, Katayama Y, Matsuoka KI, Shiratori S, Nakazawa H, Kanda J, et al. Impact of event-free survival status after stem cell transplantation on subsequent survival of patients with lymphoma. Blood Advances. 5: 1412-1424. PMID 33666656 DOI: 10.1182/bloodadvances.2020003735 |
0.348 |
|
| 2021 |
Shimomura Y, Hara M, Yamamoto H, Uchida N, Kawakita T, Ashida T, Takada S, Ikeda T, Morishige S, Maruyama Y, Wake A, Ichinohe T, Fukuda T, Takanashi M, Atsuta Y, et al. Adding melphalan to fludarabine and a myeloablative dose of busulfan improved survival after allogeneic hematopoietic stem cell transplantation in a propensity score-matched cohort of hematological malignancies. Bone Marrow Transplantation. PMID 33658646 DOI: 10.1038/s41409-021-01217-w |
0.332 |
|
| 2021 |
Yanada M, Uchida N, Ichinohe T, Fukuda T, Kanda J, Kanda Y, Atsuta Y, Nakasone H. Does one model fit all? Predicting non-relapse mortality after allogeneic hematopoietic cell transplantation. Bone Marrow Transplantation. PMID 33658644 DOI: 10.1038/s41409-021-01236-7 |
0.321 |
|
| 2021 |
Isobe M, Konuma T, Masuko M, Uchida N, Miyakoshi S, Sugio Y, Yoshida S, Tanaka M, Matsuhashi Y, Hattori N, Onizuka M, Aotsuka N, Kouzai Y, Wake A, Kimura T, et al. Single cord blood transplantation for acute myeloid leukemia patients aged 60 years or older: a retrospective study in Japan. Annals of Hematology. PMID 33624134 DOI: 10.1007/s00277-021-04464-5 |
0.425 |
|
| 2021 |
Takagi S, Ogura S, Araoka H, Uchida N, Mitsuki T, Yuasa M, Kageyama K, Kaji D, Taya Y, Nishida A, Kimura M, Ishiwata K, Yamamoto H, Yamamoto G, Asano-Mori Y, et al. The impact of graft cell source on bloodstream infection in the first 100 days after allogeneic hematopoietic cell transplantation. Bone Marrow Transplantation. PMID 33608659 DOI: 10.1038/s41409-021-01229-6 |
0.432 |
|
| 2021 |
Akahoshi Y, Arai Y, Nishiwaki S, Mizuta S, Marumo A, Uchida N, Kanda Y, Sakai H, Takada S, Fukuda T, Fujisawa S, Ashida T, Tanaka J, Atsuta Y, Kako S. Minimal residual disease (MRD) positivity at allogeneic hematopoietic cell transplantation, not the quantity of MRD, is a risk factor for relapse of Philadelphia chromosome-positive acute lymphoblastic leukemia. International Journal of Hematology. PMID 33570732 DOI: 10.1007/s12185-021-03094-x |
0.336 |
|
| 2021 |
Sakurai M, Mori T, Kato K, Kanaya M, Mizuno S, Shiratori S, Wakayama T, Uchida N, Kobayashi H, Kubo K, Amano I, Ohta T, Miyazaki Y, Kanda J, Fukuda T, et al. Outcome of allogeneic hematopoietic stem cell transplantation for follicular lymphoma relapsing after autologous transplantation: analysis of the Japan Society for Hematopoietic Cell Transplantation. Bone Marrow Transplantation. PMID 33514920 DOI: 10.1038/s41409-020-01192-8 |
0.401 |
|
| 2021 |
Watanabe M, Kanda J, Fukuda T, Uchida N, Ikegame K, Kato J, Kobayashi H, Atsuta Y, Kondo E, Suzuki R. Impact of Graft-Versus-Host Disease on Lymphoma Progression after Allogeneic Stem Cell Transplantation: Retrospective Analysis from the Adult Lymphoma Working Group of the Japan Society for Hematopoietic Cell Transplantation (JSHCT) Transplantation and Cellular Therapy. 27: S270. DOI: 10.1016/S2666-6367(21)00341-9 |
0.399 |
|
| 2021 |
Fujimoto A, Anzai T, Fukuda T, Uchida N, Ohta T, Mori T, Sawa M, Yoshioka S, Miyamoto T, Uchiyama H, Katayama Y, Matsuoka K, Shiratori S, Nakazawa H, Kanda J, et al. Impact of Event-Free Survival Status after Stem Cell Transplantation on Subsequent Survival in Lymphoma Patients Transplantation and Cellular Therapy. 27: S62-S65. DOI: 10.1016/S2666-6367(21)00091-9 |
0.362 |
|
| 2020 |
Yanada M, Konuma T, Yamasaki S, Kondo T, Fukuda T, Shingai N, Sawa M, Ozawa Y, Tanaka M, Uchida N, Nakamae H, Katayama Y, Matsuoka KI, Kimura T, Kanda Y, et al. Relapse of acute myeloid leukemia after allogeneic hematopoietic cell transplantation: clinical features and outcomes. Bone Marrow Transplantation. PMID 33268829 DOI: 10.1038/s41409-020-01163-z |
0.414 |
|
| 2020 |
Ogura S, Kimura M, Takagi S, Mitsuki T, Yuasa M, Kageyama K, Kaji D, Nishida A, Taya Y, Ishiwata K, Yamamoto H, Asano-Mori Y, Yamamoto G, Uchida N, Wake A, et al. Characteristics of gram-negative bacteremia during febrile neutropenia among allogeneic hematopoietic stem cell transplant recipients on levofloxacin prophylaxis. European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology. PMID 33185742 DOI: 10.1007/s10096-020-04096-z |
0.308 |
|
| 2020 |
Takenaka K, Onishi Y, Mori T, Hirakawa T, Tada Y, Uchida N, Kobayashi T, Kanda Y, Ozawa Y, Ota S, Iida H, Fukushima K, Kimua T, Fukuda T, Atsuta Y, et al. Negative Impact of Cytomegalovirus Reactivation on Survival in Adult Patients with Aplastic Anemia After an Allogeneic Hematopoietic Stem Cell Transplantation: A Report from Transplantation-Related Complication and Adult Aplastic Anemia Working Groups of the Japan Society for Hematopoietic Cell Transplantation. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 33039517 DOI: 10.1016/j.bbmt.2020.10.001 |
0.473 |
|
| 2020 |
Onishi Y, Mori T, Yamazaki H, Takenaka K, Yamaguchi H, Shingai N, Ozawa Y, Iida H, Ota S, Uchida N, Miyamoto T, Katayama Y, Kato J, Yoshioka S, Onizuka M, et al. Cyclosporine/methotrexate versus tacrolimus/methotrexate with or without anti-thymocyte globulin as GVHD prophylaxis in adult patients with aplastic anemia. Annals of Hematology. PMID 33033911 DOI: 10.1007/s00277-020-04290-1 |
0.404 |
|
| 2020 |
Yamasaki S, Mori J, Kanda J, Imahashi N, Uchida N, Doki N, Tanaka M, Katayama Y, Eto T, Ozawa Y, Takada S, Onizuka M, Hino M, Kanda Y, Fukuda T, et al. Effect of allogeneic HCT from unrelated donors in AML patients with intermediate- or poor-risk cytogenetics: a retrospective study from the Japanese Society for HCT. Annals of Hematology. PMID 32940726 DOI: 10.1007/S00277-020-04261-6 |
0.528 |
|
| 2020 |
Konuma T, Ishiyama K, Igarashi A, Uchida N, Ozawa Y, Fukuda T, Ueda Y, Matsuoka KI, Mori T, Katayama Y, Onizuka M, Ichinohe T, Atsuta Y. Effects of acute and chronic graft-versus-myelodysplastic syndrome on long-term outcomes following allogeneic hematopoietic cell transplantation. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 32895232 DOI: 10.1158/1078-0432.Ccr-20-1104 |
0.461 |
|
| 2020 |
Kuwatsuka Y, Atsuta Y, Hirakawa A, Uchida N, Inamoto Y, Najima Y, Ikegame K, Eto T, Ozawa Y, Ichinohe T, Inoue M, Kimura T, Okamoto S, Miyamura K, Fukuda T. Use of unapproved or off-label drugs in Japan for the treatment of graft-versus-host disease and post-transplant viral infection. International Journal of Hematology. PMID 32875487 DOI: 10.1007/S12185-020-02972-0 |
0.399 |
|
| 2020 |
Yuasa M, Yamamoto H, Mitsuki T, Kageyama K, Kaji D, Taya Y, Nishida A, Ishiwata K, Takagi S, Yamamoto G, Mori YA, Wake A, Koike Y, Makino S, Uchida N, et al. Prognostic impact of cytogenetic evolution on the outcome of allogeneic stem cell transplantation in patients with acute myeloid leukemia in non-remission: A single institute analysis of 212 recipients. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 32871257 DOI: 10.1016/J.Bbmt.2020.08.026 |
0.49 |
|
| 2020 |
Hirakawa Y, Fujimoto T, Ishida S, Uchida N, Sawa S, Kiyosue T, Ishizaki K, Nishihama R, Kohchi T, Bowman JL. Induction of Multichotomous Branching by CLAVATA Peptide in Marchantia polymorpha. Current Biology : Cb. PMID 32822612 DOI: 10.1016/J.Cub.2020.07.016 |
0.317 |
|
| 2020 |
Harada K, Fuji S, Seo S, Uchida N, Kawakita T, Yano S, Ozawa Y, Yoshioka S, Onishi Y, Noguchi Y, Onizuka M, Matsuhashi Y, Kimura T, Ichinohe T, Atsuta Y, et al. Comparison of immunosuppressant regimens in salvage cord blood transplantation for graft failure after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplantation. PMID 32820226 DOI: 10.1038/S41409-020-00999-9 |
0.522 |
|
| 2020 |
Tachibana T, Najima Y, Akahoshi Y, Hirabayashi S, Harada K, Doki N, Uchida N, Fukuda T, Sawa M, Ogata M, Takada S, Tanaka M, Matsuhashi Y, Tanaka J, Onizuka M, et al. The impacts of BCR-ABL1 mutations in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia who underwent allogeneic hematopoietic cell transplantation. Annals of Hematology. PMID 32803312 DOI: 10.1007/S00277-020-04212-1 |
0.363 |
|
| 2020 |
Murata M, Suzuki R, Nishida T, Shirane S, Shimazu Y, Minami Y, Mori T, Doki N, Kanda Y, Uchida N, Tanaka M, Ishikawa J, Togitani K, Fukuda T, Ichinohe T, et al. Allogeneic Hematopoietic Stem Cell Transplantation for Post-essential Thrombocythemia and Post-polycythemia Vera Myelofibrosis. Internal Medicine (Tokyo, Japan). 59: 1947-1956. PMID 32801269 DOI: 10.2169/Internalmedicine.4375-19 |
0.531 |
|
| 2020 |
Yanada M, Konuma T, Mizuno S, Saburi M, Shinohara A, Tanaka M, Marumo A, Sawa M, Uchida N, Ozawa Y, Onizuka M, Yoshioka S, Nakamae H, Kondo T, Kimura T, et al. Predicting non-relapse mortality following allogeneic hematopoietic cell transplantation during first remission of acute myeloid leukemia. Bone Marrow Transplantation. PMID 32796950 DOI: 10.1038/S41409-020-01032-9 |
0.471 |
|
| 2020 |
Miyao K, Terakura S, Kimura F, Konuma T, Miyamura K, Yanada M, Kako S, Morhishima S, Uchida N, Toya T, Ozawa Y, Fukuda T, Tanaka M, Sawa M, Takada S, et al. Updated comparison of 7/8 allele-matched unrelated bone marrow transplantation and single-unit umbilical cord blood transplantation as alternative donor in adults with acute leukemia. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 56101. PMID 32784070 DOI: 10.1016/J.Bbmt.2020.08.001 |
0.487 |
|
| 2020 |
Kageyama K, Uchida N, Yamamoto H, Takagi S, Ebihara M, Yuasa M, Kaji D, Nishida A, Ishiwata K, Yamamoto G, Asano-Mori Y, Izutsu K, Wake A, Yoneyama A, Makino S, et al. HHV-6 associated diseases are one of the major factors on higher early CNS complications in CB recipients than in those of BM/PBSC. Bone Marrow Transplantation. PMID 32782352 DOI: 10.1038/S41409-020-01028-5 |
0.352 |
|
| 2020 |
Mizuno S, Yanada M, Kawamura K, Masuko M, Uchida N, Ozawa Y, Iwato K, Ohashi K, Ikegame K, Kim SW, Tanaka M, Eto T, Kanda Y, Fukuda T, Atsuta Y, et al. Allogeneic hematopoietic cell transplantation efficacy in patients with Philadelphia chromosome-positive acute myeloid leukemia in complete remission. Bone Marrow Transplantation. PMID 32737447 DOI: 10.1038/S41409-020-01011-0 |
0.437 |
|
| 2020 |
Muranushi H, Shindo T, Hishizawa M, Tokunaga M, Wake A, Nakano N, Eto T, Hidaka M, Choi I, Miyamoto T, Uchida N, Moriuchi Y, Miyazaki Y, Fukuda T, Ichinohe T, et al. GVHD-free, relapse-free survival provides novel clues for optimizing allogeneic-HSCT for adult T-cell leukemia/lymphoma. Bone Marrow Transplantation. PMID 32665675 DOI: 10.1038/S41409-020-00996-Y |
0.512 |
|
| 2020 |
Uchida N, Matsumoto K, Sakura T, Hidaka M, Miyamoto T, Eto T, Maeda Y, Murayama T, Fujishima N, Yoshimoto G, Morita K, Kishimoto J, Teshima T, Taniguchi S, Yamashita T, et al. Myeloablative intravenous busulfan-containing regimens for allo-HSCT in AML or MDS patients over 54 years old: combined results of three phase II studies. International Journal of Hematology. PMID 32656637 DOI: 10.1007/S12185-020-02941-7 |
0.483 |
|
| 2020 |
Henzan H, Takase K, Kamimura T, Mori Y, Yoshimoto G, Iwasaki H, Nagafuji K, Ogawa R, Eto T, Uchida N, Fujisaki T, Kato K, Minami M, Kikushige Y, Akashi K, et al. Measurable residual disease after the first consolidation predicts the outcomes of patients with acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy. International Journal of Hematology. PMID 32524309 DOI: 10.1007/S12185-020-02911-Z |
0.368 |
|
| 2020 |
Yuasa M, Yamamoto H, Kageyama K, Kaji D, Taya Y, Takagi S, Yamamoto G, Asano-Mori Y, Wake A, Yoneyama A, Makino S, Uchida N, Taniguchi S. Splenomegaly negatively impacts neutrophil engraftment in cord blood transplantation: A single institute analysis of 502 recipients. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 32505808 DOI: 10.1016/J.Bbmt.2020.05.018 |
0.441 |
|
| 2020 |
Kurosawa S, Shimomura Y, Tachibana T, Ishiyama K, Ota S, Kobayashi T, Uchida N, Fukushima K, Ashida T, Matsuoka KI, Kanda J, Ichinohe T, Atsuta Y, Murata M, Aoki J. Outcome of allogeneic hematopoietic stem cell transplantation in patients with myelodysplastic/myeloproliferative neoplasms-unclassifiable: a retrospective nationwide study of the Japan Society for Hematopoietic Cell Transplantation: Allo-HSCT for patients with MDS/MPN-U. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 32454216 DOI: 10.1016/J.Bbmt.2020.05.013 |
0.489 |
|
| 2020 |
Akahoshi Y, Nishiwaki S, Arai Y, Harada K, Najima Y, Kanda Y, Shono K, Ota S, Fukuda T, Uchida N, Shiratori S, Tanaka M, Tanaka J, Atsuta Y, Kako S. Reduced-intensity conditioning is a reasonable alternative for Philadelphia chromosome-positive acute lymphoblastic leukemia among elderly patients who have achieved negative minimal residual disease: a report from the Adult Acute Lymphoblastic Leukemia Working Group of the JSHCT. Bone Marrow Transplantation. 55: 1317-1325. PMID 32447350 DOI: 10.1038/S41409-020-0951-0 |
0.447 |
|
| 2020 |
Imahashi N, Terakura S, Kondo E, Kako S, Uchida N, Kobayashi H, Inamoto Y, Sakai H, Tanaka M, Ishikawa J, Kozai Y, Matsuoka KI, Kimura T, Fukuda T, Atsuta Y, et al. Comparison of reduced-intensity/toxicity conditioning regimens for umbilical cord blood transplantation for lymphoid malignancies. Bone Marrow Transplantation. PMID 32440015 DOI: 10.1038/S41409-020-0905-6 |
0.465 |
|
| 2020 |
Yanada M, Takami A, Yamasaki S, Arai Y, Konuma T, Uchida N, Najima Y, Fukuda T, Tanaka M, Ozawa Y, Ikegame K, Takanashi M, Ichinohe T, Okamoto S, Atsuta Y, et al. Allogeneic hematopoietic cell transplantation for adults with acute myeloid leukemia conducted in Japan during the past quarter century. Annals of Hematology. 99: 1351-1360. PMID 32363416 DOI: 10.1007/S00277-020-04051-0 |
0.532 |
|
| 2020 |
Kida M, Usuki K, Uchida N, Fukuda T, Katayama Y, Kondo T, Eto T, Matsuoka KI, Matsuhashi Y, Ota S, Sawa M, Miyamoto T, Ichinohe T, Kimura T, Atsuta Y, et al. Outcome and Risk Factors for Therapy-Related Myeloid Neoplasms Treated with Allogeneic Stem Cell Transplantation in Japan. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 32320746 DOI: 10.1016/J.Bbmt.2020.04.004 |
0.464 |
|
| 2020 |
Yokoyama H, Takenaka K, Nishida T, Seo S, Shinohara A, Uchida N, Tanaka M, Takahashi S, Onizuka M, Kozai Y, Yasuhiro S, Ozawa Y, Katsuoka Y, Doki N, Sawa M, et al. Favorable effect of cytomegalovirus reactivation on outcomes in cord blood transplantation and its differences among disease risk or types. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 32311477 DOI: 10.1016/J.Bbmt.2020.04.002 |
0.431 |
|
| 2020 |
Kawamura K, Kanda J, Ohashi K, Fukuda T, Iwato K, Eto T, Fujiwara SI, Mori T, Fukushima K, Ozawa Y, Uchida N, Ashida T, Ichinohe T, Atsuta Y, Kanda Y. Influence of HLA 1-3-locus mismatch and antithymocyte globulin administration in unrelated bone marrow transplantation. Annals of Hematology. PMID 32206853 DOI: 10.1007/S00277-020-03995-7 |
0.469 |
|
| 2020 |
Yanada M, Fukuda T, Tanaka M, Ota S, Toya T, Mori T, Uchida N, Ozawa Y, Nakamae H, Kanda Y, Ichinohe T, Atsuta Y, Yano S. Long-term results of reduced-intensity conditioning allogeneic hematopoietic cell transplantation for older patients with acute myeloid leukemia: a retrospective analysis of 10-year follow-up data. Bone Marrow Transplantation. PMID 32203266 DOI: 10.1038/S41409-020-0868-7 |
0.482 |
|
| 2020 |
Yamashita T, Takami A, Uchida N, Fukuda T, Eto T, Shiratori S, Ota S, Akasaka T, Miyakoshi S, Kondo T, Hidaka M, Kanda J, Atsuta Y, Yano S. Reduced-intensity stem cell transplantation for acute myeloid leukemia with fludarabine-based conditioning with intravenous busulfan versus melphalan. Bone Marrow Transplantation. 55: 1955-1965. PMID 32203256 DOI: 10.1038/S41409-020-0856-Y |
0.481 |
|
| 2020 |
Kaito S, Nakajima Y, Hara K, Toya T, Nishida T, Uchida N, Mukae J, Fukuda T, Ozawa Y, Tanaka M, Ikegame K, Katayama Y, Kuriyama T, Kanda J, Atsuta Y, et al. Heterogeneous impact of cytomegalovirus reactivation on nonrelapse mortality in hematopoietic stem cell transplantation. Blood Advances. 4: 1051-1061. PMID 32191806 DOI: 10.1182/Bloodadvances.2019000814 |
0.418 |
|
| 2020 |
Akahoshi Y, Igarashi A, Fukuda T, Uchida N, Tanaka M, Ozawa Y, Kanda Y, Onizuka M, Ichinohe T, Tanaka J, Atsuta Y, Kako S. Impact of graft-versus-host disease and graft-versus-leukemia effect based on minimal residual disease in Philadelphia chromosome-positive acute lymphoblastic leukemia. British Journal of Haematology. PMID 32119132 DOI: 10.1182/Blood-2019-123983 |
0.442 |
|
| 2020 |
Akahoshi Y, Igarashi A, Fukuda T, Uchida N, Tanaka M, Ozawa Y, Kanda Y, Onizuka M, Ichinohe T, Tanaka J, Atsuta Y, Kako S. Impact of graft‐versus‐host disease and graft‐versus‐leukemia effect based on minimal residual disease in Philadelphia chromosome‐positive acute lymphoblastic leukemia British Journal of Haematology. 190: 84-92. PMID 32119132 DOI: 10.1111/Bjh.16540 |
0.436 |
|
| 2020 |
Yabe H, Tabuchi K, Uchida N, Takahashi S, Onishi Y, Aotsuka N, Sugio Y, Ikegame K, Ichinohe T, Takahashi M, Kato K, Atsuta Y, Kanda Y. Could the minimum number of haematopoietic stem cells to obtain engraftment exist in unrelated, single cord blood transplantation? British Journal of Haematology. 189: e56-e60. PMID 32108331 DOI: 10.1111/Bjh.16465 |
0.458 |
|
| 2020 |
Harada K, Fuji S, Seo S, Kanda J, Ueki T, Kimura F, Kato K, Uchida N, Ikegame K, Onizuka M, Matsuoka KI, Doki N, Kawakita T, Onishi Y, Yano S, et al. Comparison of the outcomes after haploidentical and cord blood salvage transplantations for graft failure following allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplantation. PMID 32051535 DOI: 10.1038/S41409-020-0821-9 |
0.528 |
|
| 2020 |
Yokoyama Y, Maie K, Fukuda T, Uchida N, Mukae J, Sawa M, Kubo K, Kurokawa M, Nakamae H, Ichinohe T, Atsuta Y, Chiba S. A high CD34 cell dose is associated with better disease-free survival in patients with low-risk diseases undergoing peripheral blood stem cell transplantation from HLA-matched related donors. Bone Marrow Transplantation. 55: 1726-1735. PMID 32042104 DOI: 10.1038/S41409-020-0817-5 |
0.419 |
|
| 2020 |
Fujimoto A, Hiramoto N, Yamasaki S, Inamoto Y, Ogata M, Sugio Y, Fukuda T, Uchida N, Ikegame K, Matsuoka KI, Shiratori S, Kondo T, Miyamoto T, Eto T, Ichinohe T, et al. Low incidence of post-transplant lymphoproliferative disorder after allogeneic stem cell transplantation in patients with lymphoma treated with rituximab. Hematological Oncology. PMID 31953867 DOI: 10.1002/Hon.2714 |
0.503 |
|
| 2020 |
Mizumura S, Yoshii S, Asano-Mori Y, Narita M, Seki N, Takahashi R, Sakurai R, Yoshino T, Takahashi M, Fukawa M, Uchida N, Taniguchi S, Makino S. CAUSES OF RECIPIENT BLOOD GROUP ANTIGEN POSITIVITY AFTER ENGRAFTMENT AFTER MAJOR/MINOR AND MINOR ABO MISMATCH IN CORD BLOOD TRANSPLANTATION Japanese Journal of Transfusion and Cell Therapy. 66: 718-726. DOI: 10.3925/JJTC.66.718 |
0.317 |
|
| 2020 |
Fuse K, Masuko M, Mizuno S, Harada K, Uchida N, Doki N, Fukuda T, Tanaka M, Ozawa Y, Ikegame K, Eto T, Kanda Y, Ichinohe T, Atsuta Y, Yanada M. Significance of Marker Chromosome on the Outcome of Allogeneic Hematopoietic Stem Cell Transplantation for AML Blood. 136: 40-41. DOI: 10.1182/BLOOD-2020-138979 |
0.311 |
|
| 2020 |
Akahoshi Y, Nishiwaki S, Arai Y, Harada K, Doki N, Kanda Y, Shono K, Ohta S, Fukuda T, Uchida N, Tanaka J, Atsuta Y, Kako S. Myeloablative Vs Reduced-Intensity Conditioning for Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Among Patients over 50 Years Old Who Achieved Negative Minimal Residual Disease Biology of Blood and Marrow Transplantation. 26. DOI: 10.1016/J.Bbmt.2019.12.717 |
0.478 |
|
| 2020 |
Kuno M, Yamasaki S, Fukuda T, Mori T, Uchida N, Katayama Y, Onizuka M, Ichinohe T, Atsuta Y, Inamoto Y. Incidence, Risk Factors and Outcomes of Therapy-Related Myeloid Malignancies after Hematopoietic Cell Transplantation: Analysis of the Japan Society for Hematopoietic Cell Transplantation Late Complications and QOL Working Group Biology of Blood and Marrow Transplantation. 26. DOI: 10.1016/J.Bbmt.2019.12.179 |
0.497 |
|
| 2019 |
Konuma T, Kanda J, Inamoto Y, Hayashi H, Kobayashi S, Uchida N, Sugio Y, Tanaka M, Kobayashi H, Kouzai Y, Takahashi S, Eto T, Mukae J, Matsuhashi Y, Fukuda T, et al. Improvement of early mortality in single-unit cord blood transplantation for Japanese adults from 1998 to 2017. American Journal of Hematology. PMID 31849102 DOI: 10.1002/Ajh.25705 |
0.425 |
|
| 2019 |
Arai Y, Kondo T, Fuse K, Shibasaki Y, Masuko M, Sugita J, Teshima T, Uchida N, Fukuda T, Kakihana K, Ozawa Y, Eto T, Tanaka M, Ikegame K, Mori T, et al. Using a machine learning algorithm to predict acute graft-versus-host disease following allogeneic transplantation. Blood Advances. 3: 3626-3634. PMID 31751471 DOI: 10.1182/Bloodadvances.2019000934 |
0.395 |
|
| 2019 |
Ogata M, Uchida N, Fukuda T, Ikegame K, Kamimura T, Onizuka M, Kato K, Kobayashi H, Sasahara Y, Sawa M, Sawada A, Hasegawa D, Masuko M, Miyamoto T, Okamoto S. Clinical practice recommendations for the diagnosis and management of human herpesvirus-6B encephalitis after allogeneic hematopoietic stem cell transplantation: the Japan Society for Hematopoietic Cell Transplantation. Bone Marrow Transplantation. PMID 31745253 DOI: 10.1038/S41409-019-0752-5 |
0.401 |
|
| 2019 |
Yokoyama H, Morishima Y, Fuji S, Uchida N, Takahashi S, Onizuka M, Tanaka M, Yuju O, Eto T, Ozawa Y, Takada S, Takanashi M, Kato K, Kanda Y, Ichinohe T, et al. Impact of HLA Allele Mismatch at HLA-A, -B, -C, and -DRB1 in Single Cord Blood Transplantation. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 31715305 DOI: 10.1016/J.Bbmt.2019.11.001 |
0.437 |
|
| 2019 |
Ikeda T, Mori K, Kawamura K, Mori T, Hagiwara S, Ueda Y, Kahata K, Uchida N, Tsukada N, Murakami S, Yamamoto M, Takahashi T, Ichinohe T, Onizuka M, Atsuta Y, et al. Comparison between autologous and allogeneic stem cell transplantation as salvage therapy for multiple myeloma relapsing/progressing after autologous stem cell transplantation. Hematological Oncology. PMID 31674032 DOI: 10.1002/Hon.2688 |
0.495 |
|
| 2019 |
Kanda J, Kawase T, Tanaka H, Kojima H, Morishima Y, Uchida N, Nagafuji K, Matsuhashi Y, Ohta T, Onizuka M, Sakura T, Takahashi S, Miyakoshi S, Kobayashi H, Eto T, et al. Effects of haplotype matching on outcomes after adult single cord blood transplantation. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 31605821 DOI: 10.1016/J.Bbmt.2019.09.035 |
0.456 |
|
| 2019 |
Yanada M, Konuma T, Yamasaki S, Kuwatsuka Y, Masuko M, Tanaka M, Ozawa Y, Toya T, Fukuda T, Ota S, Sawa M, Uchida N, Nakamae H, Eto T, Kanda J, et al. Time-Varying Effects of Graft Type on Outcomes for Patients with Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 31605818 DOI: 10.1016/J.Bbmt.2019.09.036 |
0.533 |
|
| 2019 |
Konuma T, Kondo T, Mizuno S, Doki N, Aoki J, Fukuda T, Tanaka M, Sawa M, Katayama Y, Uchida N, Ozawa Y, Morishige S, Matsuoka KI, Ichinohe T, Onizuka M, et al. Conditioning intensity for allogeneic hematopoietic cell transplantation in acute myeloid leukemia patients with poor-prognosis cytogenetics in first complete remission. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 31562960 DOI: 10.1016/J.Bbmt.2019.09.025 |
0.515 |
|
| 2019 |
Morishima Y, Morishima S, Murata M, Arima N, Uchida N, Sugio Y, Takahashi S, Matsuhashi Y, Onizuka M, Eto T, Nagafuji K, Onishi Y, Inoue M, Atsuta Y, Fukuda T, et al. Impact of homozygous conserved extended HLA haplotype on single cord blood transplantation: Lessons for induced pluripotent stem cell banking and transplantation in allogeneic settings. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 31521817 DOI: 10.1016/J.Bbmt.2019.09.009 |
0.478 |
|
| 2019 |
Kanda J, Hayashi H, Ruggeri A, Kimura F, Volt F, Takahashi S, Labopin M, Kako S, Tozatto-Maio K, Yano S, Sanz G, Uchida N, Van Lint MT, Kato S, Mohty M, et al. Prognostic factors for adult single cord blood transplantation among European and Japanese populations: the Eurocord/ALWP-EBMT and JSHCT/JDCHCT collaborative study. Leukemia. PMID 31409921 DOI: 10.1038/S41375-019-0534-5 |
0.506 |
|
| 2019 |
Nishiwaki S, Mizuta S, Ohashi K, Fukuda T, Uchida N, Tachibana T, Onizuka M, Ozawa Y, Onishi Y, Takahashi S, Eto T, Nakamae H, Tanaka J, Ichinohe T, Atsuta Y, et al. Different impact of BCR-ABL transcripts on allogeneic hematopoietic cell transplantation from different graft sources for Ph+ALL with minimal residual disease. American Journal of Hematology. PMID 31403213 DOI: 10.1002/Ajh.25612 |
0.446 |
|
| 2019 |
Akahoshi Y, Nishiwaki S, Mizuta S, Ohashi K, Uchida N, Tanaka M, Fukuda T, Ozawa Y, Takahashi S, Onizuka M, Shiratori S, Nakamae H, Kanda Y, Ichinohe T, Atsuta Y, et al. Tyrosine kinase inhibitor prophylaxis after transplant for Philadelphia chromosome-positive acute lymphoblastic leukemia. Cancer Science. PMID 31402561 DOI: 10.1111/Cas.14167 |
0.466 |
|
| 2019 |
Kawase T, Tanaka H, Kojima H, Uchida N, Ohashi K, Fukuda T, Ozawa Y, Ikegame K, Eto T, Mori T, Miyamoto T, Hidaka M, Shiratori S, Takanashi M, Atsuta Y, et al. Impact of high frequency HLA haplotypes on clinical cytomegalovirus reactivation in allogeneic hematopoietic stem cell transplantation. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 31400501 DOI: 10.1016/J.Bbmt.2019.07.042 |
0.424 |
|
| 2019 |
Kondo E, Shimizu-Koresawa R, Chihara D, Mizuta S, Izutsu K, Ikegame K, Uchida N, Fukuda T, Ichinohe T, Atsuta Y, Suzuki R. Allogeneic haematopoietic stem cell transplantation for primary mediastinal large B-cell lymphoma patients relapsing after high dose chemotherapy with autologous stem cell transplantation: data from the Japan Society for Haematopoietic Cell Transplantation registry. British Journal of Haematology. 186: e219-e223. PMID 31355916 DOI: 10.1111/Bjh.16115 |
0.49 |
|
| 2019 |
Yamasaki S, Nitta H, Kondo E, Uchida N, Miyazaki T, Ishiyama K, Kiyota M, Matsuoka H, Ichinohe T, Fukuda T, Atsuta Y, Suzumiya J, Suzuki R. Effect of allogeneic hematopoietic cell transplantation for patients with T-prolymphocytic leukemia: a retrospective study from the Adult Lymphoma Working Group of the Japan Society for hematopoietic cell transplantation. Annals of Hematology. PMID 31327025 DOI: 10.1007/S00277-019-03759-Y |
0.433 |
|
| 2019 |
Yanada M, Mori J, Aoki J, Masuko M, Harada K, Uchida N, Doki N, Fukuda T, Sakura T, Kanamori H, Sawa M, Kondo T, Katayama Y, Kanda J, Ichinohe T, et al. Allogeneic hematopoietic cell transplantation for patients with a history of multiple relapses of acute myeloid leukemia. Annals of Hematology. PMID 31203422 DOI: 10.1007/S00277-019-03736-5 |
0.536 |
|
| 2019 |
Nakasone H, Kawamura K, Yakushijin K, Shinohara A, Tanaka M, Ohashi K, Ota S, Uchida N, Fukuda T, Nakamae H, Matsuoka KI, Kanda J, Ichinohe T, Atsuta Y, Inamoto Y, et al. BM is preferred over PBSCs in transplantation from an HLA-matched related female donor to a male recipient. Blood Advances. 3: 1750-1760. PMID 31182560 DOI: 10.1182/Bloodadvances.2019000077 |
0.519 |
|
| 2019 |
Nishiwaki S, Miyamura K, Kanda Y, Takanashi M, Uchida N, Fukuda T, Ikegame K, Ohashi K, Eto T, Ozawa Y, Shiratori S, Iwato K, Matsuoka KI, Hidaka M, Ichinohe T, et al. A consideration for efficient unrelated hematopoietic stem cell source acquisition-from an experience of Japan. Bone Marrow Transplantation. PMID 31089273 DOI: 10.1038/S41409-019-0542-0 |
0.311 |
|
| 2019 |
Yanada M, Konuma T, Kuwatsuka Y, Kondo T, Kawata T, Takahashi S, Uchida N, Miyakoshi S, Tanaka M, Ozawa Y, Sawa M, Nakamae H, Aotsuka N, Kanda J, Takanashi M, et al. Unit selection for umbilical cord blood transplantation for adults with acute myeloid leukemia in complete remission: a Japanese experience. Bone Marrow Transplantation. PMID 31068659 DOI: 10.1038/S41409-019-0539-8 |
0.425 |
|
| 2019 |
Harada K, Konuma T, Machida S, Mori J, Aoki J, Uchida N, Ohashi K, Fukuda T, Tanaka M, Ikegame K, Ozawa Y, Iwato K, Eto T, Onizuka M, Ichinohe T, et al. Risk stratification and prognosticators of acute myeloid leukemia with myelodysplasia-related changes patients undergoing allogeneic stem cell transplantation: a retrospective study of the Adult Acute Myeloid Leukemia Working Group of the Japan Society for Hematopoietic Cell Transplantation. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 31054982 DOI: 10.1016/J.Bbmt.2019.04.025 |
0.506 |
|
| 2019 |
Yamasaki S, Aoki J, Mori J, Mizuno S, Uchida N, Ohashi K, Fukuda T, Ikegame K, Eto T, Ogawa Y, Tanaka M, Hidaka M, Iwato K, Sawa M, Ichinohe T, et al. Better disease control before allogeneic stem cell transplantation is crucial to improve the outcomes of transplantation for acute myeloid leukemia patients with extramedullary disease. Bone Marrow Transplantation. PMID 30971777 DOI: 10.1038/S41409-019-0527-Z |
0.502 |
|
| 2019 |
Fuji S, Miyamura K, Kanda Y, Fukuda T, Kobayashi T, Ozawa Y, Iwato K, Uchida N, Eto T, Ashida T, Mori T, Sawa M, Ichinohe T, Atsuta Y, Kanda J, et al. Short-term clinical outcomes after HLA 1-locus mismatched uPBSCT are similar to that after HLA-matched uPBSCT and uBMT. International Journal of Hematology. PMID 30877606 DOI: 10.1007/S12185-019-02631-Z |
0.453 |
|
| 2019 |
Kimura F, Kanda J, Ishiyama K, Yabe T, Yoshifuji K, Fukuda T, Ozawa Y, Iwato K, Eto T, Mori T, Uchida N, Ota S, Sakura T, Ichinohe T, Atsuta Y, et al. ABO blood type incompatibility lost the unfavorable impact on outcome in unrelated bone marrow transplantation. Bone Marrow Transplantation. PMID 30867557 DOI: 10.1038/S41409-019-0496-2 |
0.489 |
|
| 2019 |
Itonaga H, Ishiyama K, Aoki K, Aoki J, Ishikawa T, Uchida N, Ohashi K, Ueda Y, Fukuda T, Sakura T, Ohno Y, Iwato K, Okumura H, Kondo T, Ichinohe T, et al. Increased opportunity for prolonged survival after allogeneic hematopoietic stem cell transplantation in patients aged 60-69 years with myelodysplastic syndrome. Annals of Hematology. 98: 1367-1381. PMID 30854574 DOI: 10.1007/S00277-019-03653-7 |
0.495 |
|
| 2019 |
Ishiyama K, Aoki J, Itonaga H, Uchida N, Takahashi S, Ohno Y, Matsuhashi Y, Sakura T, Onizuka M, Miyakoshi S, Takanashi M, Fukuda T, Atsuta Y, Nakao S, Miyazaki Y. Graft-versus-MDS effect after unrelated cord blood transplantation: a retrospective analysis of 752 patients registered at the Japanese Data Center for Hematopoietic Cell Transplantation. Blood Cancer Journal. 9: 31. PMID 30842405 DOI: 10.1038/S41408-019-0192-X |
0.546 |
|
| 2019 |
Murata M, Takenaka K, Uchida N, Ozawa Y, Ohashi K, Kim SW, Ikegame K, Kanda Y, Kobayashi H, Ishikawa J, Ago H, Hirokawa M, Fukuda T, Atsuta Y, Kondo T. Comparison of outcomes of allogeneic transplantation for primary myelofibrosis among hematopoietic stem cell source groups. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 30826464 DOI: 10.1016/J.Bbmt.2019.02.019 |
0.535 |
|
| 2019 |
Fujimoto A, Hiramoto N, Yamasaki S, Inamoto Y, Uchida N, Maeda T, Mori T, Kanda Y, Kondo T, Shiratori S, Miyakoshi S, Ishiyama K, Ikegame K, Matsuhashi Y, Tanaka J, et al. Risk factors and predictive scoring system for post-transplant lymphoproliferative disorder after hematopoietic stem cell transplantation. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 30794929 DOI: 10.1182/Blood-2018-99-110424 |
0.509 |
|
| 2019 |
Miyamura K, Yamashita T, Atsuta Y, Ichinohe T, Kato K, Uchida N, Fukuda T, Ohashi K, Ogawa H, Eto T, Inoue M, Takahashi S, Mori T, Kanamori H, Yabe H, et al. High probability of follow-up termination among AYA survivors after allogeneic hematopoietic cell transplantation. Blood Advances. 3: 397-405. PMID 30728138 DOI: 10.1182/Bloodadvances.2018026039 |
0.486 |
|
| 2019 |
Itonaga H, Ishiyama K, Aoki K, Aoki J, Ishikawa T, Ohashi K, Fukuda T, Ozawa Y, Ota S, Uchida N, Eto T, Iwato K, Ohno Y, Takanashi M, Ichinohe T, et al. Clinical impact of the loss of chromosome 7q on outcomes of patients with myelodysplastic syndromes treated with allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplantation. PMID 30718803 DOI: 10.1038/S41409-019-0469-5 |
0.385 |
|
| 2019 |
Okamoto Y, Kudo K, Tabuchi K, Tomizawa D, Taga T, Goto H, Yabe H, Nakazawa Y, Koh K, Ikegame K, Yoshida N, Uchida N, Watanabe K, Koga Y, Inoue M, et al. Hematopoietic stem-cell transplantation in children with refractory acute myeloid leukemia. Bone Marrow Transplantation. PMID 30718800 DOI: 10.1182/Blood-2018-99-111322 |
0.516 |
|
| 2019 |
Wakamatsu M, Terakura S, Ohashi K, Fukuda T, Ozawa Y, Kanamori H, Sawa M, Uchida N, Ota S, Matsushita A, Kanda Y, Nakamae H, Ichinohe T, Kato K, Murata M, et al. Impacts of thymoglobulin in patients with acute leukemia in remission undergoing allogeneic HSCT from different donors. Blood Advances. 3: 105-115. PMID 30626574 DOI: 10.1182/Bloodadvances.2018025643 |
0.503 |
|
| 2019 |
Nakasone H, Tabuchi K, Uchida N, Ohno Y, Matsuhashi Y, Takahashi S, Onishi Y, Onizuka M, Kobayashi H, Fukuda T, Ichinohe T, Takanashi M, Kato K, Atsuta Y, Yabe H, et al. Which is more important for the selection of cord blood units for haematopoietic cell transplantation: the number of CD34-positive cells or total nucleated cells? British Journal of Haematology. 185: 166-169. PMID 29808925 DOI: 10.1111/Bjh.15418 |
0.387 |
|
| 2019 |
Yamasaki S, Aoki J, Mori J, Harada K, Sawa M, Uchida N, Ohashi K, Fukuda T, Koh S, Kanamori H, Ogawa H, Okumura H, Ichinohe T, Kanda Y, Tanaka J, et al. Effect of allogeneic stem cell transplantation in patients with minimally differentiated acute myeloid leukemia Journal of Hematopoietic Cell Transplantation. 8: 50-59. DOI: 10.7889/HCT-18-017 |
0.388 |
|
| 2019 |
Yuasa M, Kageyama K, Kaji D, Taya Y, Takagi S, Yamamoto H, Yamamoto G, Asano-Mori Y, Wake A, Yoneyama A, Makino S, Uchida N, Taniguchi S. Low Lymphocyte Count at Day 30 after Single Cord Blood Transplantation Had Negative Impact on Survival, Because of Higher NRM Rate Blood. 134: 4482-4482. DOI: 10.1182/Blood-2019-130662 |
0.44 |
|
| 2019 |
Hisashi Y, Uchida N, Yuasa M, Kageyama K, Kaji D, Mitsuki T, Taya Y, Nishida A, Ishiwata K, Takagi S, Asano-Mori Y, Yamamoto G, Wake A, Taniguchi S. Pre-Engraftment Immune Reactions Has Unique Graft-Versus-Leukemia Effects after Single Cord Blood Transplantation Blood. 134: 2041-2041. DOI: 10.1182/Blood-2019-130550 |
0.436 |
|
| 2019 |
Takagi S, Mitsuki T, Yuasa M, Kageyama K, Kaji D, Taya Y, Nishida A, Ishiwata K, Yamamoto H, Yamamoto G, Asano-Mori Y, Uchida N, Wake A, Taniguchi S. Direct Comparison of Long-Term Outcome of Allogeneic Transplantation for Myelofibrosis in Chronic and Leukemic Stage in a Single Institute Blood. 134: 5382-5382. DOI: 10.1182/Blood-2019-129859 |
0.378 |
|
| 2019 |
Kaji D, Kusakabe M, Sakata-Yanagimoto M, Suehara Y, Hattori K, Ota Y, Yuasa M, Kageyama K, Taya Y, Takagi S, Yamamoto H, Asano-Mori Y, Uchida N, Wake A, Taniguchi S, et al. Clinicopathological Analysis of “Other Iatrogenic Immunodeficiency-Associated Lymphoproliferative Disorders” Reveals a Favorable Outcome Independent of the Effectiveness of Methotrexate Discontinuation in Autoimmune Disease Patients Blood. 134: 4128-4128. DOI: 10.1182/Blood-2019-127521 |
0.308 |
|
| 2019 |
Kako S, Hayakawa F, Imai K, Tanaka J, Mizuta S, Nishiwaki S, Kanamori H, Doki N, Uchida N, Ikegame K, Fukuda T, Ichinohe T, Ota S, Tanaka Y, Murayama T, et al. The Optimal Treatment Strategy for Adult Patients with Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia in First Complete Remission in the Era of High-Intensity Chemotherapy Blood. 134: 4589-4589. DOI: 10.1182/Blood-2019-126012 |
0.317 |
|
| 2019 |
Muranushi H, Shindo T, Hishizawa M, Tokunaga M, Wake A, Nakano N, Eto T, Hidaka M, Choi I, Miyamoto T, Uchida N, Moriuchi Y, Miyazaki Y, Fukuda T, Ichinohe T, et al. Graft-Versus-Host Disease-Free, Relapse-Free Survival in Allogeneic Stem Cell Transplantation for Adult T-Cell Leukemia/Lymphoma Provides a Novel Donor Selection Paradigm Blood. 134: 2008-2008. DOI: 10.1182/Blood-2019-123318 |
0.475 |
|
| 2019 |
Mizuno S, Yanada M, Kawamura K, Yano S, Masuko M, Uchida N, Ozawa Y, Iwato K, Ohashi K, Ikegame K, Kim S, Tanaka M, Eto T, Kanda Y, Fukuda T, et al. Allogeneic Stem Cell Transplantation in Patients with Philadelphia Chromosome-Positive Acute Myeloid Leukemia in Japan Blood. 134: 2045-2045. DOI: 10.1182/Blood-2019-122801 |
0.471 |
|
| 2019 |
Nishiwaki S, Mizuta S, Ohashi K, Fukuda T, Uchida N, Kanamori H, Onizuka M, Ozawa Y, Tanaka J, Ichinohe T, Atsuta Y, Kako S. PF179 DIFFERENT IMPACT OF BCR BREAKPOINT ON THE OUTCOME OF ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION FROM DIFFERENT GRAFT SOURCE FOR PH+ALL IN THE ERA OF TKI Hemasphere. 3: 42. DOI: 10.1097/01.HS9.0000558932.95646.B6 |
0.329 |
|
| 2019 |
Akahoshi Y, Nishiwaki S, Mizuta S, Ohashi K, Uchida N, Kanamori H, Fukuda T, Ozawa Y, Kanda Y, Ichinohe T, Atsuta Y, Kako S. Prophylactic Use of Tyrosine Kinase Inhibitors in Patients with Negative Results for Minimal Residual Disease after Allogeneic Stem Cell Transplantation for Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Biology of Blood and Marrow Transplantation. 25. DOI: 10.1016/J.Bbmt.2018.12.400 |
0.522 |
|
| 2019 |
Fujimoto A, Hiramoto N, Yamasaki S, Inamoto Y, Ogata M, Fukuda T, Uchida N, Ikegame K, Matsuoka K, Shiratori S, Kondo T, Miyamoto T, Ichinohe T, Kanda Y, Atsuta Y, et al. Post-Transplant Lymphoproliferative Disorder In Patients With Lymphoma After Allogeneic Hematopoietic Stem Cell Transplantation Hematological Oncology. 37: 261-262. DOI: 10.1002/Hon.70_2630 |
0.497 |
|
| 2018 |
Uchida N, Torii KU. Stem cells within the shoot apical meristem: identity, arrangement and communication. Cellular and Molecular Life Sciences : Cmls. PMID 30523363 DOI: 10.1007/S00018-018-2980-Z |
0.329 |
|
| 2018 |
Maeda Y, Ugai T, Kondo E, Ikegame K, Murata M, Uchida N, Miyamoto T, Takahashi S, Ohashi K, Nakamae H, Fukuda T, Onizuka M, Eto T, Ota S, Hirokawa M, et al. HLA discrepancy between graft and host rather than that graft and first donor impact the second transplant outcome. Haematologica. PMID 30523056 DOI: 10.3324/Haematol.2018.204438 |
0.475 |
|
| 2018 |
Wada S, Asano-Mori Y, Yamamoto H, Yuasa M, Kageyama K, Kaji D, Nishida A, Ishiwata K, Takagi S, Yamamoto G, Uchida N, Yoneyama A, Makino S, Taniguchi S. No post-transplant pure red cell aplasia development in 106 major ABO incompatible cord blood transplantation. Bone Marrow Transplantation. PMID 30401968 DOI: 10.1038/S41409-018-0375-2 |
0.483 |
|
| 2018 |
Konuma T, Harada K, Yamasaki S, Mizuno S, Uchida N, Takahashi S, Onizuka M, Nakamae H, Hidaka M, Fukuda T, Ohashi K, Kohno A, Matsushita A, Kanamori H, Ashida T, et al. Upfront allogeneic hematopoietic cell transplantation (HCT) versus remission induction chemotherapy followed by allogeneic HCT for acute myeloid leukemia with multilineage dysplasia: A propensity score matched analysis. American Journal of Hematology. PMID 30370944 DOI: 10.1002/Ajh.25336 |
0.536 |
|
| 2018 |
Konuma T, Shimomura Y, Ozawa Y, Ueda Y, Uchida N, Onizuka M, Akiyama M, Mori T, Nakamae H, Ohno Y, Shiratori S, Onishi Y, Kanda Y, Fukuda T, Atsuta Y, et al. Induction chemotherapy followed by allogeneic HCT versus upfront allogeneic HCT for advanced myelodysplastic syndrome: a propensity score matched analysis. Hematological Oncology. PMID 30370627 DOI: 10.1002/Hon.2566 |
0.512 |
|
| 2018 |
Sakaguchi M, Yamaguchi H, Najima Y, Usuki K, Ueki T, Oh I, Mori S, Kawata E, Uoshima N, Kobayashi Y, Kako S, Tajika K, Gomi S, Shono K, Kayamori K, ... ... Uchida N, et al. Prognostic impact of low allelic ratio ITD and mutation in acute myeloid leukemia. Blood Advances. 2: 2744-2754. PMID 30341082 DOI: 10.1182/Bloodadvances.2018020305 |
0.407 |
|
| 2018 |
Mitsuki T, Kimura M, Araoka H, Kageyama K, Takagi S, Yamamoto G, Nakamura S, Miyazaki Y, Uchida N, Yoneyama A, Taniguchi S. Cryptococcal meningitis following umbilical cord blood transplantation, association between the occurrence of cryptococcal infection and tacrolimus discontinuation among allogeneic hematopoietic stem cell recipients. Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy. PMID 30316744 DOI: 10.1016/J.Jiac.2018.09.006 |
0.455 |
|
| 2018 |
Atsuta Y, Kato S, Morishima Y, Ohashi K, Fukuda T, Ozawa Y, Eto T, Iwato K, Uchida N, Ota S, Onizuka M, Ichinohe T, Kanda J, Kanda Y. Comparison of HLA allele mismatch and antigen mismatch in unrelated bone marrow transplantation in patients with leukemia. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 30308326 DOI: 10.1016/J.Bbmt.2018.10.002 |
0.356 |
|
| 2018 |
Uchida N. Cord blood transplantation for leukemia in nonremission The Japanese Journal of Clinical Hematology. 59: 2315-2322. PMID 30305541 DOI: 10.11406/Rinketsu.59.2315 |
0.518 |
|
| 2018 |
Kato K, Uike N, Wake A, Yoshimitsu M, Tobai T, Sawayama Y, Takatsuka Y, Fukuda T, Uchida N, Eto T, Nakashima Y, Kondo T, Taguchi J, Miyamoto T, Nakamae H, et al. The outcome and characteristics of patients with relapsed adult T-cell leukemia/lymphoma after allogeneic hematopoietic stem cell transplantation. Hematological Oncology. PMID 30171618 DOI: 10.1002/Hon.2558 |
0.513 |
|
| 2018 |
Yamasaki S, Chihara D, Kim SW, Izutsu K, Iwato K, Fukuda T, Uchida N, Amano I, Nakazawa H, Kuroda J, Hashimoto H, Ichinohe T, Kanda Y, Atsuta Y, Suzumiya J, et al. Correction to: Impact of hematopoietic stem cell transplantation in patients with relapsed or refractory mantle cell lymphoma. Annals of Hematology. PMID 30046847 DOI: 10.1007/S00277-018-3450-2 |
0.438 |
|
| 2018 |
Konuma T, Mizuno S, Kondo T, Yamaguchi H, Fukuda T, Uchida N, Najima Y, Kanamori H, Ota S, Nakamae H, Nakamae M, Mizuno I, Sugita J, Onishi Y, Yokota A, et al. Allogeneic hematopoietic cell transplantation in adult acute myeloid leukemia with 11q23 abnormality: a retrospective study of the Adult Acute Myeloid Leukemia Working Group of the Japan Society for Hematopoietic Cell Transplantation (JSHCT). Annals of Hematology. 97: 2173-2183. PMID 29978286 DOI: 10.1007/S00277-018-3419-1 |
0.465 |
|
| 2018 |
Akahoshi Y, Mizuta S, Shimizu H, Uchida N, Fukuda T, Kanamori H, Onizuka M, Ozawa Y, Ohashi K, Ohta S, Eto T, Tanaka J, Atsuta Y, Kako S. Additional cytogenetic abnormalities with Philadelphia chromosome-positive acute lymphoblastic leukemia on allogeneic stem cell transplantation in the tyrosine kinase inhibitor era. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 29908230 DOI: 10.1016/J.Bbmt.2018.06.006 |
0.473 |
|
| 2018 |
Konuma T, Yanada M, Yamasaki S, Kuwatsuka Y, Fukuda T, Kobayashi T, Ozawa Y, Uchida N, Ota S, Hoshino T, Takahashi S, Kanda Y, Ueda Y, Takanashi M, Kanda J, et al. Allogeneic haematopoietic cell transplantation for adult acute myeloid leukaemia in second remission: a retrospective study of the Adult Acute Myeloid Leukaemia Working Group of the Japan Society for Haematopoietic Cell Transplantation (JSHCT). British Journal of Haematology. PMID 29808919 DOI: 10.1111/Bjh.15399 |
0.472 |
|
| 2018 |
Yamasaki S, Chihara D, Kim SW, Izutsu K, Iwato K, Fukuda T, Uchida N, Amano I, Nakazawa H, Kuroda J, Hashimoto H, Ichinohe T, Kanda Y, Atsuta Y, Suzumiya J, et al. Impact of hematopoietic stem cell transplantation in patients with relapsed or refractory mantle cell lymphoma. Annals of Hematology. PMID 29610968 DOI: 10.1007/S00277-018-3318-5 |
0.438 |
|
| 2018 |
Yoshinaga N, Kanda J, Aisa Y, Hagiwara S, Mori T, Fukuda T, Ishida Y, Hashimoto H, Iwato K, Kanda Y, Kurokawa M, Nakazawa H, Ota S, Uchida N, Ichinohe T, et al. Impact of HIV Infection on Transplant Outcomes after Autologous Peripheral Blood Stem Cell Transplantation: A Retrospective Study of Japanese Registry Data. Biology of Blood and Marrow Transplantation. 24: 1596-1601. PMID 29551446 DOI: 10.1016/J.Bbmt.2018.03.009 |
0.342 |
|
| 2018 |
Uchida N, Takahashi K, Iwasaki R, Yamada R, Yoshimura M, Endo TA, Kimura S, Zhang H, Nomoto M, Tada Y, Kinoshita T, Itami K, Hagihara S, Torii KU. Chemical hijacking of auxin signaling with an engineered auxin-TIR1 pair. Nature Chemical Biology. PMID 29355850 DOI: 10.1038/Nchembio.2555 |
0.575 |
|
| 2018 |
Muta T, Miyamoto T, Kamimura T, Kanda Y, Nohgawa M, Ueda Y, Iwato K, Sasaki O, Mori T, Uchida N, Iida S, Fukuda T, Atsuta Y, Sunami K. Significance of Salvage Autologous Stem Cell Transplantation for Relapsed Multiple Myeloma: A Nationwide Retrospective Study in Japan. Acta Haematologica. 139: 35-44. PMID 29339642 DOI: 10.1159/000484652 |
0.472 |
|
| 2018 |
Ogawa H, Ikegame K, Daimon T, Uchida N, Fukuda T, Kakihana K, Eto T, Ozawa Y, Kanamori H, Hidaka M, Iwato Y, Ichinohe T, Takanashi M, Atsuta Y, Kanda Y. Impact of pretransplant leukemic blast% in bone marrow and peripheral blood on transplantation outcomes of patients with acute myeloid leukemia undergoing allogeneic stem cell transplantation in non-CR. Bone Marrow Transplantation. PMID 29330394 DOI: 10.1038/S41409-017-0028-X |
0.502 |
|
| 2018 |
Takagi S, Yuasa M, Uchida N, Ebihara M, Mitsuki T, Kageyama K, Kaji D, Taya Y, Nishida A, Ishiwata K, Yamamoto H, Yamamoto G, Asano-Mori Y, Koike Y, Makino S, et al. Cord Blood Units Containing Lower CD34+ Cells (0.5 - 1.0 x 105 /kg) Could be Alternative Donor Candidates for Single-Unit Cord Blood Transplantation for Adults: A Retrospective Study of 421 Patients in a Single Institute Blood. 132: 2089-2089. DOI: 10.1182/Blood-2018-99-119827 |
0.471 |
|
| 2018 |
Ebihara M, Takagi S, Uesaka Y, Mitsuki T, Yuasa M, Kageyama K, Kaji D, Taya Y, Nishida A, Ishiwata K, Yamamoto H, Yamamoto G, Asano-Mori Y, Koike Y, Makino S, ... ... Uchida N, et al. High-Dose Intravenous Immunoglobulin and Immunosuppressive Therapy Have Therapeutic Potential for Non-Infectious Myelopathy and Peripheral Neuropathy Following Cord Blood Transplantation Blood. 132: 3390-3390. DOI: 10.1182/Blood-2018-99-116308 |
0.424 |
|
| 2018 |
Yuasa M, Ebihara M, Kaji D, Kageyama K, Nishida A, Takagi S, Yamamoto H, Yamamoto G, Asano-Mori Y, Wake A, Yoneyama A, Makino S, Uchida N, Taniguchi S. Allogeneic Stem Cell Transplantation Overcomes Negative Impact on Relapse Rate and Progression Free Survival in 294 Non-Remission AML Patients with Adverse Cytogenetic Abnormalities Other Than Monosomal or Complex Karyotype Blood. 132: 3469-3469. DOI: 10.1182/Blood-2018-99-116212 |
0.479 |
|
| 2018 |
Arai Y, Kondo T, Fuse K, Shibasaki Y, Masuko M, Sugita J, Teshima T, Uchida N, Fukuda T, Ohashi K, Ozawa Y, Ichinohe T, Kanda Y, Atsuta Y. Prediction of Acute Graft-Versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation Using a Machine Learning Algorithm Blood. 132: 68-68. DOI: 10.1182/Blood-2018-99-114794 |
0.341 |
|
| 2018 |
Murata M, Takenaka K, Uchida N, Ozawa Y, Ohashi K, Kim S, Ikegame K, Atsuta Y, Hirokawa M, Fukuda T, Kondo T. Comparison of Outcomes of Allogeneic Hematopoietic Cell Transplantation for Primary Myelofibrosis Among Stem Cell Source Groups Blood. 132: 3466-3466. DOI: 10.1182/Blood-2018-99-114745 |
0.437 |
|
| 2018 |
Nakano N, Nakasone H, Fuji S, Shinohara A, Suzuki R, Utsunomiya A, Eto T, Sawayama Y, Nakachi S, Uchida N, Fukuda T, Kanda J, Atsuta Y, Ogata M. Impact of Pretransplant HTLV-1 Seropositivity on Hematopoietic Stem Cell Transplantation for the Diseases Other Than ATLL- an Analysis on Behalf of JSHCT Complication Working Group- Blood. 132: 4641-4641. DOI: 10.1182/Blood-2018-99-114111 |
0.448 |
|
| 2018 |
Nakasone H, Kawamura K, Yakushijin K, Shinohara A, Kanamori H, Ohashi K, Fukuda T, Uchida N, Nakamae H, Kanda J, Ichinohe T, Atsuta Y, Inamoto Y, Seo S, Kimura F, et al. Would Bone Marrow be Associated with Superior Outcomes Compared with Peripheral Blood for Male Recipients with Female Donors in HLA-Matched Related Transplantation? Blood. 132: 4669-4669. DOI: 10.1182/Blood-2018-99-113790 |
0.416 |
|
| 2018 |
Shimomura Y, Hara M, Konuma T, Itonaga H, Ohashi K, Ozawa Y, Eto T, Uchida N, Mori T, Tanaka J, Fukuda T, Atsuta Y, Ishikawa T, Ishiyama K. Allogeneic Hematopoietic Stem Cell Transplantation for the Treatment of Myelodysplastic Syndrome in Adolescent and Young Adult Patients Blood. 132: 3452-3452. DOI: 10.1182/Blood-2018-99-113275 |
0.523 |
|
| 2018 |
Shimomura Y, Hara M, Tachibana T, Ohashi K, Ozawa Y, Eto T, Uchida N, Mori T, Kanda J, Ichinohe T, Atsuta Y, Ishikawa T, Ishiyama K. Epidemiology of Second Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Relapsed Myelodysplastic Syndrome Blood. 132: 3453-3453. DOI: 10.1182/Blood-2018-99-113258 |
0.484 |
|
| 2018 |
Nagafuji K, Miyamoto T, Eto T, Ogawa R, Uchida N, Takase K, Kawano N, Fujisaki T, Kamimura T, Wake A, Okumura H, Miyazaki Y, Takamatsu Y, Kurokawa T, Ohno Y, et al. Minimal Residual Disease (MRD) Status after Induction Therapy Is a Strong Prognostic Factor in the Treatment of Adult Ph (-) Â Acute Lymphoblastic Leukemia (ALL): Results of a Prospective Study (ALL MRD2008 Study) Blood. 132: 3970-3970. DOI: 10.1182/Blood-2018-99-112848 |
0.303 |
|
| 2018 |
Maeda Y, Ugai T, Kondo E, Ikegame K, Murata M, Uchida N, Miyamoto T, Takahashi S, Ohashi K, Nakamae H, Hirokawa M, Ichinohe T, Atsuta Y, Kanda Y, Kanda J. Who Is the Best Donor for the Second Transplant?: HLA Discrepancy between Graft and Host Rather Than That Graft and First Donor May Impact the Second Transplant Outcome from the JSHCT Blood. 132: 4635-4635. DOI: 10.1182/Blood-2018-99-112796 |
0.398 |
|
| 2018 |
Morishima Y, Morishima S, Murata M, Arima N, Uchida N, Ohno Y, Takahashi S, Matsuhashi Y, Onizuka M, Eto T, Atsuta Y, Fukuda T, Ichinohe T, Kato S, Kanda J. Impact of Homozygous Conserved Extended HLA Haplotypes on Cord Blood Transplantation: Implications for Induced Pluripotent Stem Cell Banking and Transplantation Blood. 132: 2097-2097. DOI: 10.1182/Blood-2018-99-110193 |
0.49 |
|
| 2018 |
Wakamatsu M, Uchida N, Ohashi K, Fukuda T, Kanamori H, Ozawa Y, Ichinohe T, Kanda Y, Murata M, Kato K, Atsuta Y, Teshima T. Role of Anti-Lymphocyte Globulin in Prophylaxis of Graft-Versus-Host Disease after Allogeneic Stem Cell Transplantation in Patients with Acute Leukemia Biology of Blood and Marrow Transplantation. 24. DOI: 10.1016/J.Bbmt.2017.12.652 |
0.5 |
|
| 2018 |
Asano-Mori Y, Kaji D, Kageyama K, Yuasa M, Nishida A, Takagi S, Yamamoto H, Yamamoto G, Yoneyama A, Makino S, Uchida N, Taniguchi S. Combination Strategy with Low-Dose Acyclovir and Vaccination Against Varicella Zoster Reactivation after Hematopoietic Stem Cell Transplantation Biology of Blood and Marrow Transplantation. 24. DOI: 10.1016/J.Bbmt.2017.12.460 |
0.393 |
|
| 2018 |
Uchida N, Eto T, Sakura T, Aisa Y, Fujishima N, Gomyo H, Nishikawa A, Maeda Y, Miyamoto T, Nagafuji K, Kishimoto J, Teshima T, Taniguchi S, Harada M, Akashi K. Prospective Multicenter Phase II Study of Myeloablative Conditioning of Iv Busulfan, Fludarabine +/− Low Dose TBI Intensified by G-CSF-Priming and Cytarabine for Myeloid Malignancies in Older Patients (≥55 Years): Final Analysis of the JSCT FB13 Study Biology of Blood and Marrow Transplantation. 24: S408. DOI: 10.1016/J.Bbmt.2017.12.421 |
0.312 |
|
| 2018 |
Uchida N, Matsumoto K, Sakura T, Hidaka M, Miyamoto T, Eto T, Maeda Y, Murayama T, Fujishima N, Yoshimoto G, Morita K, Kishimoto J, Taniguchi S, Mori S, Akashi K, et al. Myeloablative Conditioning Using Intravenous Busulfan for Older Patients (55 Years and Older) in Allogeneic Stem Cell Transplantation -Final Analysis of FB09 and Fb10 Study of JSCT- Biology of Blood and Marrow Transplantation. 24: S405-S406. DOI: 10.1016/J.Bbmt.2017.12.417 |
0.467 |
|
| 2018 |
Takagi S, Yoneyama A, Uchida N, Mitsuki T, Yuasa M, Kageyama K, Kaji D, Taya Y, Nishida A, Ishiwata K, Yamamoto H, Yamamoto G, Asano-Mori Y, Koike Y, Makino S, et al. CD34 + CD38- Leukemia Stem Cell and Karyotype Predicts Relapse after Cord Blood Transplantation for Acute Myeloid Leukemia with Myelodysplasia-Related Changes Biology of Blood and Marrow Transplantation. 24. DOI: 10.1016/J.Bbmt.2017.12.213 |
0.39 |
|
| 2017 |
Uchida N. Progresses in pretransplant conditioning strategies The Japanese Journal of Clinical Hematology. 58: 2425-2431. PMID 29332879 DOI: 10.11406/Rinketsu.58.2425 |
0.432 |
|
| 2017 |
Miyamoto T, Nagafuji K, Fujisaki T, Uchida N, Matsue K, Henzan H, Ogawa R, Takase K, Aoki T, Hidaka M, Teshima T, Taniguchi S, Akashi K, Harada M. Prospective randomization of post-remission therapy comparing autologous peripheral blood stem cell transplantation versus high-dose cytarabine consolidation for acute myelogenous leukemia in first remission. International Journal of Hematology. PMID 29243031 DOI: 10.1007/S12185-017-2389-8 |
0.467 |
|
| 2017 |
Kimura Y, Tasaka M, Torii KU, Uchida N. ERECTA-family genes coordinate stem cell functions between the epidermal and internal layers of the shoot apical meristem. Development (Cambridge, England). PMID 29217754 DOI: 10.1242/Dev.156380 |
0.305 |
|
| 2017 |
Arima N, Kanda J, Tanaka J, Yabe T, Morishima Y, Kim SW, Najima Y, Ozawa Y, Eto T, Kanamori H, Mori T, Kobayashi N, Kondo T, Nakamae H, Uchida N, et al. Japanese Recipients Who Receive HLA-Matched Hematopoietic Cell Transplantation for Myeloid Leukemia Have an Advantage to Prevent Recurrence if They Have Homozygous HLA-C1. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 29197675 DOI: 10.1016/J.Bbmt.2017.11.029 |
0.409 |
|
| 2017 |
Itonaga H, Aoki K, Aoki J, Ishikawa T, Ishiyama K, Uchida N, Sakura T, Ohashi K, Kurokawa M, Ozawa Y, Matsuoka KI, Nakamura Y, Kimura F, Iwato K, Nawa Y, et al. Prognostic Impact of Donor Source on Allogeneic Hematopoietic Stem Cell Transplantation Outcomes in Adults with Chronic Myelomonocytic Leukemia: A Nationwide Retrospective Analysis in Japan. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 29196081 DOI: 10.1016/J.Bbmt.2017.11.016 |
0.528 |
|
| 2017 |
Yamamoto C, Ogawa H, Fukuda T, Igarashi A, Okumura H, Uchida N, Hidaka M, Nakamae H, Matsuoka KI, Eto T, Ichinohe T, Atsuta Y, Kanda Y. Impact of a Low CD34+ Cell Dose on Allogeneic Peripheral Blood Stem Cell Transplantation. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 29196077 DOI: 10.1016/J.Bbmt.2017.10.043 |
0.465 |
|
| 2017 |
Yoshimitsu M, Tanosaki R, Kato K, Ishida T, Choi I, Takatsuka Y, Fukuda T, Eto T, Hidaka M, Uchida N, Miyamoto T, Nakashima Y, Moriuchi Y, Nagafuji K, Miyazaki Y, et al. Risk Assessment in Adult T-Cell Leukemia/Lymphoma Treated with Allogeneic Hematopoietic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 29155320 DOI: 10.1016/J.Bbmt.2017.11.005 |
0.475 |
|
| 2017 |
Harada K, Doki N, Aoki J, Mori J, Machida S, Masuko M, Uchida N, Najima Y, Fukuda T, Kanamori H, Ogawa H, Ota S, Ogawa K, Takahashi S, Kasai M, et al. Outcomes after allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia harboring t(7;11)(p15;p15). Haematologica. PMID 29146707 DOI: 10.3324/Haematol.2017.179804 |
0.467 |
|
| 2017 |
Saito Y, Mochizuki Y, Ogahara I, Watanabe T, Hogdal L, Takagi S, Sato K, Kaneko A, Kajita H, Uchida N, Fukami T, Shultz LD, Taniguchi S, Ohara O, Letai AG, et al. Overcoming mutational complexity in acute myeloid leukemia by inhibition of critical pathways. Science Translational Medicine. 9. PMID 29070697 DOI: 10.1126/Scitranslmed.Aao1214 |
0.329 |
|
| 2017 |
Arai Y, Kondo T, Shigematsu A, Tanaka J, Ohashi K, Fukuda T, Hidaka M, Kobayashi N, Iwato K, Sakura T, Onizuka M, Ozawa Y, Eto T, Kurokawa M, Kahata K, ... Uchida N, et al. Improved prognosis with additional medium-dose VP16 to CY/TBI in allogeneic transplantation for high risk ALL in adults. American Journal of Hematology. PMID 28983949 DOI: 10.1002/Ajh.24933 |
0.49 |
|
| 2017 |
Kawamura K, Kako S, Mizuta S, Ishiyama K, Aoki J, Yano S, Fukuda T, Uchida N, Ozawa Y, Eto T, Iwato K, Kanamori H, Kahata K, Kondo T, Sawa M, et al. Comparison of Conditioning with Fludarabine/Busulfan and Fludarabine/Melphalan in Allogeneic Transplant Recipients 50 Years or Older. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 28890406 DOI: 10.1016/J.Bbmt.2017.09.003 |
0.442 |
|
| 2017 |
Onishi Y, Mori T, Kako S, Koh H, Uchida N, Kondo T, Kobayashi T, Yabe H, Miyamoto T, Kato K, Suzuki R, Nakao S, Yamazaki H. Outcome of Second Transplantation Using Umbilical Cord Blood for Graft Failure after Allogeneic Hematopoietic Stem Cell Transplantation for Aplastic Anemia. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 28844947 DOI: 10.1016/J.Bbmt.2017.08.020 |
0.549 |
|
| 2017 |
Yanada M, Mori J, Aoki J, Harada K, Mizuno S, Uchida N, Kurosawa S, Toya T, Kanamori H, Ozawa Y, Ogawa H, Henzan H, Iwato K, Sakura T, Ota S, et al. Effect of cytogenetic risk status on outcomes for patients with acute myeloid leukemia undergoing various types of allogeneic hematopoietic cell transplantation: an analysis of 7812 patients. Leukemia & Lymphoma. 1-9. PMID 28750566 DOI: 10.1080/10428194.2017.1357173 |
0.489 |
|
| 2017 |
Kawamura K, Kanda J, Fuji S, Murata M, Ikegame K, Yoshioka K, Fukuda T, Ozawa Y, Uchida N, Iwato K, Sakura T, Hidaka M, Hashimoto H, Ichinohe T, Atsuta Y, et al. Impact of the presence of HLA 1-locus mismatch and the use of low-dose antithymocyte globulin in unrelated bone marrow transplantation. Bone Marrow Transplantation. PMID 28714944 DOI: 10.1038/bmt.2017.153 |
0.385 |
|
| 2017 |
Terakura S, Kuwatsuka Y, Yamasaki S, Wake A, Kanda J, Inamoto Y, Mizuta S, Yamaguchi T, Uchida N, Kouzai Y, Aotsuka N, Ogawa H, Kanamori H, Nishiwaki K, Miyakoshi S, et al. GvHD prophylaxis after single-unit reduced intensity conditioning cord blood transplantation in adults with acute leukemia Bone Marrow Transplantation. 52: 1261-1267. PMID 28604665 DOI: 10.1038/Bmt.2017.116 |
0.443 |
|
| 2017 |
Komeno Y, Uchida N, Satoh Y, Uryu H, Iwata Y, Masuda A, Iihara K, Yatomi Y, Taniguchi S, Ryu T. Bosutinib as a fourth-line therapy for a patient with T315I-positive lymphoid blastic phase chronic myeloid leukemia: A case report. Oncology Letters. 13: 4285-4289. PMID 28599428 DOI: 10.3892/ol.2017.5989 |
0.347 |
|
| 2017 |
Ota H, Yamamoto H, Kimura M, Araoka H, Fujii T, Umeyama T, Ohno H, Miyazaki Y, Kaji D, Taya Y, Nishida A, Ishiwata K, Tsuji M, Takagi S, Asano-Mori Y, ... ... Uchida N, et al. Successful Treatment of Pulmonary Mucormycosis Caused by Cunninghamella bertholletiae with High-Dose Liposomal Amphotericin B (10 mg/kg/day) Followed by a Lobectomy in Cord Blood Transplant Recipients. Mycopathologia. PMID 28577122 DOI: 10.1007/S11046-017-0149-1 |
0.466 |
|
| 2017 |
Kondo T, Nagamura-Inoue T, Tojo A, Nagamura F, Uchida N, Nakamae H, Fukuda T, Mori T, Yano S, Kurokawa M, Ueno H, Kanamori H, Hashimoto H, Onizuka M, Takanashi M, et al. Clinical impact of pre-transplant use of multiple tyrosine kinase inhibitors on the outcome of allo-HSCT for CML. American Journal of Hematology. PMID 28543934 DOI: 10.1002/Ajh.24793 |
0.454 |
|
| 2017 |
Mizutani M, Takami A, Hara M, Mizuno S, Yanada M, Chou T, Uchiyama H, Ohashi K, Miyamoto T, Ozawa Y, Imataki O, Kobayashi N, Uchida N, Kanamori H, Kamimura T, et al. Comparison of Autologous and Unrelated Transplants for Cytogenetically Normal Acute Myeloid Leukemia. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 28533061 DOI: 10.1016/J.Bbmt.2017.05.008 |
0.538 |
|
| 2017 |
Mori J, Yanada M, Uchida N, Fukuda T, Sakura T, Hidaka M, Watakabe-Inamoto K, Kanamori H, Ogawa H, Ichinohe T, Tanaka J, Atsuta Y, Yano S. Outcomes of Allogeneic Hematopoietic Cell Transplantation in Acute Myeloid Leukemia Patients with Abnormalities of the Short Arm of Chromosome 17. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 28455005 DOI: 10.1016/J.Bbmt.2017.04.020 |
0.479 |
|
| 2017 |
Yamasaki S, Suzuki R, Hatano K, Fukushima K, Iida H, Morishima S, Suehiro Y, Fukuda T, Uchida N, Uchiyama H, Ikeda H, Yokota A, Tsukasaki K, Yamaguchi H, Kuroda J, et al. Therapy-related acute myeloid leukemia and myelodysplastic syndrome after hematopoietic cell transplantation for lymphoma. Bone Marrow Transplantation. PMID 28368379 DOI: 10.1038/bmt.2017.52 |
0.405 |
|
| 2017 |
Shigematsu A, Kako S, Mitsuhashi K, Iwato K, Uchida N, Kanda Y, Fukuda T, Sawa M, Senoo Y, Ogawa H, Miyamura K, Takada S, Nagamura-Inoue T, Morishima Y, Ichinohe T, et al. Allogeneic stem cell transplantation for adult patients with acute lymphoblastic leukemia who had central nervous system involvement: a study from the Adult ALL Working Group of the Japan Society for Hematopoietic Cell Transplantation. International Journal of Hematology. PMID 28197965 DOI: 10.1007/S12185-017-2197-1 |
0.472 |
|
| 2017 |
Kimura M, Araoka H, Yamamoto H, Asano-Mori Y, Nakamura S, Yamagoe S, Ohno H, Miyazaki Y, Abe M, Yuasa M, Kaji D, Kageyama K, Nishida A, Ishiwata K, Takagi S, ... ... Uchida N, et al. Clinical and microbiological characteristics of breakthrough candidemia in allogeneic hematopoietic stem cell transplant recipients in a Japanese hospital. Antimicrobial Agents and Chemotherapy. PMID 28115352 DOI: 10.1128/Aac.01791-16 |
0.366 |
|
| 2017 |
Yanada M, Kurosawa S, Kobayashi T, Ozawa Y, Kanamori H, Kobayashi N, Sawa M, Nakamae H, Uchida N, Hashimoto H, Fukuda T, Hirokawa M, Atsuta Y, Yano S. Reduced-intensity conditioning allogeneic hematopoietic cell transplantation for younger patients with acute myeloid leukemia: a registry-based study. Bone Marrow Transplantation. PMID 28112749 DOI: 10.1038/Bmt.2016.358 |
0.516 |
|
| 2017 |
Kurita N, Gosho M, Yokoyama Y, Kato T, Obara N, Sakata-Yanagimoto M, Hasegawa Y, Uchida N, Takahashi S, Kouzai Y, Atsuta Y, Kurata M, Ichinohe T, Chiba S. A phase I/II trial of intrabone marrow cord blood transplantation and comparison of the hematological recovery with the Japanese nationwide database. Bone Marrow Transplantation. PMID 28067880 DOI: 10.1038/bmt.2016.319 |
0.333 |
|
| 2017 |
Fujiwara H, Fuji S, Wake A, Kato K, Takatsuka Y, Fukuda T, Taguchi J, Uchida N, Miyamoto T, Hidaka M, Miyazaki Y, Tomoyose T, Onizuka M, Takanashi M, Ichinohe T, et al. Dismal outcome of allogeneic hematopoietic stem cell transplantation for relapsed adult T-cell leukemia/lymphoma, a Japanese nation-wide study. Bone Marrow Transplantation. PMID 28067877 DOI: 10.1038/Bmt.2016.313 |
0.347 |
|
| 2017 |
Konuma T, Kondo T, Yamashita T, Uchida N, Fukuda T, Ozawa Y, Ohashi K, Ogawa H, Kato C, Takahashi S, Kanamori H, Eto T, Nakaseko C, Kohno A, Ichinohe T, et al. Outcome of allogeneic hematopoietic stem cell transplantation in adult patients with acute myeloid leukemia harboring trisomy 8. Annals of Hematology. PMID 28058493 DOI: 10.1007/S00277-016-2909-2 |
0.488 |
|
| 2017 |
Nakasone H, Fuji S, Yakushijin K, Onizuka M, Shinohara A, Ohashi K, Miyamura K, Uchida N, Takanashi M, Ichinohe T, Atsuta Y, Fukuda T, Ogata M. Impact of total body irradiation on successful neutrophil engraftment in unrelated bone marrow or cord blood transplantation. American Journal of Hematology. 92: 171-178. PMID 27880980 DOI: 10.1002/Ajh.24613 |
0.464 |
|
| 2017 |
Yamasaki S, Hirakawa A, Aoki J, Uchida N, Fukuda T, Ogawa H, Ohashi K, Kondo T, Eto T, Kanamori H, Okumura H, Iwato K, Ichinohe T, Kanda J, Onizuka M, et al. Role of reduced-intensity conditioning allogeneic hematopoietic cell transplantation in older patients with de novo acute myeloid leukemia. Annals of Hematology. 96: 289-297. PMID 27838773 DOI: 10.1007/S00277-016-2872-Y |
0.493 |
|
| 2017 |
Hashii Y, Kosaka Y, Watanabe K, Kato K, Imaizumi M, Kaneko T, Sunami S, Watanabe A, Hiramatsu H, Koga Y, Hirayama M, Nakao T, Hata T, Uchida N, Ishiyama K, et al. Clinical Significance of Wt1 mRNA Levels in Japanese Acute Lymphoblastic Leukemia Patients Journal of Leukemia. 5: 1-10. DOI: 10.4172/2329-6917.1000243 |
0.346 |
|
| 2017 |
Ogura S, Kimura M, Araoka H, Yuasa M, Kaji D, Kageyama K, Nishida A, Takagi S, Yamamoto H, Yamamoto G, Asano-Mori Y, Uchida N, Taniguchi S, Yoneyama A. The Characteristics of Febrile Neutropenia among Allogeneic Hematopoietic Stem Cell Transplant Recipients on Levofloxacin Prophylaxis Open Forum Infectious Diseases. 4. DOI: 10.1093/Ofid/Ofx163.1928 |
0.481 |
|
| 2017 |
Itonaga H, Ishiyama K, Aoki J, Aoki K, Ishikawa T, Uchida N, Ohashi K, Ueda Y, Fukuda T, Ichinohe T, Takanashi M, Atsuta Y, Miyazaki Y. Allogeneic Hematopoietic Stem Cell Transplantation for Patients Aged 60 Years or Older with Myelodysplastic Syndrome in Japan Leukemia Research. 55: S26. DOI: 10.1016/S0145-2126(17)30153-4 |
0.352 |
|
| 2017 |
Kageyama K, Yamamoto H, Uchida N, Yuasa M, Nishida A, Ishiwata K, Takagi S, Yamamoto G, Asano-Mori Y, Izutsu K, Wake A, Yoneyama A, Makino S, Taniguchi S. Promising Outcome of Allogeneic Stem Cell Transplantation for AML of Primary Induction Failure; A Single Center Analysis of 44 Cases Biology of Blood and Marrow Transplantation. 23. DOI: 10.1016/J.Bbmt.2016.12.412 |
0.442 |
|
| 2017 |
Yuasa M, Yamamoto H, Yamaguchi K, Kageyama K, Kaji D, Nishida A, Ishiwata K, Takagi S, Yamamoto G, Asano-Mori Y, Uchida N, Izutsu K, Wake A, Yoneyama A, Makino S, et al. Neutrophil (>100) and Lymphocyte Recovery Starts Earlier in Cord Blood Than in Bone Marrow Transplant—a Single Institute Analysis of 277 Unrelated Transplants Biology of Blood and Marrow Transplantation. 23. DOI: 10.1016/J.Bbmt.2016.12.356 |
0.411 |
|
| 2017 |
Yamamoto H, Uchida N, Yamaguchi K, Yuasa M, Kageyama K, Nishida A, Ishiwata K, Takagi S, Yamamoto G, Asano-Mori Y, Izutsu K, Wake A, Taniguchi S. Promising Outcomes of Urgent Cord Blood Transplantation for Fulminant Aplastic Anemia in Adults Biology of Blood and Marrow Transplantation. 23. DOI: 10.1016/J.Bbmt.2016.12.295 |
0.423 |
|
| 2016 |
Terakura S, Wake A, Inamoto Y, Murata M, Sakai R, Yamaguchi T, Takahashi S, Uchida N, Onishi Y, Ohashi K, Ozawa Y, Kanamori H, Yamaguchi H, Fukuda T, Ichinohe T, et al. Exploratory research for optimal GvHD prophylaxis after single unit CBT in adults: short-term methotrexate reduced the incidence of severe GvHD more than mycophenolate mofetil. Bone Marrow Transplantation. PMID 27941766 DOI: 10.1038/Bmt.2016.255 |
0.458 |
|
| 2016 |
Yokoyama H, Kanda J, Fuji S, Kim SW, Fukuda T, Najima Y, Ohno H, Uchida N, Ueda Y, Eto T, Iwato K, Kobayashi H, Ozawa Y, Kondo T, Ichinohe T, et al. Impact of HLA allele mismatch in unrelated bone marrow transplantation with reduced intensity conditioning regimen. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 27845190 DOI: 10.1016/J.Bbmt.2016.11.009 |
0.424 |
|
| 2016 |
Konuma T, Miyazaki Y, Uchida N, Ohashi K, Kondo T, Nakamae H, Takahashi S, Mori T, Ozawa Y, Kato C, Iwato K, Fukuda T, Ichinohe T, Atsuta Y, Ishiyama K, et al. Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with Myelodysplastic Syndrome Harboring Trisomy 8. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 27777139 DOI: 10.1016/J.Bbmt.2016.10.015 |
0.474 |
|
| 2016 |
Takenaka K, Shimoda K, Uchida N, Shimomura T, Nagafuji K, Kondo T, Shibayama H, Mori T, Usuki K, Azuma T, Tsutsumi Y, Tanaka J, Dairaku H, Matsuo K, Ozawa K, et al. Clinical features and outcomes of patients with primary myelofibrosis in Japan: report of a 17-year nationwide survey by the Idiopathic Disorders of Hematopoietic Organs Research Committee of Japan. International Journal of Hematology. PMID 27761702 DOI: 10.1007/S12185-016-2102-3 |
0.424 |
|
| 2016 |
Kanda J, Morishima Y, Terakura S, Wake A, Uchida N, Takahashi S, Ono Y, Onishi Y, Kanamori H, Aotsuka N, Ozawa Y, Ogawa H, Sakura T, Ohashi K, Ichinohe T, et al. Impact of graft-versus-host disease on outcomes after unrelated cord blood transplantation. Leukemia. PMID 27748373 DOI: 10.1038/Leu.2016.288 |
0.456 |
|
| 2016 |
Takagi S, Masuoka K, Uchida N, Kurokawa M, Nakamae H, Imada K, Iwato K, Ichinohe T, Atsuta Y, Takami A, Yano S. Allogeneic Hematopoietic Cell Transplantation for Leukemic Transformation Preceded by Philadelphia Chromosome-Negative Myeloproliferative Neoplasms: a Nationwide Survey by the Adult Aml Working Group of the Japan Society for Hematopoietic Cell Transplantation (JSHCT). Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 27667010 DOI: 10.1016/J.Bbmt.2016.09.017 |
0.526 |
|
| 2016 |
Inamoto Y, Kimura F, Kanda J, Sugita J, Ikegame K, Nakasone H, Nannya Y, Uchida N, Fukuda T, Yoshioka K, Ozawa Y, Kawano I, Atsuta Y, Kato K, Ichinohe T, et al. Comparison of graft-versus-host disease-free, relapse-free survival according to a variety of graft sources: antithymocyte globulin and single cord blood provide favorable outcomes in some subgroups. Haematologica. PMID 27662017 DOI: 10.3324/Haematol.2016.149427 |
0.492 |
|
| 2016 |
Arai Y, Kondo T, Shigematsu A, Tanaka J, Takahashi S, Kobayashi T, Uchida N, Onishi Y, Ishikawa J, Kanamori H, Sawa M, Yokota A, Kouzai Y, Takanashi M, Ichinohe T, et al. High-dose cytarabine added to CY/TBI improves the prognosis of cord blood transplantation for acute lymphoblastic leukemia in adults: a retrospective cohort study. Bone Marrow Transplantation. PMID 27643870 DOI: 10.1038/Bmt.2016.242 |
0.43 |
|
| 2016 |
Kimura M, Araoka H, Yoshida A, Yamamoto H, Abe M, Okamoto Y, Yuasa M, Kaji D, Kageyama K, Nishida A, Ishiwata K, Takagi S, Yamamoto G, Asano-Mori Y, Uchida N, et al. Breakthrough viridans streptococcal bacteremia in allogeneic hematopoietic stem cell transplant recipients receiving levofloxacin prophylaxis in a Japanese hospital. Bmc Infectious Diseases. 16: 372. PMID 27495798 DOI: 10.1186/S12879-016-1692-Y |
0.5 |
|
| 2016 |
Kuwatsuka Y, Kanda J, Yamazaki H, Mori T, Miyamura K, Kako S, Uchida N, Ohashi K, Ozawa Y, Takahashi Y, Kato C, Iwato K, Ishiyama K, Kobayashi H, Eto T, et al. A Comparison of Outcomes for Cord Blood Transplant and Unrelated Bone Marrow Transplant in Adult Aplastic Anemia. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 27401034 DOI: 10.1016/J.Bbmt.2016.07.002 |
0.519 |
|
| 2016 |
Yamamoto H, Uchida N, Yuasa M, Kageyama K, Ota H, Kaji D, Nishida A, Ishiwata K, Takagi S, Tsuji M, Asano-Mori Y, Yamamoto G, Izutsu K, Masuoka K, Wake A, et al. A Novel Reduced-Toxicity Myeloablative Conditioning Regimen Using Full-Dose Busulfan, Fludarabine, and Melphalan for Single Cord Blood Transplantation Provides Durable Engraftment and Remission in Non-Remission Myeloid Malignancies. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 27345142 DOI: 10.1016/J.Bbmt.2016.06.017 |
0.511 |
|
| 2016 |
Uchida N. Cord blood transplantation in Japan. The Japanese Journal of Clinical Hematology. 57: 531. PMID 27263776 DOI: 10.11406/Rinketsu.57.531 |
0.516 |
|
| 2016 |
Ishiyama K, Yamaguchi T, Eto T, Ohashi K, Uchida N, Kanamori H, Fukuda T, Miyamura K, Inoue Y, Taguchi J, Mori T, Iwato K, Morishima Y, Nagamura-Inoue T, Atsuta Y, et al. Acute megakaryoblastic leukemia, unlike acute erythroid leukemia, predicts an unfavorable outcome after allogeneic HSCT. Leukemia Research. 47: 47-53. PMID 27244257 DOI: 10.1016/J.Leukres.2016.04.017 |
0.364 |
|
| 2016 |
Konuma T, Tsukada N, Kanda J, Uchida N, Ohno Y, Miyakoshi S, Kanamori H, Hidaka M, Sakura T, Onizuka M, Kobayashi N, Sawa M, Eto T, Matsuhashi Y, Kato K, et al. Comparison of transplant outcomes from matched sibling bone marrow or peripheral blood stem cell and unrelated cord blood in patients 50 years or older. American Journal of Hematology. 91: E284-92. PMID 26910296 DOI: 10.1002/Ajh.24340 |
0.54 |
|
| 2016 |
Arai Y, Kondo T, Yamazaki H, Takenaka K, Sugita J, Kobayashi T, Ozawa Y, Uchida N, Iwato K, Kobayashi N, Takahashi Y, Ishiyama K, Fukuda T, Ichinohe T, Atsuta Y, et al. Allogeneic unrelated bone marrow transplantation from older donors results in worse prognosis in recipients with aplastic anemia. Haematologica. PMID 26858357 DOI: 10.3324/Haematol.2015.139469 |
0.49 |
|
| 2016 |
Itonaga H, Iwanaga M, Aoki K, Aoki J, Ishiyama K, Ishikawa T, Sakura T, Fukuda T, Najima Y, Yujiri T, Mori T, Kurokawa M, Nawa Y, Uchida N, Morishita Y, et al. Impacts of graft-versus-host disease on outcomes after allogeneic hematopoietic stem cell transplantation for chronic myelomonocytic leukemia: A nationwide retrospective study. Leukemia Research. 41: 48-55. PMID 26754557 DOI: 10.1016/J.Leukres.2015.12.009 |
0.53 |
|
| 2016 |
Yamasaki S, Suzuki R, Hatano K, Fukushima K, Iida H, Morishima S, Suehiro Y, Fukuda T, Uchida N, Uchiyama T, Atsuta Y, Suzumiya J. Therapy-Related Acute Myeloid Leukemia and Myelodysplastic Syndrome in Lymphoma Patients Receiving Hematopoietic Cell Transplantation Blood. 128: 827-827. DOI: 10.1182/Blood.V128.22.827.827 |
0.476 |
|
| 2016 |
Takagi S, Yuasa M, Uchida N, Yamaguchi K, Kageyama K, Kaji D, Taya Y, Nishida A, Ishiwata K, Yamamoto H, Yamamoto G, Asano-Mori Y, Wake A, Makino S, Yoneyama A, et al. Possible Therapeutic Potential of Recombinant Human Soluble Thrombomoduline Alpha for the Treatment of SOS/VOD: A Retrospective Study in Toranomon Hospital Blood. 128: 5747-5747. DOI: 10.1182/Blood.V128.22.5747.5747 |
0.441 |
|
| 2016 |
Kawamura K, Kanda J, Fuji S, Yoshioka K, Ozawa Y, Fukuda T, Uchida N, Iwato K, Ichinohe T, Atsuta Y, Kanda Y. Impact of the Presence of HLA 1-Locus Mismatch and the Use of Thymoglobulin in Unrelated Bone Marrow Transplantation Blood. 128: 4688-4688. DOI: 10.1182/Blood.V128.22.4688.4688 |
0.396 |
|
| 2016 |
Harada K, Doki N, Aoki J, Mori J, Machida S, Najima Y, Uchida N, Fukuda T, Kanamori H, Ogawa H, Ichinohe T, Atsuta Y, Yano S. Outcomes after Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Acute Myeloid Leukemia Harboring t(7;11)(p15;p15) Blood. 128: 4654-4654. DOI: 10.1182/Blood.V128.22.4654.4654 |
0.467 |
|
| 2016 |
Nakasone H, Yakushijin K, Fuji S, Onizuka M, Shinohara A, Ohashi K, Miyamura K, Uchida N, Takanashi M, Ichinohe T, Atsuta Y, Fukuda T, Ogata M. Impact of Total Body Irradiation on Successful Neutrophil Engraftment in Unrelated Bone Marrow or Cord Blood Transplantation Blood. 128: 3423-3423. DOI: 10.1182/Blood.V128.22.3423.3423 |
0.482 |
|
| 2016 |
Kawamura K, Kako S, Mizuta S, Ishiyama K, Aoki J, Yano S, Fukuda T, Uchida N, Ozawa Y, Eto T, Iwato K, Ichinohe T, Atsuta Y, Kanda Y. Comparison of Reduced-Intensity Conditioning with Fludarabine/Busulfan and Fludarabine/Melphalan in Patients 50 Years or Older Blood. 128: 3414-3414. DOI: 10.1182/Blood.V128.22.3414.3414 |
0.477 |
|
| 2016 |
Takenaka K, Shimoda K, Uchida N, Shimomura T, Nagafuji K, Kondo T, Shibayama H, Mori T, Usuki K, Azuma T, Tsutsumi Y, Tanaka J, Dairaku H, Matsuo K, Ozawa K, et al. Clinical Outcomes of Patients with Primary Myelofibrosis in Japan: A Nationwide Survey over a 17-Year Study Period Blood. 128: 3126-3126. DOI: 10.1182/Blood.V128.22.3126.3126 |
0.403 |
|
| 2016 |
Yamamoto H, Uchida N, Yuasa M, Kageyama K, Nishida A, Ishiwata K, Takagi S, Asano-Mori Y, Yamamoto G, Izutsu K, Wake A, Yoneyama A, Makino S, Taniguchi S. Comparable Progression-Free and Overall Survival Following Transplantation of Single Cord Blood with HLA-Matched Related Donor in Adults with Non-Remission Myeloid Malignancies Blood. 128: 2303-2303. DOI: 10.1182/Blood.V128.22.2303.2303 |
0.475 |
|
| 2016 |
Nishida A, Yuasa M, Kageyama K, Ishiwata K, Takagi S, Yamamoto H, Asano-Mori Y, Yamamoto G, Uchida N, Izutsu K, Wake A, Yoneyama A, Makino S, Taniguchi S. High Disease-Free and Overall Survival Rate Following Allogeneic Hematopoietic Stem Cell Transplantation for FLT3-Mutated Acute Myeloid Leukemia Even in Non-Remission Status Blood. 128: 2283-2283. DOI: 10.1182/Blood.V128.22.2283.2283 |
0.481 |
|
| 2016 |
Wada S, Takagi S, Yuasa M, Kageyama K, Kaji D, Nishida A, Ishiwata K, Yamamoto H, Yamamoto G, Asano-Mori Y, Uchida N, Wake A, Izutsu K, Taniguchi S. Not Severe Acute Graft-Versus-Host Disease and Limited Efficacy of Early Withdrawal of Immunosuppressant for Relapse after Cord Blood Transplantation Biology of Blood and Marrow Transplantation. 22. DOI: 10.1016/J.Bbmt.2015.11.953 |
0.459 |
|
| 2016 |
Inamoto Y, Kimura F, Kanda J, Sugita J, Ikegame K, Nakasone H, Nannya Y, Uchida N, Fukuda T, Yoshioka K, Ozawa Y, Kawano I, Atsuta Y, Kato K, Ichinohe T, et al. Comparison of Graft-Versus-Host Disease-Free, Relapse-Free Survival (GRFS) of Patients with Hematological Malignancy According to Donor Type: JSHCT Working Group Study Biology of Blood and Marrow Transplantation. 22. DOI: 10.1016/J.Bbmt.2015.11.926 |
0.404 |
|
| 2016 |
Ishiwata K, Yuasa M, Nishida A, Takagi S, Yamamoto H, Yamamoto G, Asano-Mori Y, Uchida N, Izutsu K, Wake A, Taniguchi S. Adenovirus Infection after Cord Blood Transplantation in Adult Patients Biology of Blood and Marrow Transplantation. 22. DOI: 10.1016/J.Bbmt.2015.11.529 |
0.43 |
|
| 2015 |
Yanada M, Kanda J, Ohtake S, Fukuda T, Sakamaki H, Miyamura K, Miyawaki S, Uchida N, Maeda T, Nagamura-Inoue T, Asou N, Morishima Y, Atsuta Y, Miyazaki Y, Kimura F, et al. Unrelated bone marrow transplantation or immediate umbilical cord blood transplantation for patients with acute myeloid leukemia in first complete remission. European Journal of Haematology. PMID 26680003 DOI: 10.1111/Ejh.12723 |
0.525 |
|
| 2015 |
Aoki J, Seo S, Kanamori H, Tanaka M, Fukuda T, Onizuka M, Kobayashi N, Kondo T, Sawa M, Uchida N, Iwato K, Icihnohe T, Atsuta Y, Yano S, Takami A. Impact of low-dose TBI on outcomes of reduced intensity conditioning allogeneic hematopoietic stem cell transplantation for AML. Bone Marrow Transplantation. PMID 26642343 DOI: 10.1038/Bmt.2015.297 |
0.443 |
|
| 2015 |
Mori J, Ishiyama K, Yamaguchi T, Tanaka J, Uchida N, Kobayashi T, Fukuda T, Kanamori H, Miyamura K, Takahashi S, Eto T, Hirokawa M, Mori S, Nagamura T, Atsuta Y, et al. Outcomes of allogeneic hematopoietic cell transplantation in patients with biphenotypic acute leukemia. Annals of Hematology. PMID 26499506 DOI: 10.1007/S00277-015-2536-3 |
0.482 |
|
| 2015 |
Kawano N, Kuriyama T, Yoshida S, Shimizu I, Kobayashi H, Takenaka K, Uchida N, Takami A, Yamashita K, Ueda A, Kikuchi I. Successful Secondary Umbilical Cord Blood Transplantation for Graft Failure in Acute Myelogenous Leukemia, Treated with Modified One-Day Conditioning Regimen, and Graft-Versus-Host Disease Prophylaxis Consisting of Mycophenolate and Tacrolimus. Journal of Clinical and Experimental Hematopathology : Jceh. 55: 89-96. PMID 26490521 DOI: 10.3960/Jslrt.55.89 |
0.457 |
|
| 2015 |
Terakura S, Atsuta Y, Tsukada N, Kobayashi T, Tanaka M, Kanda J, Najima Y, Fukuda T, Uchida N, Takahashi S, Nagamura-Inoue T, Morishima Y, Miyamura K. Comparison of outcomes of 8/8 and 7/8 allele-matched unrelated BMT and single unit CBT in adults with acute leukemia. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 26476205 DOI: 10.1016/J.Bbmt.2015.10.006 |
0.518 |
|
| 2015 |
Nishiwaki S, Imai K, Mizuta S, Kanamori H, Ohashi K, Fukuda T, Onishi Y, Takahashi S, Uchida N, Eto T, Nakamae H, Yujiri T, Mori S, Nagamura-Inoue T, Suzuki R, et al. Impact of MRD and TKI on allogeneic hematopoietic cell transplantation for Ph+ALL: a study from the adult ALL WG of the JSHCT. Bone Marrow Transplantation. PMID 26389833 DOI: 10.1038/Bmt.2015.217 |
0.427 |
|
| 2015 |
Yamamoto H, Uchida N, Uchida Y, Nishida A, Ota H, Kageyama K, Nasu I, Wada S, Kaji D, Ishiwata K, Takagi S, Tsuji M, Asano-Mori Y, Matsuno N, Yamamoto G, et al. Oral beclomethasone dipropionate as an initial treatment for stages 1-2 gastrointestinal tract acute graft-versus-host disease following unrelated cord blood transplantation. Annals of Hematology. PMID 26374433 DOI: 10.1007/S00277-015-2483-Z |
0.439 |
|
| 2015 |
Arai Y, Kanda J, Nakasone H, Kondo T, Uchida N, Fukuda T, Ohashi K, Kaida K, Iwato K, Eto T, Kanda Y, Nakamae H, Nagamura-Inoue T, Morishima Y, Hirokawa M, et al. Risk factors and prognosis of hepatic acute GvHD after allogeneic hematopoietic cell transplantation. Bone Marrow Transplantation. PMID 26367230 DOI: 10.1038/Bmt.2015.205 |
0.418 |
|
| 2015 |
Takenaka K, Nishida T, Asano-Mori Y, Oshima K, Ohashi K, Mori T, Kanamori H, Miyamura K, Kato C, Kobayashi N, Uchida N, Nakamae H, Ichinohe T, Morishima Y, Suzuki R, et al. Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation is Associated with a Reduced Risk of Relapse in Patients with Acute Myeloid Leukemia Who Survived to Day 100 after Transplantation: The Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working Group. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 21: 2008-16. PMID 26211985 DOI: 10.1016/J.Bbmt.2015.07.019 |
0.545 |
|
| 2015 |
Konuma T, Takahashi S, Uchida N, Kuwatsuka Y, Yamasaki S, Aoki J, Onishi Y, Aotsuka N, Ohashi K, Mori T, Masuko M, Nakamae H, Miyamura K, Kato K, Atsuta Y, et al. Effect of Granulocyte Colony-Stimulating Factor-Combined Conditioning in Cord Blood Transplantation for Myelodysplastic Syndrome and Secondary Acute Myeloid Leukemia: A Retrospective Study in Japan. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 25985920 DOI: 10.1016/J.Bbmt.2015.05.009 |
0.473 |
|
| 2015 |
Takano K, Fuji S, Uchida N, Ogawa H, Ohashi K, Eto T, Sakamaki H, Morishima Y, Kato K, Suzuki R, Fukuda T. Pre-transplant diabetes mellitus is a risk factor for non-relapse mortality, especially infection-related mortality, after allogeneic hematopoietic SCT. Bone Marrow Transplantation. 50: 553-8. PMID 25621798 DOI: 10.1038/Bmt.2014.315 |
0.367 |
|
| 2015 |
Yamamoto H, Uchida N, Matsuno N, Kon A, Nishida A, Ota H, Ikebe T, Nakano N, Ishiwata K, Araoka H, Takagi S, Tsuji M, Asano-Mori Y, Yamamoto G, Izutsu K, et al. I.v. BU/fludarabine plus melphalan or TBI in unrelated cord blood transplantation for high-risk hematological diseases. Bone Marrow Transplantation. 50: 607-9. PMID 25621796 DOI: 10.1038/Bmt.2014.316 |
0.434 |
|
| 2015 |
Nakasone H, Fukuda T, Kanda J, Mori T, Yano S, Kobayashi T, Miyamura K, Eto T, Kanamori H, Iwato K, Uchida N, Mori S, Nagamura-Inoue T, Ichinohe T, Atsuta Y, et al. Impact of conditioning intensity and TBI on acute GVHD after hematopoietic cell transplantation. Bone Marrow Transplantation. 50: 559-65. PMID 25531281 DOI: 10.1038/Bmt.2014.293 |
0.415 |
|
| 2015 |
Aguilar-Martínez JA, Uchida N, Townsley B, West DA, Yanez A, Lynn N, Kimura S, Sinha N. Transcriptional, posttranscriptional, and posttranslational regulation of SHOOT MERISTEMLESS gene expression in Arabidopsis determines gene function in the shoot apex. Plant Physiology. 167: 424-42. PMID 25524441 DOI: 10.1104/Pp.114.248625 |
0.742 |
|
| 2015 |
Tanaka M, Miyamura K, Terakura S, Imai K, Uchida N, Ago H, Sakura T, Eto T, Ohashi K, Fukuda T, Taniguchi S, Mori S, Nagamura-Inoue T, Atsuta Y, Okamoto S. Comparison of cord blood transplantation with unrelated bone marrow transplantation in patients older than fifty years. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 21: 517-25. PMID 25498906 DOI: 10.1016/J.Bbmt.2014.11.685 |
0.526 |
|
| 2015 |
Aoki K, Ishikawa T, Ishiyama K, Aoki J, Itonaga H, Fukuda T, Kakihana K, Uchida N, Ueda Y, Eto T, Mori T, Kondo T, Iwato K, Morishima Y, Tanaka J, et al. Allogeneic haematopoietic cell transplantation with reduced-intensity conditioning for elderly patients with advanced myelodysplastic syndromes: a nationwide study. British Journal of Haematology. 168: 463-6. PMID 25228239 DOI: 10.1111/Bjh.13124 |
0.463 |
|
| 2015 |
Kida M, Usuki K, Uchida N, Fukuda T, Iwato K, Matsuoka K, Eto T, Ichinohe T, Atsuta Y, Takanashi M, Takami A, Miyazaki Y, Yano S, Ishiyama K. Outcome and Risk Factors for Therapy-Related Myeloid Neoplasms Treated with Allogeneic Stem Cell Transplantation Blood. 126: 4371-4371. DOI: 10.1182/Blood.V126.23.4371.4371 |
0.437 |
|
| 2015 |
Itonaga H, Aoki K, Aoki J, Ishiyama K, Ishikawa T, Ohashi K, Fukuda T, Ozawa Y, Kobayashi N, Uchida N, Eto T, Takanashi M, Ichinohe T, Atsuta Y, Miyazaki Y. Impact of Unbalanced Translocation Der(1;7)(q10;p10) and -7/Del(7q) on the Prognostic Value after Allogeneic Hematopoietic Stem Cell Transplantation in Myelodysplastic Syndromes: A Nationwide Retrospective Study Blood. 126: 3206-3206. DOI: 10.1182/Blood.V126.23.3206.3206 |
0.39 |
|
| 2015 |
Takagi S, Araoka H, Uchida N, Abe M, Yuasa M, Kageyama K, Kaji D, Nishida A, Kimura M, Ishiwata K, Yamamoto H, Yamamoto G, Asano-Mori Y, Izutsu K, Wake A, et al. Umbilical Cord Blood Is the Most Significant Risk Factor for the Development of Bloodstream Infection after Allogeneic Hematopoietic Cell Transplantation Blood. 126: 1905-1905. DOI: 10.1182/Blood.V126.23.1905.1905 |
0.5 |
|
| 2015 |
Seo S, Kanda J, Atsuta Y, Uchida N, Ohashi K, Fukuda T, Takahashi S, Ozawa Y, Onizuka M, Takanashi M, Tsukada N, Kato S, Kimura F, Kanda Y, Miyamura K. The Impact of Donor Age on Outcome after Unrelated Bone Marrow Transplantation: Comparison with Unrelated Cord Blood Transplantation Blood. 126: 154-154. DOI: 10.1182/Blood.V126.23.154.154 |
0.509 |
|
| 2015 |
Itonaga H, Iwanaga M, Aoki K, Aoki J, Ishiyama K, Ishikawa T, Sakura T, Fukuda T, Najima Y, Yujiri T, Mori T, Kurokawa M, Nawa Y, Uchida N, Morishita Y, et al. Impacts of graft-versus-host disease on outcomes after allogeneic hematopoietic stem cell transplantation for chronic myelomonocytic leukemia: A nationwide retrospective study Leukemia Research. DOI: 10.1016/j.leukres.2015.12.009 |
0.373 |
|
| 2015 |
Takenaka K, Nishida T, Asano-Mori Y, Oshima K, Ohashi K, Mori T, Kanamori H, Miyamura K, Kato C, Kobayashi N, Uchida N, Nakamae H, Ichinohe T, Morishima Y, Suzuki R, et al. Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation is Associated with a Reduced Risk of Relapse in Patients with Acute Myeloid Leukemia Who Survived to Day 100 after Transplantation: The Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working Group Biology of Blood and Marrow Transplantation. DOI: 10.1016/j.bbmt.2015.07.019 |
0.431 |
|
| 2015 |
Yoshimitsu M, Tanosaki R, Kato K, Ishida T, Choi I, Fukuda T, Takatsuka Y, Eto T, Uchida N, Moriuchi Y, Nagamura-Inoue T, Mori S, Sakamaki H, Atsuta Y, Utsunomiya A. Risk Stratification of Outcomes Among Patients with Adult T-Cell Leukemia/Lymphoma Receiving Allogeneic Hematopoietic Cell Transplantation: A Retrospective Analysis of the JSHCT ATL Working Group Biology of Blood and Marrow Transplantation. 21. DOI: 10.1016/J.Bbmt.2014.11.699 |
0.457 |
|
| 2015 |
Kanda J, Morishima Y, Wake A, Terakura S, Uchida N, Takahashi S, Ono Y, Onishi Y, Kanamori H, Aotsuka N, Kato K, Atsuta Y, Murata M. Impact of Acute and Chronic Graft-Versus-Host Disease on Outcomes after Single Cord Blood Transplantation: A Retrospective Analysis By the JSHCT Gvhd Working Group Biology of Blood and Marrow Transplantation. 21. DOI: 10.1016/J.Bbmt.2014.11.535 |
0.449 |
|
| 2015 |
Arai Y, Kanda J, Nakasone H, Kondo T, Uchida N, Fukuda T, Ohashi K, Ogawa H, Nagamura-Inoue T, Morishima Y, Hirokawa M, Atsuta Y, Murata M. Analysis of Risk Factors for Hepatic Acute Graft-Versus-Host Disease By Using Transplant Registry Data in Japan Biology of Blood and Marrow Transplantation. 21. DOI: 10.1016/J.Bbmt.2014.11.517 |
0.371 |
|
| 2015 |
Sugita J, Kawashima N, Fujisaki T, Kakihana K, Uchida N, Maeda Y, Ota S, Matsuo K, Miyamoto T, Nagafuji K, Eto T, Akashi K, Taniguchi S, Harada M, Teshima T. Prospective Multicenter Phase II Study of HLA-Haploidentical Peripheral Blood Stem Cell Transplantation after Reduced-Intensity Conditioning with Post-Transplant Cyclophosphamide: First Analysis of the JSCT Haplo13 Study Biology of Blood and Marrow Transplantation. 21: S313-S314. DOI: 10.1016/J.Bbmt.2014.11.499 |
0.525 |
|
| 2015 |
Mizumaki H, Takagi S, Uchida N, Kageyama K, Kaji D, Wada S, Nishida A, Ishiwata K, Tsuji M, Yamamoto H, Yamamoto G, Asano-Mori Y, Makino S, Yoneyama A, Wake A, et al. Allogeneic Hematopoietic Cell Transplantation Is a Curative Treatment Option for Advanced-Stage Chronic Myeloid Leukemia in the TKI Era, a Single Institution Retrospective Study of 29 Post AP/BC Cases Biology of Blood and Marrow Transplantation. 21. DOI: 10.1016/J.Bbmt.2014.11.475 |
0.44 |
|
| 2014 |
Konuma T, Ooi J, Uchida N, Ogawa H, Ohashi K, Kanamori H, Aotsuka N, Onishi Y, Yamaguchi H, Kozai Y, Nagamura-Inoue T, Kato K, Suzuki R, Atsuta Y, Kato S, et al. Granulocyte colony-stimulating factor combined regimen in cord blood transplantation for acute myeloid leukemia: a nationwide retrospective analysis in Japan. Haematologica. 99: e264-8. PMID 25216686 DOI: 10.3324/Haematol.2014.114504 |
0.503 |
|
| 2014 |
Yuasa M, Ishiwata K, Sugio T, Kaji D, Ota H, Tsuji M, Yamamoto H, Yamamoto G, Asano-Mori Y, Uchida N, Izutsu K, Taniguchi S. [Herpes simplex virus type 2 fulminant hepatitis after umbilical cord blood transplantation for acute myeloid leukemia]. [Rinshō Ketsueki] the Japanese Journal of Clinical Hematology. 55: 682-6. PMID 24975337 DOI: DN/JST.JSTAGE/rinketsu/55.682 |
0.327 |
|
| 2014 |
Yamamoto H, Uchida N, Matsuno N, Ota H, Kageyama K, Wada S, Kaji D, Nishida A, Ishiwata K, Takagi S, Tsuji M, Asano-Mori Y, Yamamoto G, Izutsu K, Masuoka K, et al. Anti-HLA antibodies other than against HLA-A, -B, -DRB1 adversely affect engraftment and nonrelapse mortality in HLA-mismatched single cord blood transplantation: possible implications of unrecognized donor-specific antibodies. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 20: 1634-40. PMID 24972251 DOI: 10.1016/J.Bbmt.2014.06.024 |
0.34 |
|
| 2014 |
Iida M, Fukuda T, Uchida N, Murata M, Aotsuka N, Minagawa K, Oohashi K, Fukushima K, Kondo T, Eto T, Miyamoto T, Morishima Y, Nagamura T, Atsuta Y, Suzuki R. Mycophenolate mofetil use after unrelated hematopoietic stem cell transplantation for prophylaxis and treatment of graft-vs.-host disease in adult patients in Japan. Clinical Transplantation. 28: 980-9. PMID 24943923 DOI: 10.1111/Ctr.12405 |
0.507 |
|
| 2014 |
Hosokawa K, Takami A, Tsuji M, Araoka H, Ishiwata K, Takagi S, Yamamoto H, Asano-Mori Y, Matsuno N, Uchida N, Masuoka K, Wake A, Makino S, Yoneyama A, Nakao S, et al. Relative incidences and outcomes of Clostridium difficile infection following transplantation of unrelated cord blood, unrelated bone marrow, and related peripheral blood in adult patients: a single institute study. Transplant Infectious Disease : An Official Journal of the Transplantation Society. 16: 412-20. PMID 24810244 DOI: 10.1111/tid.12224 |
0.35 |
|
| 2014 |
Takagi S, Araoka H, Uchida N, Uchida Y, Kaji D, Ota H, Nishida A, Ishiwata K, Tsuji M, Yamamoto H, Ito T, Matsuno N, Yamamoto G, Asano-Mori Y, Hayashi M, et al. A prospective feasibility study of primary prophylaxis against invasive fungal disease with voriconazole following umbilical cord blood transplantation with fludarabine-based conditioning. International Journal of Hematology. 99: 652-8. PMID 24664791 DOI: 10.1007/S12185-014-1529-7 |
0.48 |
|
| 2014 |
Ishii H, Seymour JF, Tazawa R, Inoue Y, Uchida N, Nishida A, Kogure Y, Saraya T, Tomii K, Takada T, Itoh Y, Hojo M, Ichiwata T, Goto H, Nakata K. Secondary pulmonary alveolar proteinosis complicating myelodysplastic syndrome results in worsening of prognosis: a retrospective cohort study in Japan. Bmc Pulmonary Medicine. 14: 37. PMID 24597668 DOI: 10.1186/1471-2466-14-37 |
0.359 |
|
| 2014 |
Mizumaki H, Takagi S, Uchida N, Wada S, Kageyama K, Kaji D, Nishida A, Ishiwata K, Tsuji M, Yamamoto H, Yamamoto G, Asano-Mori Y, Makino S, Yoneyama A, Wake A, et al. Allogeneic Hematopoietic Cell Transplantation Is a Curative Treatment Option for Advanced-Stage Chronic Myeloid Leukemia in the TKI Era, a Single Institution Retrospective Study of 29 Post AP/BC Cases Blood. 124: 5931-5931. DOI: 10.1182/Blood.V124.21.5931.5931 |
0.477 |
|
| 2014 |
Terakura S, Atsuta Y, Tsukada N, Kobayashi T, Tanaka M, Kanda J, Ohashi K, Fukuda T, Uchida N, Satoshi T, Nagamura-Inoue T, Morishima Y, Miyamura K. Comparison of Outcomes of Unrelated BM and CB Transplants in Young Adult Leukemia Patients. Updated Results of Japanese Registration Study Blood. 124: 45-45. DOI: 10.1182/Blood.V124.21.45.45 |
0.41 |
|
| 2014 |
Kato K, Miyamoto T, Yonemoto K, Uchida N, Ogawa H, Fukuda T, Takahashi S, Ohashi K, Eto T, Nagamura-Inoue T, Sakamaki H, Morishima Y, Suzuki R, Atsuta Y, Akashi K. Second Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT) for Relapse of Hematological Malignancies after First Allo-HSCT Blood. 124: 3947-3947. DOI: 10.1182/Blood.V124.21.3947.3947 |
0.551 |
|
| 2014 |
Aoki K, Suzuki R, Chihara D, Suzuki T, Kim S, Fukuda T, Uchida N, Tsudo M, Matsuoka K, Ago H, Nagamura-Inoue T, Morishima Y, Sakamaki H, Atsuta Y, Suzumiya J. Reduced-Intensity Conditioning of Allogeneic Transplantation for Nodal Peripheral T-Cell Lymphomas Blood. 124: 2585-2585. DOI: 10.1182/Blood.V124.21.2585.2585 |
0.471 |
|
| 2014 |
Yuasa M, Yamamoto H, Kageyama K, Kaji D, Wada S, Nishida A, Takagi S, Tsuji M, Yamamoto G, Asano-Mori Y, Uchida N, Izutsu K, Wake A, Yoneyama A, Makino S, et al. Second Cord Blood Transplantation for Relapsed Myeloid Malignancies Following Allogeneic Transplantation – a Single Institute Analysis for 85 Recipients Blood. 124: 2565-2565. DOI: 10.1182/Blood.V124.21.2565.2565 |
0.541 |
|
| 2014 |
Wake A, Kai S, Okada M, Kato K, Uchida N, Kobayashi N, Aotsuka N, Ishikawa J, Takahashi S, Eto T, Taniguchi S, Atsuta Y, Kato S. Comparison of Outcomes after Double or Single-Unit Cord Blood Transplantation in Patients with Hematological Malignancies Using TBI-Containing Myeloablative Conditioning Regimen, a Retrospective Matched Control Study on Behalf of C-SHOT0507 and JSHCT Registry Data in Japan Blood. 124: 2548-2548. DOI: 10.1182/Blood.V124.21.2548.2548 |
0.457 |
|
| 2014 |
Takagi S, Masuoka K, Uchida N, Kurokawa M, Nakamae H, Tsudo M, Iwato K, Ichinohe T, Atsuta Y, Takami A. Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Acute Myeloid Leukemia Transformed from Ph-Negative Myeloproliferative Neoplasm: A Study from the Adult AML Working Group of the Japan Society for Hematopoietic Cell Transplantation (JSHCT) Blood. 124: 2547-2547. DOI: 10.1182/Blood.V124.21.2547.2547 |
0.394 |
|
| 2014 |
Kageyama K, Yamamoto H, Yuasa M, Kaji D, Wada S, Nishida A, Ishiwata K, Takagi S, Tsuji M, Yamamoto G, Asano-Mori Y, Uchida N, Izutsu K, Wake A, Yoneyama A, et al. Early Central Nervous System Complications after Allogeneic Stem Transplantation: A Single-Center Analysis of 723 Patients Including 456 Cord Blood Recipients Blood. 124: 2468-2468. DOI: 10.1182/Blood.V124.21.2468.2468 |
0.504 |
|
| 2014 |
Asano-Mori Y, Wake A, Kageyama K, Kaji D, Ishiwata K, Takagi S, Yamamoto H, Yamamoto G, Uchida N, Izutsu K, Yoneyama A, Makino S, Taniguchi S. Clinical Comparison of Incidences, Risk Factors and Outocmes of Chronic Graft-Versus-Host Desease in Unrelated Cord Blood Transplantation and Unrelated Bone Marrow Transplantation Blood. 124: 1172-1172. DOI: 10.1182/Blood.V124.21.1172.1172 |
0.508 |
|
| 2014 |
Nakasone H, Fukuda T, Kanda J, Mori T, Teshima T, Yano S, Uchida N, Kakihana K, Eto T, Mori S, Nagamura T, Ichinohe T, Atsuta Y, Murata M. Impact of Conditioning Intensity with or without Total Body Irradiation on Acute Graft-Versus-Host Disease and Clinical Outcomes Biology of Blood and Marrow Transplantation. 20. DOI: 10.1016/J.Bbmt.2013.12.463 |
0.334 |
|
| 2014 |
Uchida N, Hidaka M, Sakura T, Miyamoto T, Fujisaki T, Eto T, Maeda Y, Fukuno K, Matsumoto K, Morita K, Kishimoto J, Fukuda T, Teshima T, Taniguchi S, Mori S, et al. Prospective Multicenter Phase II Study of Myeloablative Conditioning Consisted of Intravenous Busulfan and Fludarabine +/- Total Body Irradiation for Older Patients (55 years and older): Final Analysis of the JSCT FB09 Study Biology of Blood and Marrow Transplantation. 20: S253. DOI: 10.1016/J.Bbmt.2013.12.426 |
0.492 |
|
| 2014 |
Kageyama K, Yamamoto H, Kaji D, Ota H, Ishiwata K, Tsuji M, Yamamoto G, Asano-Mori Y, Uchida N, Izutsu K, Taniguchi S. Cord Blood Transplantation for Primary Refractory Acute Myeloid Leukemia Biology of Blood and Marrow Transplantation. 20. DOI: 10.1016/J.Bbmt.2013.12.244 |
0.454 |
|
| 2014 |
Yamamoto H, Takagi S, Uchida N, Kageyama K, Kaji D, Wada S, Nishida A, Ota H, Ishiwata K, Tsuji M, Yamamoto G, Asano-Mori Y, Izutsu K, Wake A, Taniguchi S. Hemophagocytic Syndrome after Cord Blood Transplantation; Possible Implication of Severe Pre-Engraftment Immune Reactions Biology of Blood and Marrow Transplantation. 20. DOI: 10.1016/J.Bbmt.2013.12.221 |
0.372 |
|
| 2014 |
Ishiwata K, Yamamoto H, Yuasa M, Kageyama K, Kaji D, Wada S, Ota H, Tsuji M, Yamamoto G, Asano-Mori Y, Uchida N, Izutsu K, Yoneyama A, Makino S, Taniguchi S. Impact of HLA Disparity with High-Resolution HLA Typing at HLA-a, -B, -C, and –DRB1 on Engraftment after Reduced Intensity Cord Blood Transplantation in Adults Biology of Blood and Marrow Transplantation. 20. DOI: 10.1016/J.Bbmt.2013.12.215 |
0.393 |
|
| 2013 |
Uchida N. [Engraftment failure following umbilical cord blood transplantation]. [Rinshō Ketsueki] the Japanese Journal of Clinical Hematology. 54: 1966-73. PMID 24064850 DOI: DN/JST.JSTAGE/rinketsu/54.1966 |
0.322 |
|
| 2013 |
Uchida N, Tasaka M. Regulation of plant vascular stem cells by endodermis-derived EPFL-family peptide hormones and phloem-expressed ERECTA-family receptor kinases. Journal of Experimental Botany. 64: 5335-43. PMID 23881395 DOI: 10.1093/Jxb/Ert196 |
0.304 |
|
| 2013 |
Saito Y, Yuki H, Kuratani M, Hashizume Y, Takagi S, Honma T, Tanaka A, Shirouzu M, Mikuni J, Handa N, Ogahara I, Sone A, Najima Y, Tomabechi Y, Wakiyama M, ... Uchida N, et al. A pyrrolo-pyrimidine derivative targets human primary AML stem cells in vivo. Science Translational Medicine. 5: 181ra52. PMID 23596204 DOI: 10.1126/Scitranslmed.3004387 |
0.375 |
|
| 2013 |
Kanda Y, Oshima K, Kako S, Fukuda T, Uchida N, Miyamura K, Kondo Y, Nakao S, Nagafuji K, Miyamoto T, Kurokawa M, Okoshi Y, Chiba S, Ohashi Y, Takaue Y, et al. In vivo T-cell depletion with alemtuzumab in allogeneic hematopoietic stem cell transplantation: Combined results of two studies on aplastic anemia and HLA-mismatched haploidentical transplantation. American Journal of Hematology. 88: 294-300. PMID 23450467 DOI: 10.1002/Ajh.23392 |
0.5 |
|
| 2013 |
Sawa N, Ubara Y, Sumida K, Hiramatsu R, Hasegawa E, Yamanouchi M, Hoshino J, Suwabe T, Uchida N, Wake A, Taniguchi S, Takaichi K. Direct hemoperfusion with a polymyxin B column versus vasopressin for gram negative septic shock: a matched cohort study of the effect on survival. Clinical Nephrology. 79: 463-70. PMID 23253903 DOI: 10.5414/Cn107584 |
0.333 |
|
| 2013 |
Matsuno N, Yamamoto H, Watanabe N, Uchida N, Ota H, Nishida A, Ikebe T, Ishiwata K, Nakano N, Tsuji M, Asano-Mori Y, Izutsu K, Masuoka K, Wake A, Yoneyama A, et al. Rapid T-cell chimerism switch and memory T-cell expansion are associated with pre-engraftment immune reaction early after cord blood transplantation. British Journal of Haematology. 160: 255-8. PMID 23116322 DOI: 10.1111/Bjh.12097 |
0.354 |
|
| 2013 |
Yanada M, Kurosawa S, Yamaguchi T, Uchida N, Miyawaki S, Kanamori H, Usuki K, Kobayashi T, Watanabe M, Nagafuji K, Yano S, Nawa Y, Tomiyama J, Tashiro H, Nakamura Y, et al. Effect of related donor availability on outcome of AML in the context of related and unrelated hematopoietic cell transplantation. Bone Marrow Transplantation. 48: 390-5. PMID 22941379 DOI: 10.1038/Bmt.2012.159 |
0.459 |
|
| 2013 |
Uchida N, Shimada M, Tasaka M. ERECTA-family receptor kinases regulate stem cell homeostasis via buffering its cytokinin responsiveness in the shoot apical meristem. Plant & Cell Physiology. 54: 343-51. PMID 22885615 DOI: 10.1093/Pcp/Pcs109 |
0.34 |
|
| 2013 |
Kanda J, Ichinohe T, Kato S, Uchida N, Terakura S, Fukuda T, Hidaka M, Ueda Y, Kondo T, Taniguchi S, Takahashi S, Nagamura-Inoue T, Tanaka J, Atsuta Y, Miyamura K, et al. Unrelated cord blood transplantation vs related transplantation with HLA 1-antigen mismatch in the graft-versus-host direction. Leukemia. 27: 286-94. PMID 22806066 DOI: 10.1038/Leu.2012.203 |
0.472 |
|
| 2013 |
Uchida N, Yamamoto H, Taniguchi S. Umbilical cord blood transplantation in adults: Journal of Hematopoietic Cell Transplantation. 2: 1-11. DOI: 10.7889/HCT.2.1 |
0.309 |
|
| 2013 |
Kuwabara H, Ohashi K, Uchida N, Fukuda T, Miyamura K, Mori S, Kato K, Tanaka J, Adachi S, Atsuta Y. Late Relapse After Allogeneic Hematopoietic Cell Transplantation For Hematological Malignancies: A Nationwide Retrospective Study From The Late Complications and Quality-Of-Life Working Group Of The Japan Society For Hematopoietic Cell Transplantation Blood. 122: 4630-4630. DOI: 10.1182/Blood.V122.21.4630.4630 |
0.526 |
|
| 2013 |
Yamamoto H, Kageyama K, Kaji D, Wada S, Nishida A, Ota H, Takagi S, Tsuji M, Yamamoto G, Asano-Mori Y, Uchida N, Izutsu K, Wake A, Yoneyama A, Makino S, et al. Infliximab Versus Rabbit Anti-Thymocyte Globulin As a Salvage Treatment For Steroid-Refractory Acute Graft-Versus-Host Disease After Reduced-Intensity Cord Blood Transplantation In Adults Blood. 122: 4592-4592. DOI: 10.1182/Blood.V122.21.4592.4592 |
0.491 |
|
| 2013 |
Araoka H, Kimura M, Kaji D, Ota H, Ishiwata K, Tsuji M, Yamamoto H, Yamamoto G, Uchida N, Izutsu K, Yoneyama A, Makino S, Taniguchi S. Unrelated Cord Blood Does Not Increase An Overall Risk Of Invasive Fungal Infections Compared To Unrelated Bone Marrow: A Single Center Retrospective Analysis For 749 Recipients Blood. 122: 4541-4541. DOI: 10.1182/Blood.V122.21.4541.4541 |
0.452 |
|
| 2013 |
Nishida A, Kaji D, Ota H, Ishiwata K, Tsuji M, Yamamoto H, Takagi S, Asano-Mori Y, Yamamoto G, Uchida N, Izutsu K, Wake A, Makino S, Taniguchi S. Comparable 2-Year-Overall and Progression Free Survival Among Unrelated Cord Blood Transplantation, Unrelated Bone Marrow Transplantation, and Related Peripheral Blood Stem Cell Transplantation In Adult Patients With Standard-Risk Hematological Diseases; A Single Center Retrospective Analysis Blood. 122: 3400-3400. DOI: 10.1182/Blood.V122.21.3400.3400 |
0.55 |
|
| 2013 |
Yokoyama H, Uchida N, Kakihana K, Fukuda T, Kanamori H, Ogawa H, Nagamura T, Tanaka J, Morishima Y, Atsuta Y, Takami A. Influence Of Donor Source On Relapse and Survival In Patients With Acute Myeloid Leukemia After Allogeneic Hematopoietic Cell Transplantation: A Retrospective Analysis From The Japan Society For Hematopoietic Cell Transplantation (JSHCT) AML Working Group Blood. 122: 3361-3361. DOI: 10.1182/Blood.V122.21.3361.3361 |
0.489 |
|
| 2013 |
Kaji D, Ota Y, Nishida A, Yamamoto H, Ota H, Ishiwata K, Tsuji M, Yamamoto G, Asano-Mori Y, Uchida N, Wake A, Izutsu K, Taniguchi S. Clinicopathological Study Of 12 Cases Of EBV-Associated Post-Transplant Lymphoproliferative Disorder (PTLD) After Allogeneic SCT: A Single Institution Analysis Of 825 Transplants Including 572 Cord Blood Transplants In Toranomon Hospital Blood. 122: 3323-3323. DOI: 10.1182/Blood.V122.21.3323.3323 |
0.521 |
|
| 2013 |
Kakiuchi S, Nishimura H, Ota H, Nishida A, Ishiwata K, Araoka H, Yamamoto H, Asano-Mori Y, Uchida N, Izutsu K, Wake A, Makino S, Yoneyama A, Lim C, Saijo M, et al. Prospective Weekly Surveillance Of Respiratory Viruses Using Viral Culture In First 100 Days After Allogeneic Stem Cell Transplantation Blood. 122: 2050-2050. DOI: 10.1182/Blood.V122.21.2050.2050 |
0.377 |
|
| 2013 |
Uchida N, Kageyama K, Kaji D, Wada S, Nishida A, Ota H, Ishiwata K, Tsuji M, Takagi S, Yamamoto G, Asano-Mori Y, Izutsu K, Wake A, Taniguchi S. A Novel Reduced-Toxicity Myeloablative Conditioningusing Full-Dose Busulfan and Melphalan For Cord Blood Transplantation Provides Durable Engraftment and Remission Without Increasing Non-Relapse Mortality In Advanced Myeloid Malignancies Blood. 122: 2042-2042. DOI: 10.1182/Blood.V122.21.2042.2042 |
0.533 |
|
| 2013 |
Yuasa M, Uchida N, Kaji D, Ota H, Ishiwata K, Tsuji M, Yamamoto H, Yamamoto G, Asano-Mori Y, Makino S, Yoneyama A, Wake A, Izutsu K, Taniguchi S. Prognostic Significance Of The Cytogenetic Evolution After The Hematopoietic Stem Cell Transplantation In Adult Acute Myeloid Leukemia Blood. 122: 1391-1391. DOI: 10.1182/Blood.V122.21.1391.1391 |
0.495 |
|
| 2013 |
Asano-Mori Y, Narita M, Tsuchihashi R, Ota H, Nishida A, Ishiwata K, Tsuji M, Yamamoto H, Yamamoto G, Uchida N, Izutsu K, Yoneyama A, Makino S, Taniguchi S. A Cross-Sectional Analysis of Influential Factors On Health-Related Quality of Life in Long-Term Survivors After Hematopoietic Stem Cell Transplantation Biology of Blood and Marrow Transplantation. 19. DOI: 10.1016/J.Bbmt.2012.11.103 |
0.359 |
|
| 2012 |
Usuki K, Kurosawa S, Uchida N, Yakushiji K, Waki F, Matsuishi E, Kagawa K, Furukawa T, Maeda Y, Shimoyama M, Ago H, Yamano Y, Yano S, Fujishima N, Takamatsu Y, et al. Comparison of autologous hematopoietic cell transplantation and chemotherapy as postremission treatment in non-M3 acute myeloid leukemia in first complete remission. Clinical Lymphoma, Myeloma & Leukemia. 12: 444-51. PMID 22999942 DOI: 10.1016/J.Clml.2012.07.004 |
0.423 |
|
| 2012 |
Uchida N, Shimada M, Tasaka M. Modulation of the balance between stem cell proliferation and consumption by ERECTA-family genes. Plant Signaling & Behavior. 7: 1506-8. PMID 22990445 DOI: 10.4161/Psb.22080 |
0.317 |
|
| 2012 |
Kimura M, Araoka H, Uchida N, Ohno H, Miyazaki Y, Fujii T, Nishida A, Izutsu K, Wake A, Taniguchi S, Yoneyama A. Cunninghamella bertholletiae pneumonia showing a reversed halo sign on chest computed tomography scan following cord blood transplantation. Medical Mycology. 50: 412-6. PMID 22103345 DOI: 10.3109/13693786.2011.631153 |
0.35 |
|
| 2012 |
Fuji S, Mori T, Lee V, Cheng J, Linton N, Lie A, Khattry N, Shigematsu A, Uchida N, Eto T, Thang ND, Liu Y, Yang D, Kim JS, Moon JH, et al. A Multi-Center International Survey Related to the Nutritional Support after Hematopoietic Stem Cell Transplantation Endorsed by the ASIA Pacific Blood and Marrow Transplantation (APBMT) Food and Nutrition Sciences. 3: 417-421. DOI: 10.4236/Fns.2012.33060 |
0.393 |
|
| 2012 |
Asano-Mori Y, Ishiwata K, Ikebe T, Ota H, Nishida A, Tsuji M, Yamamoto H, Uchida N, Izutsu K, Yoneyama A, Makino S, Taniguchi S. Prophylactic Foscarnet and Suppression of Pre-Engraftment Immune Reaction Are Essential to Overcome the Development of HHV-6 Encephalitis From the Experience of 496 Adult Cord Blood Transplants in Toranomon Hospital Blood. 120: 461-461. DOI: 10.1182/Blood.V120.21.461.461 |
0.43 |
|
| 2012 |
Nishida A, Ota H, Ishiwata K, Tsuji M, Yamamoto H, Asano-Mori Y, Yamamoto G, Uchida N, Izutsu K, Wake A, Yoneyama A, Makino S, Taniguchi S. Comparative Outcomes of Reduced-Intensity and Myeloablative Conditioning in Unrelated Cord Blood Transplantation for Adult Standard-Risk Hematological Diseases Blood. 120: 4498-4498. DOI: 10.1182/Blood.V120.21.4498.4498 |
0.507 |
|
| 2012 |
Tsuji M, Ota H, Nishida A, Ishiwata K, Yamamoto H, Yamamoto G, Asano-Mori Y, Uchida N, Izutsu K, Masuoka K, Wake A, Makino S, Yoneyama A, Taniguchi S. Entecavir Is Safe and Effective As Prophylaxis for Reactivation of Hepatitis B Virus in Allogeneic Stem Cell Transplant Recipients with Chronic or Resolved Viral Hepatitis B Infection Blood. 120: 4144-4144. DOI: 10.1182/Blood.V120.21.4144.4144 |
0.319 |
|
| 2012 |
Uchida N, Masuoka K, Ota H, Nishida A, Ishiwata K, Tsuji M, Yamamoto H, Asano-Mori Y, Wake A, Yoneyama A, Makino S, Izutsu K, Taniguchi S. Promising Outcome for Patients with AML-MRC Following Cord Blood Transplantation: Is Induction Chemotherapy Before Transplant Necessary? Blood. 120: 3132-3132. DOI: 10.1182/Blood.V120.21.3132.3132 |
0.533 |
|
| 2012 |
Ishiwata K, Ota H, Nishida A, Tsuji M, Yamamoto H, Yamamoto G, Asano-Mori Y, Uchida N, Izutsu K, Makino S, Yoneyama A, Taniguchi S. Impact of HLA Haplotype Matching On Engraftment in Reduced Intensity Cord Blood Transplantation. Blood. 120: 3043-3043. DOI: 10.1182/Blood.V120.21.3043.3043 |
0.497 |
|
| 2011 |
Uchida N, Wake A, Nakano N, Ishiwata K, Takagi S, Tsuji M, Yamamoto H, Kato D, Matsuno N, Masuoka K, Araoka H, Asano-Mori Y, Izutsu K, Makino S, Yoneyama A, et al. Mycophenolate and tacrolimus for graft-versus-host disease prophylaxis for elderly after cord blood transplantation: a matched pair comparison with tacrolimus alone. Transplantation. 92: 366-71. PMID 21677598 DOI: 10.1097/Tp.0B013E318223D7Ac |
0.415 |
|
| 2011 |
Yamamoto H, Kato D, Uchida N, Ishiwata K, Araoka H, Takagi S, Nakano N, Tsuji M, Asano-Mori Y, Matsuno N, Masuoka K, Izutsu K, Wake A, Yoneyama A, Makino S, et al. Successful sustained engraftment after reduced-intensity umbilical cord blood transplantation for adult patients with severe aplastic anemia. Blood. 117: 3240-2. PMID 21233316 DOI: 10.1182/Blood-2010-08-295832 |
0.491 |
|
| 2011 |
Kurosawa S, Yamaguchi T, Miyawaki S, Uchida N, Kanamori H, Usuki K, Yamashita T, Watanabe M, Yakushiji K, Yano S, Nawa Y, Taguchi J, Takeuchi J, Tomiyama J, Nakamura Y, et al. A Markov decision analysis of allogeneic hematopoietic cell transplantation versus chemotherapy in patients with acute myeloid leukemia in first remission. Blood. 117: 2113-20. PMID 21106987 DOI: 10.1182/Blood-2010-05-285502 |
0.422 |
|
| 2011 |
Kurosawa S, Yamaguchi T, Uchida N, Miyawaki S, Usuki K, Watanabe M, Yamashita T, Kanamori H, Tomiyama J, Nawa Y, Yano S, Takeuchi J, Yakushiji K, Sano F, Uoshima N, et al. Comparison of allogeneic hematopoietic cell transplantation and chemotherapy in elderly patients with non-M3 acute myelogenous leukemia in first complete remission. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 17: 401-11. PMID 20667478 DOI: 10.1016/J.Bbmt.2010.07.013 |
0.46 |
|
| 2011 |
Masuoka K, Uchida N, Ishiwata K, Takagi S, Tsuji M, Yamamoto H, Seo S, Matsuno N, Wake A, Makino S, Yoneyama A, Taniguchi S. What is the upper age limit for performing allo-SCT? Cord blood transplantation for an 82-year-old patient with AML. Bone Marrow Transplantation. 46: 619-20. PMID 20581883 DOI: 10.1038/Bmt.2010.159 |
0.446 |
|
| 2011 |
Ota H, Masuoka K, Uchida N, Kaihori I, Taya Y, Nishida A, Ikebe T, Ishiwata K, Tsuji M, Asano-Mori Y, Izutsu K, Matsuno N, Wake A, Yoneyama A, Makino S, et al. Possible Two Different Mechanisms of Engraftment Failure in Cord Blood Transplantation: Graft Rejection and Poor Graft Function Blood. 118: 651-651. DOI: 10.1182/Blood.V118.21.651.651 |
0.503 |
|
| 2011 |
Nishida A, Ota H, Ikebe T, Ishiwata K, Tsuji M, Yamamoto H, Asano-Mori Y, Uchida N, Izutsu K, Wake A, Yoneyama A, Makino S, Taniguchi S. Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for Secondary Pulmonary Alveolar Proteinosis with Trisomy-8 Myelodysplastic Syndrome Blood. 118: 4705-4705. DOI: 10.1182/Blood.V118.21.4705.4705 |
0.434 |
|
| 2011 |
Hosokawa K, Tsuji M, Araoka H, Ishiwata K, Takagi S, Yamamoto H, Asano-Mori Y, Matsuno N, Uchida N, Masuoka K, Wake A, Makino S, Yoneyama A, Takami A, Nakao S, et al. Clostridium Difficile Infections After Allogenic Hematopoietic Stem Cell Transplantation: Comparison of Cord Blood to Other Grafts Blood. 118: 4573-4573. DOI: 10.1182/Blood.V118.21.4573.4573 |
0.536 |
|
| 2011 |
Uchida N, Yamamoto H, Taya Y, Ota H, Nishida A, Ikebe T, Tainosho S, Kimura M, Ishiwata K, Tsuji M, Araoka H, Asano-Mori Y, Izutsu K, Masuoka K, Makino S, et al. Graft-Versus-Host Disease Prophylaxis Using Tacrolimus + Mycophenolate in Cord Blood Transplantation for Elderly; Impact of Mycophenolate Dosing Blood. 118: 4563-4563. DOI: 10.1182/Blood.V118.21.4563.4563 |
0.518 |
|
| 2011 |
Ishiwata K, Nishida A, Ota H, Ikebe T, Tsuji M, Yamamoto H, Asano-Mori Y, Uchida N, Izutsu K, Taniguchi S. Infliximab Treatment for Steroid-Refractory Acute Graft-Versus-Host Disease After Reduced-Intensity Cord Blood Transplantation in Adults Blood. 118: 4553-4553. DOI: 10.1182/Blood.V118.21.4553.4553 |
0.531 |
|
| 2011 |
Asano-Mori Y, Ota H, Nishida A, Ikebe T, Ishiwata K, Tsuji M, Yamamoto H, Uchida N, Izutsu K, Yoneyama A, Makino S, Kishino S, Taniguchi S. Clinical and Pharmacokinetic Evaluation of Prophylactic Micafungin 150mg Daily Against Invasive Fungal Infections in Cord Blood Transplant Recipients Blood. 118: 1961-1961. DOI: 10.1182/Blood.V118.21.1961.1961 |
0.485 |
|
| 2011 |
Ikebe T, Tsuchihashi R, Asano-Mori Y, Ota H, Taya Y, Nishida A, Tainosyo S, Ishiwata K, Tsuji M, Araoka H, Uchida N, Izutsu K, Masuoka K, Wake A, Yoneyama A, et al. Prospective Weekly Multiple Viral Monitoring in Blood Using Multiplex PCR Assay Early After Hematopoietic Stem Cell Transplantation Blood. 118: 1954-1954. DOI: 10.1182/Blood.V118.21.1954.1954 |
0.379 |
|
| 2011 |
Nakano N, Nishida A, Ohota H, Ikebe T, Shimazu H, Ishiwata K, Araoka H, Tsuji M, Yamamoto H, Asano-Mori Y, Izutsu K, Uchida N, Yoneyama A, Wake A, Makino S, et al. Safety of Liposomal Amphotericin B in Allogenic Hematopoietic Transplantation (HSCT) Recipients Biology of Blood and Marrow Transplantation. 17. DOI: 10.1016/J.Bbmt.2010.12.499 |
0.436 |
|
| 2011 |
Nishida A, Wake A, Yamamoto H, Ishiwata K, Nakano N, Tsuji M, Asano-Mori Y, Uchida N, Izutsu K, Araoka H, Yoneyama A, Makino S, Taniguchi S. Incidence and Clinical Features of Idiopathic Pneumonia Syndrome and Diffuse Alveolar Hemorrhage After Unrelated Cord Blood Transplantation Biology of Blood and Marrow Transplantation. 17. DOI: 10.1016/J.Bbmt.2010.12.479 |
0.38 |
|
| 2011 |
Asano-Mori Y, Nishida A, Ikebe T, Ishiwata K, Nakano N, Tsuji M, Yamamoto H, Izutsu K, Uchida N, Masuoka K, Wake A, Yoneyama A, Makino S, Taniguchi S. Varicella Zoster Reactivation After Cord Blood Transplantation: Comparison With Unrelated Bone Marrow Transplantation Biology of Blood and Marrow Transplantation. 17. DOI: 10.1016/J.Bbmt.2010.12.438 |
0.455 |
|
| 2011 |
Yamamoto H, Matsuno N, Watanabe N, Narita M, Nishida A, Ishiwata K, Nakano N, Tsuji M, Tsuchihashi R, Asano-Mori Y, Uchida N, Izutsu K, Wake A, Nakauchi H, Taniguchi S. Rapid Chimerism – Switch of Lymphocytes and Phenotypic Conversion of Naïve T Cells Early After Cord Blood Transplantation Biology of Blood and Marrow Transplantation. 17. DOI: 10.1016/J.Bbmt.2010.12.234 |
0.413 |
|
| 2010 |
Kurosawa S, Yamaguchi T, Miyawaki S, Uchida N, Sakura T, Kanamori H, Usuki K, Yamashita T, Okoshi Y, Shibayama H, Nakamae H, Mawatari M, Hatanaka K, Sunami K, Shimoyama M, et al. Prognostic factors and outcomes of adult patients with acute myeloid leukemia after first relapse. Haematologica. 95: 1857-64. PMID 20634493 DOI: 10.3324/Haematol.2010.027516 |
0.495 |
|
| 2010 |
Takagi S, Ota Y, Uchida N, Takahashi K, Ishiwata K, Tsuji M, Yamamoto H, Asano-Mori Y, Matsuno N, Masuoka K, Wake A, Miyakoshi S, Ohashi K, Taniguchi S. Successful engraftment after reduced-intensity umbilical cord blood transplantation for myelofibrosis. Blood. 116: 649-52. PMID 20439618 DOI: 10.1182/Blood-2009-11-252601 |
0.518 |
|
| 2010 |
Saito Y, Kitamura H, Hijikata A, Tomizawa-Murasawa M, Tanaka S, Takagi S, Uchida N, Suzuki N, Sone A, Najima Y, Ozawa H, Wake A, Taniguchi S, Shultz LD, Ohara O, et al. Identification of therapeutic targets for quiescent, chemotherapy-resistant human leukemia stem cells. Science Translational Medicine. 2: 17ra9. PMID 20371479 DOI: 10.1126/Scitranslmed.3000349 |
0.305 |
|
| 2010 |
Saito Y, Uchida N, Tanaka S, Suzuki N, Tomizawa-Murasawa M, Sone A, Najima Y, Takagi S, Aoki Y, Wake A, Taniguchi S, Shultz LD, Ishikawa F. Induction of cell cycle entry eliminates human leukemia stem cells in a mouse model of AML. Nature Biotechnology. 28: 275-80. PMID 20160717 DOI: 10.1038/Nbt.1607 |
0.378 |
|
| 2010 |
Nishida A, Yamamoto H, Ohta Y, Karasawa M, Kato D, Uchida N, Wake A, Taniguchi S. T-cell post-transplant lymphoproliferative disorder in a patient with chronic idiopathic myelofibrosis following allogeneic PBSC transplantation. Bone Marrow Transplantation. 45: 1372-4. PMID 20010865 DOI: 10.1038/Bmt.2009.347 |
0.473 |
|
| 2010 |
Uchida N, Kimura S, Koenig D, Sinha N. Coordination of leaf development via regulation of KNOX1 genes. Journal of Plant Research. 123: 7-14. PMID 19506991 DOI: 10.1007/S10265-009-0248-2 |
0.749 |
|
| 2010 |
Wake A, Uchida N, Ishiwata K, Araoka H, Tsuji M, Nakano N, Yamamoto H, Takagi S, Kato D, Matsuno N, Seo S, Asano-Mori Y, Masuoka K, Makino S, Yoneyama A, et al. Clinical characteristics and GVL effects of chronic Graft-Versus-Host Disease (GVHD) following reduced-intensity cord blood transplantation (RICBT) F1000research. 1. DOI: 10.7490/F1000Research.137.1 |
0.445 |
|
| 2010 |
Ito T, Ino K, Nasu I, Minowa M, Furusawa M, Okuno Y, Uchida Y, Tamura H, Hasebe S, Tuji M, Takagi S, Yamamoto H, Mori Y, Matsuno N, Uchida N, et al. Gvhd Prophylaxis Using Tacrolimus Alone Following Reduced-Intensity Cord Blood Transplantation In Adult Patients: Retrospective Analysis Of 39 Patients With Special Attention To Serum Concentration Of Tacrolimus Japanese Journal of Transfusion and Cell Therapy. 56: 359-364. DOI: 10.3925/Jjtc.56.359 |
0.451 |
|
| 2010 |
Nishida A, Wake A, Yamamoto H, Ishiwata K, Nakano N, Tsuji M, Asano-Mori Y, Uchida N, Izutsu K, Masuoka K, Yoneyama A, Makino S, Taniguchi S. Incidence and Clinical Features of Idiopathic Pneumonia Syndrome and Diffuse Alveolar Hemorrhage After Unrelated Cord Blood Transplantation. Blood. 116: 4535-4535. DOI: 10.1182/Blood.V116.21.4535.4535 |
0.443 |
|
| 2010 |
Uchida N, Hidaka M, Sakura T, Miyamoto T, Fujisaki T, Eto T, Maeda Y, Fukuno K, Matsumoto K, Morita K, Kishimoto J, Fukuda T, Teshima T, Taniguchi S, Mori S, et al. Prospective Multicenter Phase II Study of Myeloablative Conditioning Consisted of Intravenous Busulfan and Fludarabine +/− Total Body Irradiation for Older Patients (55 years and older): Results of the JSCT FB09 Study. Blood. 116: 3477-3477. DOI: 10.1182/Blood.V116.21.3477.3477 |
0.517 |
|
| 2010 |
Tainosho S, Masuoka K, Nishida A, Nakano N, Ishiwata K, Tsuji M, Yamamoto H, Asano-Mori Y, Uchida N, Izutsu K, Wake A, Makino S, Yoneyama A, Taniguchi S. Outocomes of Second Unrelated Cord Blood Transplant for Relapse After First Allogeneic Transplant In Adult Patients with Progressive Acute Myeloid Leukimia/Myelodysplastic Syndrome. Blood. 116: 1295-1295. DOI: 10.1182/Blood.V116.21.1295.1295 |
0.551 |
|
| 2010 |
Asano-Mori Y, Shimazu H, Ishiwata K, Nakano N, Tsuji M, Yamamoto H, Uchida N, Masuoka K, Wake A, Taniguchi S. Late Viral Infections After Cord Blood Transplantation: Comparison with Unrelated Bone Marrow Transplantation Blood. 116: 1260-1260. DOI: 10.1182/Blood.V116.21.1260.1260 |
0.411 |
|
| 2010 |
Uchida N, Wake A, Yamamoto H, Yoneyama A, Nishida A, Shimazu H, Nakano N, Ishiwata K, Tsuji M, Asano-Mori Y, Makino S, Masuoka K, Taniguchi S. Rapid Switch To Donor-Type Dominant Chimerism And Early Lymphocyte Recovery Following Reduced-Intensity Cord Blood Transplantation Biology of Blood and Marrow Transplantation. 16. DOI: 10.1016/J.Bbmt.2009.12.364 |
0.436 |
|
| 2010 |
Nakano N, Wake A, Yamamoto H, Shimazu H, Ishiwata K, Tuji M, Mori-Asano Y, Uchida N, Yoneyama A, Makino S, Taniguchi S. Unrelated Cord Blood Transplantation (UCBT) Using Myeloablative And Non-Myeloablative Conditioning For 38 Patients With Adult Acute Lymphoblastic Leukemia (ALL) Biology of Blood and Marrow Transplantation. 16: S216. DOI: 10.1016/J.Bbmt.2009.12.190 |
0.469 |
|
| 2010 |
Yamamoto H, Uchida N, Ishiwata K, Nakano N, Tsuji M, Araoka H, Mori-Asano Y, Wake A, Yoneyama A, Makino S, Taniguchi S. Intravenous Busulfan/Fludarabine-Based Conditioning Regimen Is A Feasible And Effective Option In Unrelated Cord Blood Transplantation Biology of Blood and Marrow Transplantation. 16. DOI: 10.1016/J.Bbmt.2009.12.188 |
0.449 |
|
| 2009 |
Yamamoto H, Uchida N, Ishiwata K, Araoka H, Takagi S, Tsuji M, Kato D, Matsuhashi Y, Seo S, Matsuno N, Masuoka K, Wake A, Yoneyama A, Makino S, Taniguchi S. Possible graft-versus-host disease involving the central nervous system soon after cord blood transplantation. American Journal of Hematology. 84: 764-6. PMID 19760796 DOI: 10.1002/Ajh.21518 |
0.455 |
|
| 2009 |
Takagi S, Masuoka K, Uchida N, Ishiwata K, Araoka H, Tsuji M, Yamamoto H, Kato D, Matsuhashi Y, Kusumi E, Ota Y, Seo S, Matsumura T, Matsuno N, Wake A, et al. High incidence of haemophagocytic syndrome following umbilical cord blood transplantation for adults. British Journal of Haematology. 147: 543-53. PMID 19709082 DOI: 10.1111/J.1365-2141.2009.07863.X |
0.522 |
|
| 2009 |
Sawa N, Ubara Y, Katori H, Hoshino J, Suwabe T, Takemoto F, Uchida N, Masuoka K, Wake A, Taniguchi S, Takaichi K. The long-term survival rate of catecholamine-resistant septic shock in Japanese patients who received vasopressin therapy. Clinical Nephrology. 72: 129-36. PMID 19640370 DOI: 10.5414/Cnp72129 |
0.329 |
|
| 2009 |
Matsuno N, Wake A, Uchida N, Ishiwata K, Araoka H, Takagi S, Tsuji M, Yamamoto H, Kato D, Matsuhashi Y, Seo S, Masuoka K, Miyakoshi S, Makino S, Yoneyama A, et al. Impact of HLA disparity in the graft-versus-host direction on engraftment in adult patients receiving reduced-intensity cord blood transplantation. Blood. 114: 1689-95. PMID 19535797 DOI: 10.1182/Blood-2008-12-194696 |
0.479 |
|
| 2009 |
Kurosawa S, Yamaguchi T, Uchida N, Sakura T, Usuki K, Watanabe M, Yamashita T, Kanamori H, Tomiyama J, Nawa Y, Yano S, Takeuchi J, Yakushiji K, Sano F, Uoshima N, et al. Comparison of Allogeneic Hematopoietic Cell Transplantation and Chemotherapy as Post-Remission Strategy in Elderly Patients with Non-M3 AML in CR1: Retrospective Analysis with 1036 Patients. Blood. 114: 524-524. DOI: 10.1182/Blood.V114.22.524.524 |
0.477 |
|
| 2009 |
Masuoka K, Ishiwata K, Tsuji M, Takagi S, Yamamoto H, Mori Y, Matsuno N, Uchida N, Wake A, Makino S, Yoneyama A, Taniguchi S. Comparative Single Institute Analysis of Cord Blood Transplantation From Unrelated Donors with Unrelated Bone Marrow or Related Peripheral Blood Stem-Cell Transplants in Adult Patients with Acute Myeloid Leukemia / Myelodysplastic Syndrome. Blood. 114: 3382-3382. DOI: 10.1182/Blood.V114.22.3382.3382 |
0.553 |
|
| 2009 |
Tsuji M, Wake A, Uchida N, Ishiwata K, Nakano N, Takagi S, Yamamoto H, Mori Y, Matsuno N, Masuoka K, Makino S, Yoneyama A, Taniguchi S. Impact of ABO Imcompatibility On Acute GvHD and Thrombotic Microangiopathy After Reduced-Intensity Cord Blood Transplantation. Blood. 114: 2298-2298. DOI: 10.1182/Blood.V114.22.2298.2298 |
0.52 |
|
| 2009 |
Kurosawa S, Yamaguchi T, Uchida N, Miyawaki S, Kanamori H, Usuki K, Yamashita T, Watanabe M, Yakushiji K, Yano S, Nawa Y, Taguchi J, Takeuchi J, Nakamura Y, Nannya Y, et al. A Markov Decision Analysis of Post-Remission Strategies in 2029 Patients with AML in First Remission (CR1): Should We Perform Allogeneic Hematopoietic Cell Transplantation in CR1?. Blood. 114: 2281-2281. DOI: 10.1182/Blood.V114.22.2281.2281 |
0.369 |
|
| 2009 |
Saito Y, Uchida N, Tanaka S, Tomizawa-Murasawa M, Suzuki N, Takagi S, Najima Y, Aoki Y, Sone A, Wake A, Taniguchi S, Shultz LD, Ishikawa F. Cell Cycle Entry Potentiates Elimination of Chemotherapy-Resistant Human AML Stem Cells. Blood. 114: 1422-1422. DOI: 10.1182/Blood.V114.22.1422.1422 |
0.414 |
|
| 2009 |
Wake A, Uchida N, Ishiwata K, Araoka H, Tsuji M, Nakano N, Yamamoto H, Takagi S, Kato D, Matsuno N, Seo S, Asano-Mori Y, Masuoka K, Makino S, Yoneyama A, et al. Clinical Characteristics and GVL Effect of Chronic Graft-Versus-Host disease Following Reduced-Intensity Umbilical Cord Blood Transplantation (RICBT). Blood. 114: 1162-1162. DOI: 10.1182/Blood.V114.22.1162.1162 |
0.473 |
|
| 2009 |
Yamamoto H, Uchida Y, Ito T, Uchida N, Ishiwata K, Nakano N, Takagi S, Tsuji M, Araoka H, Mori-Asano Y, Matsuno N, Masuoka K, Wake A, Yoneyama A, Makino S, et al. Oral Beclomethasone Dipropionate Monotherapy as An Initial Treatment for Stage 1-2 Gastrointestinal Tract Acute Graft-Versus-Host Disease Following Unrelated Cord Blood Transplantation. Blood. 114: 1153-1153. DOI: 10.1182/Blood.V114.22.1153.1153 |
0.47 |
|
| 2009 |
Saito T, Katoh T, Matsuno N, Uchida N, Wake A, Taniguchi S, Mizuno K. P-428 Predictors of Pericardial Effusion as Acute Graft-versus-Host Disease of Cord Blood Transplantation Cvd Prevention and Control. 4. DOI: 10.1016/S1875-4570(09)60620-3 |
0.458 |
|
| 2009 |
Masuoka K, Ishiwata K, Takagi S, Tsuji M, Yamamoto H, Matsuno N, Uchida N, Wake A, Taniguchi S. Outcomes of A Second Reduced-Intensity Unrelated Cord Blood Transplantation Following Graft Failure Biology of Blood and Marrow Transplantation. 15: 110. DOI: 10.1016/J.Bbmt.2008.12.338 |
0.441 |
|
| 2009 |
Taniguchi S, Masuoka K, Wake A, Uchida N, Matsuno N, Takagi S, Yamamoto H, Tsuji H, Ishiwata K, Yoshimi M, Mori YA, Makino S, Araoka H, Yoneyama A. Reduced-Intensity Cord Blood Transplantation for Adult Patients with Acute Myeloid Leukemia/Myelodysplastic Syndrome Biology of Blood and Marrow Transplantation. 15: 50. DOI: 10.1016/J.Bbmt.2008.12.155 |
0.45 |
|
| 2008 |
Uchida N, Wake A, Takagi S, Yamamoto H, Kato D, Matsuhashi Y, Matsumura T, Seo S, Matsuno N, Masuoka K, Kusumi E, Yuji K, Miyakoshi S, Matsuzaki M, Yoneyama A, et al. Umbilical cord blood transplantation after reduced-intensity conditioning for elderly patients with hematologic diseases. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 14: 583-90. PMID 18410901 DOI: 10.1016/J.Bbmt.2008.03.003 |
0.485 |
|
| 2008 |
Yamamoto H, Kato D, Uchida N, Ishiwata K, Takagi S, Tsuji M, Araoka H, Yoshimi M, Narita M, Sagawa K, Matsuno N, Masuoka K, Wake A, Yoneyama A, Makino S, et al. Reduced-Intensity Unrelated Cord Blood Transplantation for Adult Patients with Severe Aplastic Anemia Blood. 112: 4408-4408. DOI: 10.1182/Blood.V112.11.4408.4408 |
0.497 |
|
| 2008 |
Takagi S, Ishiwata K, Tsuji M, Yamamoto H, Kato D, Seo S, Matsuno N, Uchida N, Masuoka K, Wake A, Makino S, Yoneyama A, Taniguchi S. Voriconazole Is Safe and Effective as a Prophylactic Regimen of Invasive Fungal Infections for High Risk Patients after Reduced-Intensity Umbilical Cord Blood Transplantation Blood. 112: 4355-4355. DOI: 10.1182/Blood.V112.11.4355.4355 |
0.524 |
|
| 2008 |
Uchida N, Yamamoto H, Matsuno N, Ishiwata K, Tsuji M, Takagi S, Araoka H, Kato D, Yoshimi M, Seo S, Masuoka K, Wake A, Narita M, Sagawa K, Yoneyama A, et al. Pre-Transplant Conditioning Using Intravenous Busulfan Is a Feasible and Effective Option in Reduced-Intensity Cord Blood Transplantation. Blood. 112: 3273-3273. DOI: 10.1182/Blood.V112.11.3273.3273 |
0.53 |
|
| 2008 |
Ishiwata K, Yamamoto H, Takagi S, Tsuji M, Kato D, Araoka H, Yoshimi M, Narita M, Sagawa K, Matsuno N, Uchida N, Masuoka K, Wake A, Yoneyama A, Makino S, et al. HHV6-Associated Limbic Encephalitis after Reduced-Intensity Umbilical Cord Blood Transplantation. Blood. 112: 2208-2208. DOI: 10.1182/Blood.V112.11.2208.2208 |
0.442 |
|
| 2008 |
Taniguchi S, Wake A, Masuoka K, Uchida N, Matsuno N, Takagi S, Yamamoto H, Tsuji M, Ishiwata K, Mayumi Y, Sagawa K, Narita M, Makino S, Araoka H, Yoneyama A. Reduced-Intensity Unrelated Cord Blood Transplantation in Adult – a Single Center Analysis of 318 Transplants. Blood. 112: 1970-1970. DOI: 10.1182/Blood.V112.11.1970.1970 |
0.542 |
|
| 2008 |
Wake A, Uchida N, Ishiwata K, Takagi S, Tsuji M, Yamamoto H, Yoshimi M, Narita M, Sagawa K, Araoka H, Kato D, Matsuno N, Masuoka K, Yoneyama A, Makino S, et al. Single Institute Analysis of Reduced Intensity Cord Blood Transplantation from Unrelated Donors for Adults with Advanced Lymphoid Malignancies. Blood. 112: 1963-1963. DOI: 10.1182/Blood.V112.11.1963.1963 |
0.495 |
|
| 2008 |
Seo S, Uchida N, Yamamoto H, Takagi S, Tsuji M, Kato D, Matsuno N, Masuoka K, Wake A, Taniguchi S. 375: The Analysis of Chronic GVHD after Cord Blood Transplantation in Comparison with Bone Marrow Transplantation Biology of Blood and Marrow Transplantation. 14: 137. DOI: 10.1016/J.Bbmt.2007.12.385 |
0.461 |
|
| 2008 |
Yamamoto H, Wake A, Ishiwata K, Tuji M, Takagi S, Kato D, Matsuhashi Y, Sea S, Matsuno N, Uchida N, Masuoka K, Yoneyama A, Taniguchi S. 138: Characteristics of 11 Cases of Pre-Engraftment Lymphocytosis after Reduced-Intensity Cord Blood Transplantation Biology of Blood and Marrow Transplantation. 14: 52-53. DOI: 10.1016/J.Bbmt.2007.12.147 |
0.431 |
|
| 2008 |
Wake A, Uchida N, Ishiwata K, Takagi S, Tsuji M, Kato D, Yamamoto H, Seo S, Matsuno N, Masuoka K, Miyakoshi S, Makino S, Yoneyama A, Taniguchi S. 134: Clinical Characteristics of Early Onset Non-Infectious Pulmonary Complications following Cord Blood Transplantation Biology of Blood and Marrow Transplantation. 14: 51. DOI: 10.1016/J.Bbmt.2007.12.143 |
0.4 |
|
| 2007 |
Uchida N, Townsley B, Chung KH, Sinha N. Regulation of SHOOT MERISTEMLESS genes via an upstream-conserved noncoding sequence coordinates leaf development. Proceedings of the National Academy of Sciences of the United States of America. 104: 15953-8. PMID 17898165 DOI: 10.1073/Pnas.0707577104 |
0.752 |
|
| 2007 |
Miyakoshi S, Kami M, Tanimoto T, Yamaguchi T, Narimatsu H, Kusumi E, Matsumura T, Takagi S, Kato D, Kishi Y, Murashige N, Yuji K, Uchida N, Masuoka K, Wake A, et al. Tacrolimus as prophylaxis for acute graft-versus-host disease in reduced intensity cord blood transplantation for adult patients with advanced hematologic diseases. Transplantation. 84: 316-22. PMID 17700155 DOI: 10.1097/01.Tp.0000269796.23593.16 |
0.494 |
|
| 2007 |
Miyakoshi S, Kusumi E, Matsumura T, Hori A, Murashige N, Hamaki T, Yuji K, Uchida N, Masuoka K, Wake A, Kanda Y, Kami M, Tanaka Y, Taniguchi S. Invasive fungal infection following reduced-intensity cord blood transplantation for adult patients with hematologic diseases. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 13: 771-7. PMID 17580255 DOI: 10.1016/J.Bbmt.2007.02.012 |
0.505 |
|
| 2007 |
Narimatsu H, Kami M, Miyakoshi S, Yuji K, Matusmura T, Uchida N, Masuoka K, Wake A, Hamaki T, Yamashita S, Yoneyama A, Taniguchi S. Value of pretransplant screening for colonization of Pseudomonas aeruginosa in reduced-intensity umbilical cord blood transplantation for adult patients. Annals of Hematology. 86: 449-51. PMID 17256143 DOI: 10.1007/S00277-007-0260-3 |
0.416 |
|
| 2007 |
Saito Y, Yoshida S, Saito N, Fukata M, Ozawa H, Doi T, Miyamoto T, Ohshima K, Uchida N, Taniguchi S, Akashi K, Harada M, Shultz LD, Ishikawa F. Human AML Stem Cells Remain Quiescent and Exhibit Chemotherapy Resistance within the Bone Marrow Endosteal Region. Blood. 110: 780-780. DOI: 10.1182/Blood.V110.11.780.780 |
0.407 |
|
| 2007 |
Seo S, Uchida N, Ishiwata K, Tsuji M, Yamamoto H, Takagi S, Kato D, Matsuno N, Masuoka K, Atsushi W, Taniguchi S. The Analysis of Chronic GVHD after Cord Blood Transplantation in Comparison with Bone Marrow Transplantation. Blood. 110: 5092-5092. DOI: 10.1182/Blood.V110.11.5092.5092 |
0.539 |
|
| 2007 |
Takagi S, Ishiwata K, Tsuji M, Yamamoto H, Kato D, Matsuhashi Y, Kusumi E, Seo S, Matsuno N, Matsumura T, Uchida N, Masuoka K, Wake A, Miyakoshi S, Yoneyama A, et al. Bloodstream Infection after Reduced-Intensity Umbilical Cord Blood Transplantation Versus Other Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation. Blood. 110: 4981-4981. DOI: 10.1182/Blood.V110.11.4981.4981 |
0.518 |
|
| 2007 |
Wake A, Uchida N, Ishiwata K, Takagi S, Tsuji M, Kato D, Yamamoto H, Seo S, Matsuno N, Masuoka K, Miyakoshi S, Makino S, Yoneyama A, Taniguchi S. Clinical Characteristics of Early and Late Non-Infectious Pulmonary Complications Following Cord Blood Transplantation. Blood. 110: 4945-4945. DOI: 10.1182/Blood.V110.11.4945.4945 |
0.456 |
|
| 2007 |
Uchida N, Nishida A, Shimazu H, Nakano N, Ishiwata K, Tsuji M, Yamamoto H, Asano-Mori Y, Masuoka K, Wake A, Yoneyama A, Makino S, Taniguchi S. Comparative Single-Institute Analysis of Cord Blood Transplantation from Unrelated Donors with Unrelated Bone Marrow or Related Peripheral Blood Stem-Cell Transplants in Elderly Patients with Hematologic Diseases after Reduced Intensity-Conditioning Regimen. Blood. 110: 2011-2011. DOI: 10.1182/Blood.V110.11.2011.2011 |
0.549 |
|
| 2007 |
Masuoka K, Miyakoshi S, Ishiwata K, Tsuji M, Takagi S, Yamamoto H, Kato D, Matsuhashi K, Seo S, Matsuno N, Uchida N, Wake A, Yoneyama A, Taniguchi S. Comparison of Outcomes of Bone Marrow and Umbilical Cord Blood Transplants from Unrelated Donors in Adult Patients with Acute Myeloid Leukemia/Myelodysplastic Syndrome. Blood. 110: 2010-2010. DOI: 10.1182/Blood.V110.11.2010.2010 |
0.53 |
|
| 2007 |
Ishiwata K, Uchida N, Yamamoto H, Takagi S, Kato D, Seo S, Matsuno N, Masuoka K, Wake A, Miyakoshi S, Yoneyama A, Taniguchi S. Incidence of Adenovirus and BK Virus Reactivation and Diseases Following Reduced-Intensity Cord Blood Transplantation for Adult Patients. Blood. 110: 1073-1073. DOI: 10.1182/Blood.V110.11.1073.1073 |
0.521 |
|
| 2007 |
Uchida N, Wake A, Takagi S, Yamamoto H, Kato D, Matsuhashi Y, Seo S, Matsuno N, Masuoka K, Yoneyama A, Miyakoshi S, Taniguchi S. 342: GVHD prophylaxis with tacrolimus offers low early mortality and better survival after reduced-intensity cord blood transplantation in elderly patients (≥55 years) Biology of Blood and Marrow Transplantation. 13: 124. DOI: 10.1016/J.Bbmt.2006.12.347 |
0.472 |
|
| 2006 |
Seo S, Uchida N, Yamamoto H, Matsuno N, Matsuhashi Y, Takagi S, Kato D, Masuoka K, Wake A, Miyakoshi S, Taniguchi S. Reduced-Intensity Cord Blood Transplantation in Adult Patients for the Recurrence after Allogeneic Transplantation. Blood. 108: 5346-5346. DOI: 10.1182/Blood.V108.11.5346.5346 |
0.532 |
|
| 2006 |
Matsuhashi Y, Takagi S, Yamamoto H, Kato D, Matsuno N, Seo S, Uchida N, Masuoka K, Wake A, Miyakoshi S, Yoneyama A, Taniguchi S. Prophylactic and Preemptive Anti-Fungal Therapy after Cord Blood Transplantation: A Retrospective Analyses of 188 Adult Patients. Blood. 108: 5320-5320. DOI: 10.1182/Blood.V108.11.5320.5320 |
0.378 |
|
| 2006 |
Uchida N, Fukuda T, Wake A, Kim S, Masuoka K, Mori S, Miyakoshi S, Tanosaki R, Takaue Y, Taniguchi S. Durable Engraftment with Minimal Toxicities after Allogeneic Hematopoietic Stem Cell Transplantation with a Reduced-Intensity Regimen Incorporating Fludarabine and 8 mg/kg Busulfan. Blood. 108: 5246-5246. DOI: 10.1182/Blood.V108.11.5246.5246 |
0.539 |
|
| 2006 |
Matsuno N, Wake A, Uchida N, Takagi S, Kato D, Matsuhashi Y, Seo S, Masuoka K, Miyakoshi S, Matsuzaki M, Yoneyama A, Taniguchi S. Impact of Human Leukocyte Antigen Compatibility on Engraftment in Adult Patients Receiving Reduced-Intensity Umbilical Cord Blood Transplantation Using Calcineurin Inhibitor Alone for GVHD Prophylaxis. Blood. 108: 3147-3147. DOI: 10.1182/Blood.V108.11.3147.3147 |
0.479 |
|
| 2006 |
Yamamoto H, Uchida N, Matsumura T, Takagi S, Kato D, Matsuhashi Y, Seo S, Matsuno N, Masuoka K, Wake A, Miyakoshi S, Yoneyama A, Taniguchi S. High Incidence of Cytomegalovirus Reactivation and Diseases Following Reduced-Intensity Cord Blood Transplantation for Adult Patients. Blood. 108: 2846-2846. DOI: 10.1182/Blood.V108.11.2846.2846 |
0.423 |
|
| 2006 |
Miyakoshi S, Masuoka K, Kato D, Takagi S, Kawano T, Matumura T, Matuhshi Y, Uchida N, Wake A, Taniguchi S. Tacrolimus as prophylaxis for acute graft-versus-host disease in reduced intensity cord blood transplantation for adult patients with advanced hematologic diseases Biology of Blood and Marrow Transplantation. 12: 37. DOI: 10.1016/J.Bbmt.2005.11.114 |
0.467 |
|
| 2006 |
Uchida N, Wake A, Takagi S, Kato D, Kawano T, Matsuhashi Y, Kusumi E, Matsumura T, Masuoka K, Miyakoshi S, Taniguchi S. Hematopoietic stem-cell transplantation from unrelated umbilical cord blood in elderly patients (>54 years): Older age is no longer a contraindication when using reduced-intensity conditioning Biology of Blood and Marrow Transplantation. 12: 9. DOI: 10.1016/J.Bbmt.2005.11.032 |
0.464 |
|
| 2005 |
Sieburg HB, Cho RH, Dykstra B, Uchida N, Eaves CJ, Muller-Sieburg CE. The hematopoietic stem compartment consists of a limited number of discrete stem cell subsets. Blood. 107: 2311-6. PMID 16291588 DOI: 10.1182/Blood-2005-07-2970 |
0.406 |
|
| 2005 |
Matsumura T, Kami M, Kusumi E, Myojo T, Takagi S, Kato D, Yuji K, Uchida N, Masuoka K, Wake A, Miyakoshi S, Morinaga S, Kanda Y, Taniguchi S. Reactivation of Cytomegalovirus Following Reduced-Intensity Cord Blood Transplantation for Adult Patients. Blood. 106: 5454-5454. DOI: 10.1182/Blood.V106.11.5454.5454 |
0.472 |
|
| 2005 |
Uchida N, Miyakoshi S, Matsumura T, Yuji K, Takagi S, Kato D, Kawano T, Kusumi E, Masuoka K, Wake A, Taniguchi S. Reduced-Intenisty Unrelated Cord Blood Transplantation for Patients with Advanced Malignant Lymphoma. Blood. 106: 5453-5453. DOI: 10.1182/Blood.V106.11.5453.5453 |
0.531 |
|
| 2005 |
Kawano T, Matsumura T, Takagi S, Kato D, Yuji K, Uchida N, Masuoka K, Wake A, Miyakoshi S, Taniguchi S. Cord Blood Transplantation for Adult Acute Lymphoblastic Leukemia. Blood. 106: 5450-5450. DOI: 10.1182/Blood.V106.11.5450.5450 |
0.479 |
|
| 2005 |
Wake A, Kato D, Takagi S, Kawano T, Kusumi E, Matsumura T, Narimatsu H, Yuji K, Masuoka K, Uchida N, Miyakoshi S, Taniguchi S. Reduced-Intensity Cord Blood Transplantation (RICBT) Is a Feasible Approach for Advanced Adult T-Cell Leukemia (ATL). Blood. 106: 5448-5448. DOI: 10.1182/Blood.V106.11.5448.5448 |
0.523 |
|
| 2005 |
Miyakoshi S, Yuji K, Kusumi E, Kato D, Takagi S, Uchida N, Matsumura T, Masuoka K, Wake A, Taniguchi S. Comparison among Related Peripheral Blood Stem Cell Transplantation (R-PBSCT), Unrelated Bone Marrow Transplantation (U-BMT), and Unrelated Cord Blood Transplantation (U-CBT) with Reduced Intensity Regimens for Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS). Blood. 106: 5441-5441. DOI: 10.1182/Blood.V106.11.5441.5441 |
0.444 |
|
| 2005 |
Takagi S, Miyakoshi S, Oota Y, Kato D, Kawano T, Kusumi E, Matsumura T, Yuji K, Uchida N, Masuoka K, Wake A, Yoneyama A, Taniguchi S. Reduced-Intensity Unrelated Cord Blood Transplantation (RICBT) for Myelofibrosis (MF). Blood. 106: 5437-5437. DOI: 10.1182/Blood.V106.11.5437.5437 |
0.447 |
|
| 2005 |
Miyakoshi S, Yuji K, Kusumi E, Kato D, Takagi S, Matsumura T, Uchida N, Masuoka K, Wake A, Taniguchi S. Invasive Fungal Infections in Reduced Intensity Cord Blood Transplantation (RICBT). Blood. 106: 3226-3226. DOI: 10.1182/Blood.V106.11.3226.3226 |
0.46 |
|
| 2005 |
Yuji K, Miyakoshi S, Takagi S, Kato D, Miura Y, Narimatsu H, Kusumi E, Kishi Y, Matsumura T, Kobayashi K, Hamaki T, Uchida N, Kami M, Masuoka K, Murashige N, et al. Reduced-Intensity Unrelated Cord-Blood Transplantation (RI-UCBT) for Patients with High-Risk Myeloid Malignancies. Blood. 106: 2891-2891. DOI: 10.1182/Blood.V106.11.2891.2891 |
0.546 |
|
| 2005 |
Masuoka K, Miyakoshi S, Takagi S, Kato D, Kusumi E, Matsumura T, Yuji K, Uchida N, Wake A, Taniguchi S. Hemophagocytic Syndrome (HPS) Post Reduced Intensity Cord Blood Transplantation (RI-CBT) in Adult Patients with Hematological Diseases. Blood. 106: 2743-2743. DOI: 10.1182/Blood.V106.11.2743.2743 |
0.471 |
|
| 2004 |
Uchida N, Dykstra B, Lyons K, Leung F, Kristiansen M, Eaves C. ABC transporter activities of murine hematopoietic stem cells vary according to their developmental and activation status. Blood. 103: 4487-95. PMID 14988157 DOI: 10.1182/Blood-2003-11-3989 |
0.371 |
|
| 2000 |
Uchida N, Taniguchi S, Harada N, Shibuya T. Myocardial ischemia following allogeneic bone marrow transplantation: possible implication of tacrolimus overdose. Blood. 96: 371-372. DOI: 10.1182/Blood.V96.1.371.013K56B_371_372 |
0.414 |
|
| Show low-probability matches. |